var title_f2_14_2272="Basic case 5 with answer";
var content_f2_14_2272=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Sinus bradycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 79px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Marked sinus bradycardia at a rate of 25 to 30 beats/min. The normal P waves (upright in lead II) and PR interval and consistent with a sinus mechanism with normal atrioventricular (AV) conduction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ary Goldberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2272=[""].join("\n");
var outline_f2_14_2272=null;
var title_f2_14_2273="Percutaneous transtracheal ventilation stopcock";
var content_f2_14_2273=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Percutaneous transtracheal ventilation via three-way stopcock",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 300px; height: 444px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG8ASwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKM0UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABmiiigAoopKAFooooAKYJoicCRD9GFYHj/UzpXhS+ljz50i+TFt67m4z+HJ/CsbwHpy2OmJI5YsE6tQB3QIPQg0teHfFDxBPp4kewu5recdCjlSDXJ/Dz4w69pl55PiOSTVdOkb7zACaL3B43D2P50rgfTtFUdE1Wz1vTINQ06US20wyrYwfcEdiKvUwCiikzk/SgBaKKKACiiigAooooAx/F/iC18K+GdR1zUI55LSxiMsiQAFyM44BIGee5FeMf8ADVfgf/oFeJP/AAHg/wDj1egfH7/kjXiz/ryP8xR8Af8AkjXhP/ryH8zQB5//AMNV+B/+gV4k/wDAeD/49R/w1X4H/wCgV4k/8B4P/j1e/wBFAHgH/DVfgj/oFeJP/AeD/wCPUf8ADVfgf/oFeJP/AAHg/wDj1e/0UAeAf8NV+B/+gV4k/wDAeD/49R/w1X4H/wCgV4k/8B4P/j1e/wBFAHgH/DVfgf8A6BXiT/wHg/8Aj1H/AA1X4H/6BXiT/wAB4P8A49Xv9FAHgH/DVfgf/oFeJP8AwHg/+PUf8NV+B/8AoFeJP/AeD/49Xv8ARQB4B/w1X4H/AOgV4k/8B4P/AI9R/wANV+B/+gV4k/8AAeD/AOPV7/RQB4B/w1X4H/6BXiT/AMB4P/j1H/DVfgf/AKBXiT/wHg/+PV7/AEUAeAf8NV+B/wDoFeJP/AeD/wCPUf8ADVfgf/oFeJP/AAHg/wDj1e/0UAeAf8NV+B/+gV4k/wDAeD/49R/w1X4H/wCgV4k/8B4P/j1e/wBFAHgH/DVfgf8A6BXiT/wHg/8Aj1H/AA1X4H/6BXiT/wAB4P8A49Xv+aKAPAP+Gq/A/wD0CvEn/gPB/wDHqP8AhqvwP/0CvEn/AIDwf/Hq9/qG7uIrS0muZ2CRRIXdjxgAZNAHjVh450/4rrY3WgxXsFlaSt5kd3GqsZMAA/KzDGD6969EuSun6KByG25PFcz4IvYdXv59QkuoXmuJC+0SA4XPA69hipfiRqP2a2do2IULtIHSkM8S+KOom61MxxSjae1cmXSy0trmQbkhjMrFOWKgZ4p+pS/b9TdnG5QSG4610/wQsYNO+Imn6XqbE6azGbTppOnmgZEBPr1Zc9cYpvYk6Lwr+0n4F0Hw9Y6Yml+I2+zxhWYW0GGbqx/13c5rW/4ar8D/APQK8Sf+A8H/AMer3+igZ4B/w1X4H/6BXiT/AMB4P/j1H/DVfgf/AKBXiT/wHg/+PV7/AEUAeAf8NV+B/wDoFeJP/AeD/wCPUf8ADVfgf/oFeJP/AAHg/wDj1e/5ooA8A/4ar8D/APQK8Sf+A8H/AMeo/wCGq/A//QK8Sf8AgPB/8er3+igDzD4X/Gvw58R9fuNI0Oy1eC5htWu2a8ijRCiuikArIxzlx29a9PrwDwb/AMnk+O/+wLH/AOgWde/0AcB8fv8AkjXiz/ryP8xR8Af+SNeE/wDryH8zR8fv+SNeLP8AryP8xR8Af+SNeE/+vIfzNAHf0UUUAFFFFABRRRQAUUUUAFFFHegAooooAKD0oooAKKKKACiiigApKUUUAFeT+Ii3iz4iTafNJJLomlqkL224iOac/MxYD720FRg8A5r0nXtSi0bRb7UrjmO1haYju2BnA9z0rgvg/pcy6adQ1EZvLqR7mYnrvc7j/PFAHX3OkaTb2Swf2ZZbFHCiFQB+leY+N/C1jcQSfYLy7092HKLIZIj9UY/yxXp+sTgZySB615p4uvNkEm4k8468GgZ4ZLaT6HftBf4aJmwtwnKN9fQ/WvoT4feBbXUPhtPbassiS6qROJIztkgKnMToezKQGB9a4/wLpcerzXH22JJrWRcOrgEEfSvYfh4ksfheBXmaW2V3W0Lj5hADhAT34HB9MUibFTwF4gvLtrvQPEZVPEulbVuCF2rdxH/V3MY/uvjkD7rBlOOK7CuR8feHrvUFtNa8OssXibSt0lozHCXCH79tL6o4A5/hYKw6c6vhLxDZ+J9Dh1Kx3x7iY5oJRtkt5VOHikXsynII/HoRTGbFKaKKAAUUUUAFFFFAHgHg3/k8nx3/ANgWP/0Cyr3+vAPBv/J5Pjv/ALAsf/oFnXv9AHAfH7/kjXiz/ryP8xR8Af8AkjXhP/ryH8zR8fv+SNeLP+vI/wAxR8Af+SNeE/8AryH8zQB39FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAJUN9cpZWNxdSK7RwRtKyou5iFGSAO546VOaSgD531T4xeHfHuhLZnVv7Cja4SSRLiykm3ojZCkqcDJAP4V6P4R8UW9zZrFpN/oupqRkCG4MUhH+4w4rgfiX8BI7zULnV/Bbw20szGSXTpPljZu5jbouf7p49x0rxOV7XS7UylvMuo38sohxhgefmHH5UWA+rPEGsmGNjf2N9ZoP+WjR748eu5cgD64ry3xXqSXjKtpPHNDKQoMbbgPfiqPw08dakziziubgO/ASdvMjI/HpXot3oOj+Iisl5Yrp+pg7heWQ2HP8AtL0b8aWoFXQrCWz0FLeAkXd4y2sbKehc4J/AZP4V7BaW8dpaw28K7YokCKPQAYFefeGYbm18TWFrrIh8uCFzZ3EfCXEp4PB+6wQHjPOTjpXopOKYBXMx+H00nxdeeIbO+WzsbuAnUrVwPLkkQDZcA5+RgoKsejDGeVzXTmuN+MHhy/8AFvw113Q9ImWK/u4VERZtoYq6sUJ7bgpX8aANnw94p0HxJ5//AAj+safqXkECUWs6yFM9M4PAPrWzXiTaDrOteK5fEFz4Uv8ARbCy8PSaW1lDcxLc3kpIKpE0bkKqYG1yRzg464wJdM8Z6D8MPEmpeK76+i8S6W1pqVtfve7reZIlQiABSOeHRwQN7MDlqAPoyivmbxE2o6J4c8Gap4wvrqa21AX2p39muqrauLmVVeELvkQlYwwGxW4PIB6VVTw34613wx4SvGk165sJNDjVGs5/9It7syM3mlXni5KlMOS2AMY9QD6jorwGbwb4wlvrnWJP7ZOrQ+I7SW2/4mDBPse2MTHyw/l4Pz5GM8YHHX36gDwDwb/yeT47/wCwNH/6BZ17/XgHg3/k8nx3/wBgWP8A9As69/oA4D4/f8ka8Wf9eR/mKPgD/wAka8J/9eQ/maPj9/yRrxZ/15H+Yo+AP/JGvCf/AF5D+ZoA7+iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAEopaQUAeVftC+L00Pwk2iWc3/E41kGCNFPzJCeJHPoMfKPc8dDXznqFkqXFnpsCgpboGYDoXIyc/SvQ/i3FBqnxp1KW5YiHS7KBCd2OSpfA/wC+q5fw/pFzeXLOk3lzSMWy43KST0IoEdB4R8L2VzFdahO01q1rHuWe3bYVftkdD+Nen/C+41XxL4bF6JtPZ4biS2kDRspJQ9cg9wQeB3rzrxVrE3h/w82nXtusMxXeZYHzHJ/UH2NevfAnTk0/4XaKy/6y8RryQ+rSMW/lgfhQM6KDSbqZoxqL2xiikWVVhVs7lOQdx/wrSu5v9KtbdeWdix9lH/18VbFct4S1H+3tW1jU4ubKGc2Fs3ZxH/rHHsXJH/AaAOpooooA4L4k/Eqy8DX2mWd1Yyzy3yu6SPPFbQqExkGWVgu7kYXP5VXvvifpMdhrMlzpt08em3lpZTR/u2DtcBCpHzYIG8Z+nGa6Dxd4J0bxaVGsi+ZPLMMkdvfTQJNGTkpIqMA4z61kaj8JvB1/qUl7JpssUshgLJBdSxREw4EZMasFyAoHTp9TQBlw/FTTr7UrWC50C+Swm1C502G9lMTIbmHcSAoYsAQpwxA5/OsfVPjObjwpd3mn6Re6bc3Oi3Gq6VPdmKRJvK+8CqMSCCQcHqPSt3wt8J9N0i4u76/nlv8AUWu7y6tXeWTybYzk5KwligcBsFgATUfg/wCDmg6P4YXTtVM+p3b6c2mzXElxKQIWOWWJWYiIE8kLigB3/C17KzurbSb+xu31qUaesMSBR9rN0ud8eT91Cr7icYxXpneuFufh5aXHxH0DxMzwiDRNOaztbfyyX3kkBmcnkKpIAx1JOa7ugDwDwb/yeT47/wCwLH/6BZ17/XgHg3/k8nx3/wBgWP8A9As69/oA4D4/f8ka8Wf9eR/mKT4A/wDJGvCf/XkP5ml+P3/JGvFn/Xkf5ij4A/8AJGvCf/XkP5mgDv6KKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK5b4l622heDr6aA/6bOBa2oHUyyfKpH0yW/4DQB886hN/ber6/qCNvOq6lKYzt/5YR/Ihz7hRXd+GdHisLJ7qcoFjTc2T6CpNB8DXVlBbNFEfssEaoGGDnHU/ieal+J+oQ+HfDMFqCPOuBuIPXYP/r0gPNzb/wDCwvidpmiESfY3kMt1g9IU+Zh+PC/jX1fDDHBDHDAixxRqEREGFVRwAB2FeD/st+H3aHWfFl2h3XkhtLQn/nkpy7D2LYH/AAA11H7QnjW48DeH/D2oWtw8KvrdulysYBaS3Ad5FGfUKB+NAG38ZfFj+EfBNxNYgyaxfOthp0S/ee4k4XH0GW/DHet3wToMfhjwnpWjxkN9kgVHcfxv1dvxYk/jXinhzxJp/wAVfi3L4onuorfwX4OjH2R7phEstzJwJm3dANpIzgjanQkivoVWV1VkIZSMgg5BFMB1FJS0AFFFBoAKKSloAO9FFFAHgHg3/k8nx3/2BY//AECzr3+vAPBv/J5Pjv8A7A0f/oFnXv8AQBwHx+/5I14s/wCvI/zFHwB/5I14T/68h/M0fH7/AJI14s/68j/MUfAH/kjXhP8A68h/M0Ad/RRRQAZooooAKKKKACiiigAooooADRRRQACiiigAooooAKKK5Tx94qHhrTvtMD20sltLby3kLt86WjyiN5QBz8uSc9PlNAHV15b8U4tTPi3w/JFbLqVkNwisklWN1l/ikJbgjaQB6c+tepVwukSrrfiu/wBXYBrS0Bt7c9QQp+Yj6tn8qAKV/wCN10uJtP1vRdQ0UFf3dxKUlhb23Ixx+IFfPfxD1K88Ta7Z6VaS/aLi7nS2tyGyBvbA/Dmu7+L+rvq2vw6bbsWDsN6g5wK6nwL8HYNP8Z6f4snvAI4Yd0GnLDhUkKbd5YnnqTgAc4pAeqeGdGtvD3h/T9IsVxb2cKwrxjdgcsfcnJPua+Wv20tUl1Hxb4X8N2UUk08UDTiOIFmkeZwiKFHJb93wOvzV9cVytl4D0K18d6h4va3a4127VEE07bhbqqBMRDHy5A5PXk84JFMDxH4H/s6xad9m1zx/GlxeAiSHSThooj2MvZ2/2eg75zgfS4AAwBgD0paSgBaKQdKWgAooooAMUlKKMUAJS0lL3oA8A8G/8nk+O/8AsCx/+gWde/14B4N/5PJ8d/8AYFj/APQLOvf6AOA+P3/JGvFn/Xkf5ik+AP8AyRrwn/15D+Zpfj9/yRrxZ/15H+YpPgD/AMka8J/9eQ/maAPQKKQ00sRQA+iomkI9qQytnjBoAmoqDzmHYZpDcgcFT+FAFjvRUC3MRJG7B9xUysrD5SD9KAFooooAKKKKACiiigAooooAK85+JmmQS+I9BmuSI7PVorrw7eMByUuIy0fPtJEAPd69G7Vy/wAS9NudT8FaimnK7ajbBb2zCLuYzwsJUAHqWQD8aAOH1P4lweHPhDpd3rDXB1uWFrFoIk3zebCTHPIV7KpRmJPAyPUV02pTW3hXwakMbhd0edy/TrXl+h3f2zxfNqa+H/7E8L+J7uTStRt7qPN5NLPE22RySfKBcbdikDLEnkjGJ4l8S3194P0vQpiV1Oxd9LvMHP7yBvLJ/EAH8aQF34UaVJ4p8Zy6hcKzwRvksx6qK+lwAAABgDgCuF+D/h5dD8KwuybZpwGOeuO1d3TASilFBoASiiloAKKKKACiiigAopKKAFooo70AeAeDf+TyfHf/AGBY/wD0Czr3+vAPBv8AyeT47/7Asf8A6BZ17/QBwHx+/wCSNeLP+vI/zFJ8Av8AkjXhP/ryH8zS/H7/AJI14s/68j/MUnwB/wCSNeE/+vIf+hGgDvj0pvbNPIpp6UAR4I6k4prYFPbk1GxOfWgY08c+tRP065zTi2egpmc884oAhYZHB5pm8qcDIb1FPx8v+FRLjPQ47igCtcJOuXsbt7eUcnjfGfqp/piqr+Kr7SwDrelSyW/e704GZQPVo/vj8N1XjndgA4qN2K45PFAGlomv6TrsRk0jULe7A5ZY3+ZP95eq/iBWpXnmseG9I1W5jur6zC3icJcwMYpl+jqQ1VoLDxRpC/8AEo8UNdQgfLBrMAn/APIqbX/PNAj0yivOY/GHi6ywNS8KW98nebTL9ckeoSQKf1q5D8TtGj/5DFprGjHOM31i4TP++m5f1oA7qiqGkazpmsQ+dpOoWt7H/eglV8fXB4q+aACsjxVqn9k6LNOnM7YihX1duB/j+Fa9cVfMfEHjFbdSTY6Xy57NIev5Dj8aAOa+IFhJpnwd1BIZCuqIq38Up+950TrKG+pKfrXCeIvCXiHVfEl94v8ACCaZFpesafDrNu12+5hN5QLxJEOWdgqsScDk962vjfr0t3NDpVhKAZW8sqOeKZoHgG08E+G/DvieSe7mv9Pv7dRLdztILezlfyXiRc4VAJi3TtSGe36DfQ6noenX9qNtvdW8c8Y9FZQQPyNXq474TEQ+EBpZcu+j3dzppJ67YpWCf+Q9h/GuxpiClpKKAFopKBQAoryz43eI/FXhGzg1nQbu0XT42ijkt5rBpULNJtZ5Zw48qMKy4O08g+1ekwahZ3F9dWUF3by3lqENxAkitJCHBK71ByuQCRnrg4rnfE/w78L+KdTS/wBe0v7ZcKqIQ1xKsbqhLKHjVgj4JP3gaAIvEnxA03R7bV/It7+9u9Ntnu3iSzmSN0Rd7bZynlH5eeGOelc3D8adHu9YOnafZXNxNLd2draMGAW588HLr6CMqwb6V6hPBFPbSW80avBIhjdCOCpGCMemK5TR/hr4R0efQ5tO0aOGXRBKLBvNkYw+aSXzuY7sljjdnGeMUAcxZ/GCO68Tz6NFock7mK8ezltbpZluWtwSyZA2hiB2ZsEgHFb/AMPPiLYeO7m4XRraX7Nb2ltcTXDMNqyzKW8n3ZQPm7CiHwN4M8I3D+Jo7E2R0xLm6843M7x26OC0xWLcVUEZOFX6Cl+EHhKx8JeEFj067jvhqM76lJdxweQsxlwVKpk7VC7QBntQB24ooooA8A8G/wDJ5Pjv/sCx/wDoFnXv9eAeDf8Ak8nx3/2BY/8A0Czr3+gDgPj9/wAka8Wf9eR/mKT4A/8AJGvCf/XkP5ml+P3/ACRrxZ/15H+YpPgD/wAka8J/9eQ/maAO/NMPT2pxprHg0ARnAOOcUw5B44qTg5rFm1xLXXE0+8sbq3gmYRQ3r7fKlkxnYMHI4zgkAEgigZpsM1Gw44bFSyfL7fSoSCeDke9ADHIA+9+ZqvITjcBxnmrBxz0NRMSDjj1JoAxde8QadoUumRalcGObUrgWtsioWLufp0Hqavyj5iSQCD0rz7x3uu/jT8PrQqGhgjuLkn0OOP1Ar0K4IFxkkbW6DFAETZI75Pr2qFgUxzkngZqUyclWP0JqJs7e+OwNADdzhQAMDtTDIRgMT06noacWPVh970FQYDY3N0NAGPqPhrSr1xM9ksV0DkXFsTDKD7OuDUFvceMvD77tN1KLxDZAZFlqWI7gL/sTqOT/ALwP1rek4cH5sE4xioZSdxIHb8qAJLT4j2F9ZTwG2u9N1xUIWwvYirFumVYZV1z3B6VLFs8M+E5p55R58imSRz1JPJ/Ws3RbY6z4jVzxaWPHI4Ld65f4w6499fQ6HYn97MwXb6LSEYPgPS5fGPjN9RmGbcPuyRjAHWvc/GejjWPBesaTEgzcWckMQ9G2nYfwODXB/DnVtM8M6pB4dvreS0ubtAba7kx5U794gezDqAevavWTQgOX8BWM0VlcatcCSGbWvIvp7R49ht5jBGjr+JTJ98109LRTAKSlrifEXjOeTVZvD/gq1i1bxBGP37uxFpp+ejXDjv3Ea/McdhzQBseLfFeleFraGTU5ZHuLl/LtbO3Qy3Fy/wDdjjHLHkZ7DuRXn/x38L+IfEp0aTw9ZXd2bZJmMHnRC3LsF2+bG8iE9Dh1YleflOa7Lwj4Lg0S7l1bU7uXWfEtwmyfU7lQGC9fLiQcRR552r+JJ5rq+aAPnuf4b+KoNS8XS6dYfZdS1bRrSK11G21A+VBPHFtniwz+Yd54ViDgc5BzWZ4j0XXNA0+GVtLvtK0jUPE+kx2WhJqIeUAKyzASK+1fNbH8Y6ZOK+mKKAPn628B+KodL0v7bpFxeaFHrF9dyeGU1JQ8dvIiiBPMLhG8tg7bd+P3nfFJq3gTxdc6x5tjpdzbPImm/wBlXR1YONDSIjz4nBbdIWw3Khg27k8V9BUUAeC6l4I8QzN4xivfD1zqer6gupiz1saoixiGW3kSGHymcEcsqbSuwE7t3FdL8FvDvibw7d6jD4stmneS1tBbX6zqUjRIVU2oiDEoUYH5gMP1JzXqtJQAtFFFAHgHg3/k8nx3/wBgWP8A9As69/rwDwb/AMnk+O/+wLH/AOgWde/0AcB8fv8AkjXiz/ryP8xSfAL/AJI14T/68h/6EaX4/f8AJGvFn/Xkf5ik+AP/ACRrwn/15D/0I0Ad8elNNOPSmnpQAwgc+9Y9xoVpISUnvYpN28Ms7NtbscNkfpWw3Soz+dAzmDfa9ocrf2zAmr6WTxeWUe2eIf8ATSL+ID+8n/fNbNhqNlqtmLnTLqC7tycb4m3YI6g+h9jVxSQ3y555rnNW8Mq95Jqfh64/sjWW5aREzDcH0mj6N9eGHrQBtPvwdpAzzzUDKxHzH8RWDoHih7zVJdD16ybS9eiUsIid0V2g/wCWkD/xD1HUd639rl+Pu88HtQBxPjfbYeP/AALq8wTyWnn013I6NLHmP/x5cfjXWXOUJXBznk+9cF4luLrx9fQaN4aWNdL0+8jubvWJV3RmWI7lihH8RyMMw4ArVuPE2s2ruuq+D9SlKHBm02SOdH/2gCQ2PYigDoMllBZQCDj60cqORxjGK5U/EHQonX+0YdY05jni806VAPxCkVpaf4w8MakMWWuafIzcbGlCN+TYNAGkVZVwAMDvUeB17jrVpUEkYaIqyHoVORVcIY3IGMg9xQBEUYsWLYz2rO1ac21sdnMzHZGM8ljWngngdc9ap6Lbrq/iEyZY2tiSPmHBbufw6UAX90fhnwo0kuBNIpZj3rynwWkmsa3e63fB2QNtjB6fWtb4s662r6zFoNjuLMw3begWtrStOj0zTIrZT0HJx3pMRDr9ha63ZSWd7GXikIK4OGVh0ZT2I7Gt34b+LriS5/4RnxNL/wATmFSbW4bgX8I/iH/TQD7w/H1xkTDDkZIxzyKyNc0lNZshA0ssF3DIJba6i4e3kHKupoA9yqO6uIbS2luLuaOC3iUvJJIwVUUckkngAeteXeGfirDa2b6Z4yR4fEtvhIoLeMudTzwrW6jqxPBXsfQdNq38Naj4ruotQ8dIkdijB7bQI3Dwxkch7hhxM/8As/cXtuPNMCs+pax8QS0Ph6a50bwqRiTVwuy5vQe1sCPkTH/LVhk5+UfxV2fh7Q9N8OaVFp2i2cVpZx9EQdSerMTyzHuxJJ71pAADAGAKQ0AFLSUtABRRRQACiiigAooooAKKO9FAHgHg3/k8nx3/ANgWP/0Czr3+vAPBv/J5Pjv/ALAsf/oFnXv9AHAfH7/kjXiz/ryP8xSfAH/kjXhP/ryX/wBCNL8fv+SNeLP+vI/zFJ8Av+SNeE/+vJf/AEI0Ad+aYeRTz0pnHfpQAwjHU/jUZ5Ht0qRjyOaZnJoGRNxTWyD06cA089+uKY4AHWgDK8Q6PZa9Zpbaijgo/mQzxNslgfs6OOVIrl9X0zxXFpr6dLOmt6XKdsskTi2vjH3TP3GyOCRtOK7eTPTPPrUf3eOvNAHK2/ivQNJsoLCe1u9CihGxIbmzZI4wOwZQV/HNX7LxFot6M2euadNgdEuEz+IzWy8rcDIZT1BGazLnR9JmffcaZYSSE53NbqT+eKAIp/EGkW523GsWC/79wv8AjWDc614G1e6SznvNCvLiRtgikCMWY9ByK6OLTrCEKIbGzQL02wr/AIUzUNK0zVLKe01Kyt5beVCHDRjj3B7EetAHOTfD7Q4ZS+li80eYkEvp9y8Q/wC+clf0qtd2/jLRcNp13aeI7ZetveAW9xj0Ei/Kx+oFN+FWry3/AIQtre8a5klh80W9zOuPtNushVJAe/AAOf611xHzLyTn2oA5X/hJbq5t5Yn0TU9PvGG1BcIuxm/2WBOcda6K8mh8I+DWMjATMhJJ9TXP2niCwvvEdxO9tql1ZaY5gaW2sZJYxKPvjKg5I9q5Hx34mh8b6/aaZpE3m2O/5yAR0/hIIyPoaAJ/h9ZS3t5e65fJ+8lciIt1x2xXabmL4YDp1zWDetqvh+KOSy09NR0iOMedbw8XMRHV1HRx7cGr2nappeq6U2q2V/C1lGGM0jnYIuOQ4P3SPekxFiX5lwqksDwMdTXIeIvFLxam2i+F7VNS18kCUZIgsgf4pnHQ/wCyOTUU2qap42Zrfw1LLpfh/ftl1oria4A6rbKeg7eYfw6Vr6XpFh4e042GkwLBbqS7Pnc8j/3nY8sx9TQBxuqeG5NE0y78Q3N5LfeK7Ei8XUZONhQ58uNOipjIx3zzX03pd4uoaXZ3sYIS5hSZQewZQR/Ovnb4hSXDeGGsrYM9/qsqWFtH3d5Dj+Wa+idLtF0/TLSzQ5S3hSEH1CqB/ShAWqDRQfr1pgFFFFABRRRQAUUUdqACiiigAooo70AeAeDf+TyfHf8A2BY//QLOvf68A8G/8nk+O/8AsCx/+gWde/0AcB8fv+SNeLP+vI/zFJ8Af+SNeE/+vIf+hGl+P3/JGvFn/Xkf5ik+AP8AyRrwn/15D+ZoA73B3Ek8dhUFzdwWqF7lxGg6swOB9TVg008ggjINAESPHNEssEiyxtyHQhgfxFIc4rLbQI7W4e50OT7BO5LSRqMwSn1ZOx9xg/WqR8WabBqjaXrU8Wn6ioB2vIDEwPTD9BnsGwaBm6TyfamP1/DipimQCpyp5BHQ1C/3jnrQBG2QOefWoyAhyTkdalx2zwOaifnO0HPf2oAhb5V92qOUjHPNSkZ6HjpSBD1I4xkkmgCuVIb/AArlfiTqJtNEj0u0nEWqa04sbfnlA3+sl9cIuTn6UuqeNYXun0vwjbHxDrK8MID/AKPbE95ZegA9Bk8Unh3wpcWmqv4g16/Go+JZI9iyquIbRf8AnnCp6D1J5P40AdDpXhlI9Ls47HfbJZWyWdoJRktCuOXHYtj6jj6Via9q9zo5SzTTrmXW7giOzt0Qukrn+Lf0CDqxOMCuz0/WDJMLe7hdJNwTzVGUZiM4/wBn8am8RR2baRczajbrPBbxtMVI5+VSePegRD4a01NB0S0sZrhJJwC0spwvmysdzsB7kk47CvPJhYeIviFcaxoqQfZbOKSxuJ48f6VOGHYdQnI3d8kdBXO+JvCHhq0bTbXVdNie/wBQtJtR1W+ctNJb26bcxQBidhZ5EjXHbPfFJrHhiDT1tPD/AIf8DaZb6pdR/uJrCeRZtKDZCTzzhfmwRkrkk7SBuFIDp/EXiGw8MaebzV5SrudkEMa75rh+gSNByxP/AOuvO9S8Dan4tvJte1VLfRZnKPBowG+KfadwN5jh2PoOnvzW98OdKSW1l1vX5pdR8XRTS2N3cXOD9maJyhjiUDCLxngZOc+1dbOdxP7wbj0yO9AzjG8cRWAWDxVpt3otyn7slIWktiBxlGUdPbtUMnjXw/czpb6bdTarevzHaWcDySuR2AxXYzHzYQCxYZOcjj8q5rxFYxXNqZ7A/YdUtQZLO7gAV45AM9R1U9CDwQaBHT/DrwXqk+ux+KfGECW1zChTTtNDB/swbrI5HBkI446D36dr438YaR4L0c6hrc7De3l29tCu+e5kPSOJOrMTj2GeSBzWJZ/EOyt/hZpnizVgxkuoIwttAu6S4uW+UQxL1ZmcEAenJ4BNU/Afgq+l1tvGfjwx3PimdSLa1Db4NIhPSKLsXx96TucgcZLMDMt9G8efEJRd+I9UuvBmgygNDpOlOBfsvYzXBHyHodijocMARVsfAb4csWa48PtczPy8019cO7n1J8zr9K9QozQB5feeBNa8IwtffDTV7wiEA/8ACP6pctcWc6j+CN3JeFzkkNuxkAHAya6j4eeM7HxtoZvrOKa0u4JGt72xuF2zWk68NG49vXv7HIHUV5X8RPD2teH/ABEPH3gS3N1fqixazo68f2pbr0Zcf8tkH3T1IGBn7jgHqdLXO+BvGWh+N9Fj1Lw9epcRkDzYiQJbdjn5JE6qeD7HGQSMGuioAKKKKACig0dKACgUUUAeAeDf+TyfHf8A2BY//QLOvf68A8G/8nk+O/8AsDR/+gWde/0AcB8fv+SNeLP+vI/zFJ8Af+SNeE/+vIfzNL8fv+SNeLP+vI/zFJ8Af+SNeE/+vIfzNAHfnpTQM04+lczrN5f6vNPpPh25Fq8ZCXeobA/2fP8ABGDw0mPXhc5OTxQBS8W+JroakPDXhNFuPEUyBpJWXdDp8Z/5ayn1/up1Y+1X9C8LaZo2hyaY0QvxcEvez3aiR7uQ/eeTPUn06AcCr2haLY6BYG002LaGYvLK53STOerux5Zj6mrrGgZwc/gG602UzeB/Et7oQzk2Mqi7sz7CNzlP+AkfSkk1b4h6YgW/8LaTrqjrNpl95DH32Sj/ANmNdyeT16Ux3IYYBoA4D/hY14j7bz4f+MIXHB8u1SVc+xV+frTR8RLueRksPAHi6R+n762SFc/Vm4rv/OYMQG49jUbuxbhuTQB5xceLvF81ylr/AGDpHhfzGCx3GuXu8SZ7KIxgt7FhWvF8OLjV2EnjfxHfa1HnIsbcfY7THoUQ7n/Fvwrp76GG8tntr6GKeCUbXilUMrD3BrnrSw1DwmWfw40t/pIJL6VPJloxj/l3dun+4xx6EUAbd34J0WS0SDT4ZNI8sBUk0tzbMAPXbwfxBrH/AOEE1iOTNt451sJ2WaGCXH4lBW94a8X6N4iBSxuTHdocSWdypinjI6go3P4jI966CgRx+gLNoGvS6ZqVzPeG9WOS3upFAMrqpEgIUAAjapx6H2q94gGrm2uIfs8N1ZXKmBlgys0IYbd/Jw4GckcHHTPSnJMb/wAaSRLkwaXbjcexml7fUIv/AI/VrxNqp0nTS8Efn30zCG1gzgyyt0H0HJJ7AE0AedeJ4v7cgivZLW6a9srWTTdWs7Zd1zbgtHIs8Sf8tArxKwxncrHGSMVd8M/FLSpo5V1LX9J1KVf9VHpNtO9wQPvNJBhnjx3Hbnmu1j0C1ns7UaxHFf3sSANcyINxbvg9hnPFVV8G6LaNJPollb6PfvybuxhSORj/ALeB849mzQB5bI6+HG1bxFosq694K1S7kv7ma2+efTZnwZCyDlo+5GNyc5GBmt22ure+tYbzTp47qzmXck0Z3KQfQitHULZLTWoLq6uYdA8TSYjW+jXFnqYHRJVJwWPYEhx/CxArC8T+Ebnwys/irw2kWnoMyaroolAtrgD70sJ4CSY56AN3APUAlmkD8ncCeBn1rC8V6pb6H4d1HUbt1WOKFsFjgFiMKB6kkip/FPizQ/D+iRatqNw3kTRCWCID95ICMjCn6jrVbwD4K1L4jajZ+KvHtobXQICJdL0Jx/rT/DNcDuPRT17/AC8MgLvwS8OXuv2HhzX9fspLTSNHtAmiafN1eRh+8vXX1bJCA5wvzAchj7jRSUwFpKMY6UtABQKOvWigDgPFnwn8MeItVOrpHeaNrp5/tTR7g2tx3ySR8pJzgsVJx3rEb4U+IYTssPil4sjt/wC7cOs7/wDfZwf0r1qkFAHkk/wmlht5LnUviZ8QCEG5mh1XylH4bTVezGp/DD4g6HpU+t694h8O+IY5YUOpz/aZ7a8jAZcPgfK6/KF9QT0rsviJJLfPovh2z3GbU7xHnIz+7tYWEkrE9s4VB7yCuZ+IzN4p+JXg3QNCuBJd6HqCaxqhUbo7WFVIVXPaR8kKvXBLEYwaAOl/4S7VLPUrZde8M3GnaXdTi3ivRcxzGN24TzkX/VhjgAgsASAcZrszVLWrS1v9HvrTUP8Aj0mheObnGEIIJz2471x3wL12bxD8LdCu727e6v0h8m4eT/WblOBv9yu1snrkHvSA740neilpgeAeDf8Ak8nx3/2BY/8A0Czr3+vAPBv/ACeT47/7Asf/AKBZ17/QBwHx+/5I14s/68j/ADFJ8Af+SNeE/wDryH8zS/H7/kjXiz/ryP8AMUnwC/5I14T/AOvIf+hGgDp/F2pS6T4cvbu2AN1tEcAPQyuwRP8Ax5hSeGbaKy0tbS2JaGAmNpWHzTSZ/eOT3y2fxzS+LtIl1zQLiytrkWtyWSSGYrvCOjh1JHcZUVc0y1NjpltatJ5jxIA7gY3N3OPc5oAnY4qNutPOc1T1G/t9PSNrl23StsijRSzyN6ACgZNz260w42kE8+prmP8AhMjd3E8OgaHqGri3JWeWFo0iRh1QOzAM49Fzjua1NB12w1+AtYyOlzEB59nOvlzwH0dDyP5HtQBe5xlgM0yUhDkjPFSOCDyc1BIS5OSeKAGFwVy3Pc00nBBB5PbNOcHOM49BWB4u1hdHs4QJGSe4fYrLGZGUf7KjksegHqfagCxrWlWGr2vlalZRT7TlHIw6H1Vhyp9waz5YfEHhu1lvdK1VtQ0+3QyPY6mdx2DkhJ/vA46btwrUsmYadHLNDJbfLuZJmBdR/tY715r4y0XUPF/jS/tNO8R6ta2UNvFE0NrdeXFvILEYAIPBXOfWgD1nwNBKuhf2hewmC91OQ388bHJjLgbUJ/2UCr+FN8Ozx+ILptdUFrRS8NgSeGTOGlA/2iOD/dA9a8L+JXjTxr4Fsm0bxFeHVNGv4xDLqIt1iuoUbhwjIQjnbnqAwJzXsngbxfpWow2WnW5jgWS3WXTyo2x3Vvj5THnuo4ZOox6UCO0pKWigCC+s7a/tZLW+t4ri3kG14pUDKw9wa5C78DeCNItbjUb/AEuzjtYIy7vdOzxwqOSVDkhfwArp9d1fT9B0m51PWLuKzsLZd8s0pwqjp+JJIAA5JIA5rnLCA+NfseqapaXNto8T+daWFyuxp2B+WaZO2OqoenBIzgAA4jwj8OtL8S+IE8TX+itYaLE/madp9yzvLckdLicOSVH9yLoOp54r2miigBKWiigAo6CiigAFFFFABSA5Jpaq6nLJHZy+SH3lTyi7ioxyQO59B60AcP4l1HXvEusT6F4MZNOt4P3Wo+IJEDmE9TBbr/HJ03MflT3bAGZo/iPwV4DEnhrwsl9rushzJdQabGb26mmLYeW4l+6H3dS7DHoBgUh8O+JPGcCafd/aPCXgxAVNlDIP7Q1AHJPmuuRCjE8qCWbLBiM8eg+GvDukeGNKj03QNOt7CyjxiOFcbjgDcx6s2AMsSSe5pAchf2fjnxhZPbXMlr4Q0ydSkywsLu/dDwVD8RxEjuN5HY0+bwqmivaReB7+LTtbsrGK2Fvd5aG/giUKgmAwSR08xfmGcHI4r0Gs7WNGsdYWAX0JZ7eQSwyoxSSJh3VlII9D6jg0Acd/ws6202FofFuk6hoOqr8ohmjMkEzYz+6uFBRh9Sp9RTtJ1/xb4l0u4vtDtdHskVisC36TsJ+AchgEIXnGQp6cZr0DoK5O68WyWPjrTPDt9YKi6oszWk0dwHc+Uu5jJHj5VxwGyeeOM0AeMfCi81G//av8Z3GtacNN1A6OEmtRKJQpX7IuVYAZVgAw4HDCvpOvAPBv/J5Pjv8A7Asf/oFnXv8ATA4D4/f8ka8Wf9eR/mKT4A/8ka8J/wDXkP5ml+P3/JGvFn/Xkf5ik+AP/JGvCf8A15D+ZoA740h6c049KbQAxsVk6zoOna1PbS6jC8j227yysrJwwwwO0jIOBkGtZutRt0zQMjt44rW3S3tYo4IIxtSONdqqPYCsjxD4d07W2jnuBLbahEMQ31q5ini+jDqPY5HtWwR6UyTONpxQByLXnibw/kalbDxFpi9LqyQJdoP9uLo/1Ug+1a+h61pniC3Nzo14lwqna6fdeM+jocFT7EVqElcYPSsHW/DenatdregS2OrIMR6haHy5V9iejD2YEUAasmCOc5zXJQ6dfXXxAvNR1CHGnWsaCybcDvYrg4HbGW6+tSHWr/QiIPF0Km2yAmr2qHyW/wCuqDJjPqeV9x0roVkWeCOe1ljmgcbkkjIZWB7gigCG6uo7W3nupyDFCjSOSOwGTXOfDnTjFo8mpXCjz7xmu5COPmc5A/AYH4UnxAhl1LSbXRIW2HVbhYpJAeVjX53/ADC4/GsT4keIbvSjpWg+GY5pNXvP3UAUfIOgJfPGB1PT60AUtctbb4ieLpdK1CH7R4d0giS9UkqJrgj5IgRzhQSxx6gV193oemSaPbaSlkkGn2yBLdYSVNvjoyN1Uj1BzTfD2hQ+G9Fh063cyuWaW4mf700zHLOfcn9MVoOD5bLn6HNAGHaeJNT8GanY2+t3z6p4bu5ltUvJwPtFnIxwgkYcOhPG48jPOa9H1zVrDQtJutU1e6jtLC1QyTTSHCqP6knAAHJJAGTXivxqvLHTvAMqapcpbpfXUECuwJ2gOGZsDk4VSeK2tK0XUPinrNp4g8W2k1l4Qs5BNpOhzjD3TDpc3S+n92P354zvBE3hfT7/AOJWs2vizxRay2nhu1fzdC0aYcue15OvQuR9xeig5HXc3rFFFABRRRQAUUUUAFFBpD7UALRRRQAlLRR2oAKKKKACsvxPr+m+GNCu9Y1u5W2sLZd0jkZPXAAHUkkgADqTWpXnPju2XVfir8P9OvCrafB9t1TyXAKy3EKRrEfqnmsw+lAFe2h8c+OkM95czeCvD8ozHawKrapMhzzI7ArAcbTtUFhyCRXUeE/A+g+FZ57rS7Rm1G4XbcX91K09zN0zukclsEgHAwMjpXTUCgDwDwb/AMnk+O/+wLH/AOgWde/14B4N/wCTyfHf/YFj/wDQLOvf6AOA+P3/ACRrxZ/15H+YpPgD/wAka8J/9eQ/maX4/f8AJGvFn/Xkf5ik+AP/ACRrwn/15D+ZoA7e8u4LNN91IsUf99+FH49qzp/E+g25/fazp6EjIBnXP862SAVwQCD2NRLa26nKwRA+oQCgDLtfEmhXcnl22s6fJJ2RbhN35ZzWlsyuVIYH05qrqWh6TqiFNS0yyu19J4Ff+YrBl+H2kRHfos+o6JNnIbTrpkX/AL9nKEf8BoA6Nw2Mcioz1zj9a5ZrTx5o2Wtr7TPElsMnyruP7HcH0AdMoT9VFRp8QtMtZhb+KLK98NXbHaDqEf7hj/szrmMj8RQM6puoz0qP5d/zcDuafA8d1Ck1pLFcwuMrJCwdT9CKY6P6Y/CgDjLW08X6zq97PrF/HomjRytFbafZqkstxGOBJJIwOM9doHTrQngi1sGlfQtT1LS55OWELq0TH1MRBX8gK69YpSxG0k1T1S6j0bSbzVL8bba0iaV+OcAZx9TQIxPDsUv9s399rN6l3Fo8H2YTNGIl3n55GIHAwNg/OuX8O6wl94/N7rmnSWk+oxn+wp3wY5IAPmH+zI33sH+HFYemnRdJgNz458T/ANl3GtB9U1DT3vdiyIx/dp5X3jwMHHULisDxX8SfDvj/AMVabpOk2fiO/wBH0stdA6JZs11NOBtQxg42KuScnrjGO9AHuM0bFiFXJDYGe9cv4y8caJ4UljtblpdR1qchbfR7BfOuZWPQbB90e5/DPSuc0rwj8VvFoMWt+IbjwxoBb5YwYpNRlTII3PGAqEjPOcg9VNepeAvh34b8Dwt/YdiPtsoInv7g+bczk4yWkPPJAJAwuecUDucX4M+HWp674hj8XfE+K3e9gP8AxK9Eibfb6evB3Oejy578gYzz8oT2KjtmqyTvcE+QuIwceYw4b6DvQIs0VD5jC4SPgjaST3Hp/WpqACkBzS0CgAFFFFABSUtFACUtJS0AFFFFABR2oooAK5D4g6Fd3x0fW9GRZNa0O5NzBGSB9ojZSk0OTwNyHg/3lWuvNIKAKumX0GpWcdzbFtjjlXXayHurA8gjuKt00KFJKqAScnA60ooA8B8G/wDJ5Pjv/sCx/wDoFnXv9eAeDf8Ak8nx3/2BY/8A0Czr3+gDgPj9/wAka8Wf9eR/mKT4A/8AJGvCf/XkP5ml+P3/ACRrxZ/15H+YrO+Clpe3HwZ8KfYtSezb7EORCkg6n1FAHqFFcLf+G/HEzH7J4+jtl7A6JE5H5tWX/wAIZ8RmY+Z8VZAp7R+H7Vf1JNAHp1FeYTfC7Vr8Z1f4leMnf1sZ4rMfkiUw/A7wreLjxFdeIPETDo2q6tNIR/3wVFAHbax4v8N6LL5WseINIsJcZ8u5vI42/JiDXF33xp+H908+nWl9NrtwQVNnYafNcmX2GE2t+eK2tI+FPgPSYVjs/CejkKchri2Wdwf96Tc3612VvDFbwrFbxpFEowqIoUAewFAHz5LZx6nJJeeBPhl400e8Zv3ji9TRVP8AwBnZSPolXrLwr8a7qRT/AMJZYaNZN0imdb24jHu3kqrH8a95ooA8a/4VH4q1KUHxJ8VfENzFj/V6fELL9VZgfyrC134Y6ZpOt6Ho0PiPxTfq0x1C7iv9TMkKwRnJ3RhQDufAB9jX0A7rGjO7BVUZJJ4A9a8y8Fwt4i1y+166UkalJuhDfwWURxEMdt7Zb8TQBrJ8NfCepam+u634esb7V7pV817tPOAAACrsbKjCgDgdq7HT7K1060jtdPtoLW2jGEhgjCIo9lHAqxTWkVfvHn0oAdRUKzM5+WJwPVuKVHZQPP2KzHA2nNAEeo25u7Ce3V9jSIVDehqm8mrMiRQWtrC2AGleQsq/RQMn8SK1HdUUs7BVHUk4ApkM8U6kwyJIBwSrA0AQafZLZxvmR5ppDuklfq5/oPQVb70UlAC0UUUAFFFFAB2pKWk7UALSUUUALRSFgo5IFRGXJwOlAEpNFMB4608UAGaKKWgBB1pe9JSigDwDwb/yeT47/wCwLH/6BZ17/XgHg3/k8nx3/wBgWP8A9As69/oA4D4/f8ka8Wf9eR/mKT4A/wDJGvCf/XkP5ml+P3/JGvFn/Xkf5ik+AP8AyRrwn/15D+ZoA9AooooAKKKCQBzwKACiobi6gtlzcTRxD/bYDNRw3RnYmKF/KH/LRvlB+g60AWqaWVcbiBn1rNF5PdRl7UhUBZCNmWDDt6VlNr9hpQjGp3NpFd7f33m3IaUH2Vcn8qTaW5UISqPlgm35alL4kan51pB4cs5Wjv8AWCYi20jZbjBmkz04Xj6sK09Ma20bRTdOqQo6qIo2YLiNRhFGfbn6mvNb7xXLfvc+I7eCO/ju5zp2lRMDD/oqHM8pzk/Mw2547cVX1PxP4o1T715b6bGRgJZQjfj/AH2yR+GKzlVjHzPSwmU18SnK6ir218t9Fd/geo2WpvdQvfarINPtIz8qM+xGHqztjP0GB9azdQ+JPhixdo11GG4kH8FqGnJ/FRj9a8fl0eK8l869ee9uO8t3K0rfqasR2Cp8kUQRR1wMCsXXm9kezSyDCx/i1HL0SX5836HoE3xcsMj7PpGqOCerqkf9TUB+KGlzDddaLqW5cjh1bH/jwrgjbkk8c9B7U37OeQBzWftqnc7f7Hy+3wP72eg2fjnwlJlJZtU01WkEoF2jvFu/NgB7cCuzsZbe/i+2W7Wd9A3AurBvm/EAnP5/hXhstqSBvAPHANV7azuNNuzeaPdT6ber/HbtgN3wy9GHsRVxxE18SOWtkGFqL9zNxfnqv0a/E+g0lvYgs1u66hZnqo+WRfUg9D9ODXnHifxJ4v0rXJtVsry1m8MSsqxGSDdFAejJMQBJGd2fm5AyM+gTw/8AESeGWKHxOiWUxGE1GIf6LMT081eqHp8w457Cu9EMc9+JUtmMd4uy6jAEkE8ZXh89OmB7g4I6Vs2qq912PEVOpldb/aKalF6a6prvF9H+K6op+GvHFlqlymn6jG2l6wyhhazsCsoP8UUg4kH059q66vI9K0SzFxr3hPVIFvdO06ZJLLzckxRSruVA3UFeRnOcYq/Bo+s6cAmh+Kr6CEHi3vo1u1A9AzfMB+NKFSVtVc0xOCw7m/ZS5dnrdqzV1Zq7Wj2adv5mem0VwCP4zIwdb0bPqNPfP/ozFTRWniCVWF/4mfHdbSzjjx+LbjWnP5HG8GlvUj/5N/8AIncHAGTwKrS39pEyq9xGGJwAGya5eLSIPvXU13eyetzOzD/vnOP0rUt4o4hiONEA6BRindmUqUF1ua73Ea9PmPtUbXDN0G0VTXPepBwcCmRyJEwO489akXPpUS54qRepBoJZIBkc9vSpB1pgGBweBT1oRI6kpaKYhKWijvQB4B4N/wCTyfHf/YFj/wDQLOvf68A8G/8AJ5Pjv/sCx/8AoFnXv9AHAfH7/kjXiz/ryP8AMUnwC/5I14T/AOvIfzNL8fv+SNeLP+vI/wAxTPgI6p8GfCZdgo+xDknHc0Ad7LOkbKhOZGztQdTiqN3qM9reRJLbILeVtiyecAd2M9MdOOuaq6lqWmLcI7Tym5VSqm3BLYPUcDHasmTWJl3f2bpReQf8t76Tn64GT/Kpckjohhas9l9+n5l261DWZpn+xrbJCmPljRppH59eFHH1p+uXsC2Xk30MS2xwZLjUJFiiBHsTkn2AA965m9m1+9BF1rLW8Z6x2EQjx/wI5b+VZ8fh6yD+dJCbq4zkT3TGV/zbNQ5vojshl0N6k/uX6u36luXxL4eRVi06G+1d0DAPBAdoJ6/vHwMc8YzWfd+JfEd3EsVvb2un264A+0SNcy/U9F/PNaZtDsC4wB2FRtChlxuDMBggc4qG5vqd9Kjhafwwv6u/4aL8DAvo9TvRt1LVb+6U9EVxDHj/AHEwKyNa0029jHY6TGiX+ozLZ27BeQz8Fj7Ku459q7ZbYZGcECsO4R/+EpmlilUXFvaLaWcfdJpi2+T/AIDGp/OpUNdToqYyVOm409OyWiv6IiFpAbkQ2CH+z7CFdPs89Cifef6s2TnuAKcloCo3A8dwK3YdPit7dLeJQY4htX2FOa2UZ2j5unNDi27ipVVSgqcdkc81qyjcobPTI705bTKLu9PzroPsm1SrD8aZ9jCnIOfb1pchr9auc+bYKoVQwHckVELThSBx0wRXRtZg7XfITuT2/GsFbm61DzV0pFhtw5Q3kwyGHqi9/qeKlqxrTrOd7P1GG2Yh92FYDq3AFZN3qWmWpIuLyFnPGyLLt+AGa6i00e0WLbdNJel8BmuGzn8OgrTtoLezdRaWsECekcYX+VHI2CxUIPVN/h/n+RwUB1HUVKaf4fvJ4SuDJdYgQj33dRW/4R0nxhokMyWWs2VjatkrYsjXMcZPdScFfoDiutWYuOT+fpT48I6sxHTketUqSTu2YVsxlKDpqCSfdc353XzSRFodg9jFM89xJd31zJ5tzcyYBkfAHAHAAAAAHQVonO8HcBUSD/aAzU0aBPduvWtUrKx5NSTlJye5KD1ANPQEg81GoOeeM1IucYPFUjBlhAcA4GcVIp4GMjJqJGJ+gp464pmTJl+Y9ePapQPlqJMdelSqRnjimZskTPGeh5qRAOtRc+1SIfamQyfpinr0NRr6gYqRRiggdSUUUxAaWkpaAPAPBv8AyeT47/7Asf8A6BZ17/XgHg3/AJPJ8d/9gWP/ANAs69/oA4D4/f8AJGvFn/Xkf5iuU+FV7p2mfBvwvd63qNpYWgs1XzbuZY0ByeASevtXV/H7/kjXiz/ryP8AMVzHwy8KaH4r+CHhOz8R6ZBqFsLQMqyZBQ5IyrAgqcdwRSaubUZ8juch4z/aF8J6KGh8NW8+u3Y4EmDBAp+rDc34Lg+tec+EfihD4v8AGi6h8TfEUul6PYbbi10+yhcQyyhhgNsySB1+YnPrXqfib9mHwlqPmSaBqGo6PMT8qMRcwr+DYf8A8erkPDXwS8SfDzxONSutA0Lxro7KY5IXkVJEUkHzAsuFDDHT5u446hcqNPbVHJanaX3x38Em48rS11XVpm+6lrZkZP8AwLB/StDTvFHjbxEUGjeC/wCybXPNzrEpUgeojABr0GyuNA00eRolrbRHAJisLUHHsdgxV9pb6df9G0yYn+9cOsY/Lk/pU6HTzTXxafh+Zy9loF+Edtd1Vr13P+qgj8mJfpjk/ia10s0jiEcShB7VrHTdQkZSJrWBcfNhC5/DpUh0Vmk3z385jAwVUKg+ucZp2J+sJbsxvsvQ7ce9VpLSxhvvtDrax3bLs81sB2HpnqavXtx4SsY3j1LVrLg/MtxfDd+W6qEvjvwFZScahZNIg4MNu0hA9iqmpbit2jopxr1f4dOUvRP/AIJDPfQRSeTBBd3soPK2lu0g/Fug/OpYP7TmBZfD98q46ySRKfy3VG/xX0HIWws9XvQehgsyq/8Aj5WqU3xF1W5YrY6Gloh6SXs24/8AfC/41HPHv9xusNi7WdG3+J2/C6NSyAvPMhCyQ3EOPNhmTa656H3HuOKz9V1vSNKHly3SXFyDgW1sPNkJ9MDp+OK5e5Emo6jPe6jdTzXE4CN8xRAo6IFHbk/nU9rBBbgrbxRQgjnamM1PO+iOqOEhF3m2/Jfjr/wB17JqOucX0ZsNL7WaNmSXn/low6D/AGRWkiKYiEVUVcBVHAA9qrxA8LkAjqDUyuQMZUL06VJc3pyxVkui/r8ywAFdVyMemKsZVxxVO3O3ODu9zVos2F28DPJPeric01qWI1C7c1OpyR057moYzhwDzxTsk8CrMJaluPa3I+6OCanVsnNVkbaqgYC+lTfMcFuMntTOeSJwCW4zkj8qep45B46mmRn36/nUh6lScmmjJk0f3ORTlBYkdx0qJOMjPPapkx1aqM2OQnPJAHfNTISOD9KiCflipEGMc9KDNky9cA81KlQoMHg9akXhuB0pmbLCnjFSKePpUKnkVKveghjqKKBTEFFFLQB4B4N/5PJ8d/8AYFj/APQLOvf68A8G/wDJ5Pjv/sCx/wDoFnXv9AHAfH7/AJI14s/68j/MVR+CX2ofBjwn9igiklNkMGV9qA5PXAJq98fv+SNeLP8AryP8xXhXw+8c65Z+AtEsbXVxa28NsESOOJCQMnqSCazq1FTV2ellmXVcfUcKVtFfW/6H0/ZWeoFM6hdQbz1W3iKgfixJqvqMGhWZEmrz2obqDezDH4Bjivn6TWPEetEbL7Xb1emIPM2n8FAFTWvgbxHezB4/DlwWPPmXTqh/Hcc/pXP9YbXuxue5/YCpO+IxCh6WX5tfkev6j8S/CelqYre8N269IrGEyfkQNv61z178W7iVtuk6A4U9Jb2cJ/44uT+tY9n8LPEk+BcXOmWUffaXlYfhgD9a37T4RRlgdR1+8lX+7bxLD+p3GnevLZWJ9hkuH+KfO/Vv/wBJSX3s5u58f+Jr3715b2iHjbbQ4x/wJsmub1LV0uHcatq7XDHtNclsfhnFew2fwr8KwMGns57xx3ubl2/QED9K6DT/AAtoGnEGx0XToGH8SWyBvzxmj2NSXxMf9sZfQ/gU39yj+OrPnOxn0lm22VubmUtwLe0ZyfyFdDBBqkm023hvWGBOFxZlB+JbFfQaqqgBQAo6AClqlh/M56vEXO7qn98r/kkeF2+jeKZcCLwxdBT/AM9biJMfm1X7Xwv4tkODpFpbg4/116rcf8BBr2akq1QXc5ZZ5UltTiv/AAL/AOSPLIvBfiZ1xI+kRjB4EkjY/wDHatR+C9fRSPtGlHp18yvSu9FV7KJzPNa77fceW3XhHxYj77RtBfjo8kq/+yms6bTPG9kGD+HLG9BOd1rfKv6OBXsdIOnPWpdFPZs0hm9SPxQjL1T/AEaPEJtbubEMureHda07aPmm+zGWMf8AA14rQ0rXtK1HCWGo28zf88y21v8Avk4Nev1m6noOk6oc6jptnct03SwqzD6HGRSVKS2Zr/adGa96m0/J3X3NX/8AJjjlyW5Rh6HsakQbckZOa1W8C6XGMafLfWHOdsNwxX/vlsiqN14V12Ik6drVtKCMbby15/76Qj+VU1JdCVXoz2nb1T/S49Tz7/Sp9pIHOBVBNE8YmIK11oCt03iOVv0yKfD4Y8VSOrXXiazjHdINNGD+LPSu+wmqfWpH8X+SZoIMH6frT19uM8Gi38OajFzJrjSnHe0QD9DVmPSL6NubuCUe8RU/oTVK/Y5pTh0kn9/+Q1cFR0xT1zxnoalFjcADfGpP+w3+NOFvKB9xvyqjJyXcYo9eKen3s9qXaV6gjHtT4sEcYoIbHKM8dBUwGKamMfSnoPrTM2SKOfw4qRRxTQOntTx0oJYUCjNFMQvWiiigDwDwb/yeT47/AOwLH/6BZ17/AF4B4N/5PJ8d/wDYFj/9As69/oA8/wDj9/yRrxZ/15H/ANCFVfgBp9mvwi8LTi0txM9mC0gjXcxyepxk1a+P3/JGvFn/AF5H/wBCFHwB/wCSNeE/+vIfzNA1JrY78DAwKKKKBC0lLQaAEooooAWiijtQAdqKKKACjtRRQAUUUUAJS0UZoAKKKKAEopaSgAoxQaKAFoNJS0ABpnlpz8oyfan0UAM8pMdKPLWn0UBcTaKBS0UAIaKWigAopKKAPAfBv/J5Pjv/ALAsf/oFnXv9eAeDf+TyfHf/AGBY/wD0Czr3+gDz/wCP3/JGvFn/AF5H/wBCFHwB/wCSNeE/+vIfzNHx+/5I14s/68j/AOhCj4Bf8ka8J/8AXkP5mgDv6WiigAoooNAAaSlooAKSlpKAFooooAKKDRQACiiigAooooAKKKKACikpaACikpaACiiigApKWkoAWiiigAooo70AHeikJpcUAIKWko70AeA+Df8Ak8nx3/2BY/8A0Czr3+vAPBv/ACeT47/7Asf/AKBZ17/QB5/8f/8AkjXiz/ryP/oQo+AP/JGvCf8A15D+Zo+P/wDyRrxZ/wBeZ/8AQhR8Af8AkjXhP/ryH8zQB6BRRRQAUUUUAFFFFABRQaKAExS0lLQAUUUUAJS0UUAFFFFABRRSUALRSCloAKKSigAFLSUUAGaKKWgAooooAKKKTmgBTRSdaKADrS0mOaBQB4D4N/5PJ8d/9gWP/wBAs69/rwDwb/yeT47/AOwLH/6BZ17/AEAef/H/AP5I14s/68z/AOhCj4A/8ka8J/8AXkP5mj4//wDJGvFn/Xkf/QhR8Af+SNeE/wDryH8zQB6BRSUtACUtFFABRQaKACgUUUAFFFFAAaKKKAEpaDRQAlLRRQAUUUUAFFFFACUUUdqAENLRS0AIKKKKAClopKACloNFABRRSUAFLRR3oA8A8G/8nk+O/wDsCx/+gWde/wBeAeDf+TyfHf8A2BY//QLOvf6APP8A4/8A/JGvFn/Xkf8A0IUfAH/kjXhP/ryH8zR8f/8AkjXiz/ryP/oQo+AP/JGvCf8A15D+ZoA9AooooAKDRRQAUlVNQ1K009N11MFJ+6igs7fRRyfwFZT6nrV6SNK0hbePtPqMnl/iI1yx/HbQB0NYnibXP7Kjt7azi+1atesY7S2zjce7seyKOWP4dSAcbUdE8a3jI0HjGz07H3kt9HVwfxkkNcb4P8S2fhbxx4ms/iXrkEHiKSVTZX16FtoJtPAHliIn5FO/fuUHJb1xwAeuabby21nGlzOZ7jGZZcY3N3IHYeg9KtV59r3xl8AaLFum8TWN25BKxae32pmI7fu8gfiQK5/SPEniz4pxF/DMkHhXwyTte9kkjuNSmXuEiUlYDwwy5LDIYUAevh1Z2QMpZeoB5FLWJ4R8L6b4V09rXTEmZ5W8y4uriUyz3Mnd5JDyzH8h2AHFblABRRRQAUlLRQAUlLRQAlFLRQAlLRSUAFFFLQAhopaSgBaRs4O3GfegUtACdqWiigBM0UEc0uKAEpaQ0ooA8A8G/wDJ5Pjv/sCx/wDoFnXv9eAeDf8Ak8nx3/2BY/8A0Czr3+gDk/ivod74l+HWvaNpao17eWxiiEjbVLZB5PbpXi/hjQ/j14a0Cx0bS08PrZWcflRB2RmC+579a+lKKAPn/P7Q/p4b/wDHKM/tD+nhv/xyvoCigD5//wCMhvTw3/45SEftDYOf+EcI/wCACvoGigD56ig/aBiYtHD4ZVj1YBMn8alz+0P6eHP/AByvoCigD5/z+0P/AHfDn/jlVb+w+PWow+TqFl4Uu4s52TxxSLn6GvoqigD5z03TPjvpkZj02w8I2cZ5K28UUYP4DFYmu+BfjLrV8uoXOn+HLfVEJK39lKLW4Bxj/WRkMfoSR7V9T0UAfOunWn7RNnbrE93ol1tGA9wYi2PqAM/U81aJ/aGHbw3/AOOV9AUUAfP+f2h/Tw5/45Rn9of+74c/8cr6AooA+f8AP7Q/93w5/wCOUZ/aH9PDn/jlfQFFAHz/AJ/aH/u+HP8AxyjP7Q/p4c/8cr6AooA+f8/tD+nhz/xyjP7Q/p4c/wDHK+gKKAPn/P7Q3p4b/wDHKM/tD+nhv/xyvoCigD5/z+0P6eG//HKM/tD+nhv/AMcr6AooA+f8/tD+nhv/AMcoz+0P6eG//HK+gKKAPn/P7Q/p4b/8coz+0P6eHP8AxyvoCigD5/z+0P6eG/8AxyjP7Q/p4c/8cr6AooA+f8/tD+nhz/xyjP7Q/p4c/wDHK+gKKAPn/P7Q/p4c/wDHKM/tD+nhz/xyvoCigDwf4P8Agfx3Y/F7WvGXjyOwEmoacbZmtZFILhoAvyjoNsX517xRRQB//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    PTV setup utilizing a three-way stopcock.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mittal MK, Baren JM. Percutaneous Transtracheal Ventilation. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2273=[""].join("\n");
var outline_f2_14_2273=null;
var title_f2_14_2274="Subepicardial transmural injury current";
var content_f2_14_2274=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73239&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73239&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Subepicardial or transmural injury as viewed from the surface electrocardiogram",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 413px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Systolic and diastolic injury currents are generated between injured and normal ventricular muscle cells during episodes of subepicardial (A) or transmural (B) injury. This results in TQ segment depression and ST segment elevation on the surface electrocardiogram.",
"    <div class=\"footnotes\">",
"     Endo: subendocardial, Epi: subepicardial.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2274=[""].join("\n");
var outline_f2_14_2274=null;
var title_f2_14_2275="Side view of neck bones and muscles";
var content_f2_14_2275=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Side view of neck bones and muscles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 531px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2275=[""].join("\n");
var outline_f2_14_2275=null;
var title_f2_14_2276="Dicloxacillin: Patient drug information";
var content_f2_14_2276=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Dicloxacillin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"     see \"Dicloxacillin: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=see_link\">",
"     see \"Dicloxacillin: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015516\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701938",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to dicloxacillin, any penicillin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12374 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-23F828356C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2276=[""].join("\n");
var outline_f2_14_2276=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015517\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015516\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015521\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015522\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015524\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015519\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015520\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015525\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015526\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=related_link\">",
"      Dicloxacillin: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/61/17363?source=related_link\">",
"      Dicloxacillin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_14_2277="Allopurinol: Patient drug information";
var content_f2_14_2277=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Allopurinol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=see_link\">",
"     see \"Allopurinol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/3/24629?source=see_link\">",
"     see \"Allopurinol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131745\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aloprim&reg;;",
"     </li>",
"     <li>",
"      Zyloprim&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F131746\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alloprin&reg;;",
"     </li>",
"     <li>",
"      Novo-Purol;",
"     </li>",
"     <li>",
"      Zyloprim&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10025519\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10025521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop gouty arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691453",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop gout attacks. It may take 6 weeks to see the full effect.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691460",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop high uric acid levels during chemo.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691467",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop kidney problems caused by gout.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to avoid side effects due to fluorouracil.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691922",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat kidney stones.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10025520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to allopurinol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10025525\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696834",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 6 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10025526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10025528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698995",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pain when passing urine or blood in urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10025523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695847",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3547294",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep taking this drug even if you are having a gout attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10025524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10025529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699556",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store tablets at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699319",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect tablets from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699479",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store liquid (suspension) in a refrigerator. Throw away any part not used after 2 weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10025530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12514 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-06EB330AA9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2277=[""].join("\n");
var outline_f2_14_2277=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131745\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131746\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025519\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025521\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025520\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025525\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025526\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025528\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025523\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025524\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025529\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10025530\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/40/25223?source=related_link\">",
"      Allopurinol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/3/24629?source=related_link\">",
"      Allopurinol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_14_2278="Cradle cap and seborrheic dermatitis in infants";
var content_f2_14_2278=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cradle cap and seborrheic dermatitis in infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Denis Sasseville, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Joseph Fowler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2278/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/14/2278/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 9, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H608072793\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seborrheic dermatitis is a self-limiting eruption consisting of erythematous plaques with greasy-looking, yellowish scales distributed on areas rich in sebaceous glands such as the scalp, the external ear, the center of the face, and the intertriginous areas.",
"   </p>",
"   <p>",
"    This topic will discuss cradle cap and seborrheic dermatitis in infants. Seborrheic dermatitis in adolescents and adults is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21961?source=see_link\">",
"     \"Seborrheic dermatitis in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H608072800\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seborrheic dermatitis occurs in infants between the ages of 3 weeks and 12 months. It has been reported in about 10 percent of infants younger than one month [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/1\">",
"     1",
"    </a>",
"    ]. The prevalence peaks at the age of 3 months (about 70 percent) and decreases steadily in the following months, affecting about 7 percent of children aged one to two years [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H608072807\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of infantile seborrheic dermatitis is not known. Transplacental transfer of maternal androgens stimulates the growth of the infant&rsquo;s sebaceous glands, which are necessary but not sufficient for the development of seborrheic dermatitis. The role of Malassezia, a lipid-dependent yeast, is not clear; Malassezia colonization has been reported in infants with seborrheic dermatitis, infants with other dermatologic conditions, and in normal infants [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H608072814\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common manifestation of seborrheic dermatitis in newborns and infants is &ldquo;cradle cap&rdquo;, an asymptomatic and non-inflammatory accumulation of yellowish, greasy scales on the scalp (",
"    <a class=\"graphic graphic_picture graphicRef55801 \" href=\"UTD.htm?21/12/21702\">",
"     picture 1",
"    </a>",
"    ). The vertex and the frontal area are commonly involved. Sometimes the eruption starts on the face, with erythematous, scaly, salmon-colored plaques. The forehead, the retroauricular areas, eyebrows and eyelids, cheeks, and nasolabial folds are commonly affected. Seborrheic dermatitis may also occur in the napkin (diaper) area (",
"    <a class=\"graphic graphic_picture graphicRef73813 \" href=\"UTD.htm?33/42/34466\">",
"     picture 2",
"    </a>",
"    ), on the trunk, with a predilection for the umbilical area, or in the intertriginous areas. It also may occur simultaneously at multiple sites (",
"    <a class=\"graphic graphic_picture graphicRef52803 \" href=\"UTD.htm?15/14/15585\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In the folds around the neck, in the axillae, and the crural region, the lesions have a moist, glistening, non-scaly aspect and tend to be confluent. In more widespread forms, large areas of the trunk may become involved with sharply marginated plaques of erythema and scaling that cover the lower abdomen, pubic and groin area, as well as the buttocks. Rarely, seborrheic dermatitis may present as an erythrodermic eruption in infants [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The infant is generally well; feeding and sleep are not disturbed. The pruritus is mild in most cases. The clinical manifestations fluctuate, but most cases eventually resolve spontaneously within weeks to a few months. Cases persisting beyond the age of 12 months are rare, and require the diagnosis to be reconsidered. (See",
"    <a class=\"local\" href=\"#H608072842\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H608072842\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of infantile seborrheic dermatitis includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atopic dermatitis",
"     </li>",
"     <li>",
"      Diaper dermatitis",
"     </li>",
"     <li>",
"      Psoriasis",
"     </li>",
"     <li>",
"      Pityriasis (tinea) amiantacea",
"     </li>",
"     <li>",
"      Langerhans cell histiocytosis",
"     </li>",
"     <li>",
"      Tinea capitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Atopic dermatitis is the other major dermatitis of infancy. It is characterized by severe pruritus that interferes with feeding and sleep. The erythematous, scaly, and crusted lesions of atopic dermatitis are generally poorly demarcated, and commonly involve the cheeks, scalp, and extensor surfaces of the limbs (",
"    <a class=\"graphic graphic_picture graphicRef77386 graphicRef77457 graphicRef56461 \" href=\"UTD.htm?28/17/28953\">",
"     picture 4A-C",
"    </a>",
"    ). The diaper area is usually spared (",
"    <a class=\"graphic graphic_picture graphicRef68746 \" href=\"UTD.htm?9/41/9875\">",
"     picture 5",
"    </a>",
"    ). A positive family history of eczema, asthma, and allergic rhinitis is often present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link&amp;anchor=H11#H11\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Irritant diaper dermatitis is caused by the moist environment and friction of the diaper. In contrast to seborrheic dermatitis, it usually spares the skin folds. However, diaper dermatitis with superimposed Candida infection has a beefy red, glistening appearance, sometimes with superficial erosions, and involves the skin folds. Transient pustules may be seen at the advancing borders, and satellites lesions are common (",
"    <a class=\"graphic graphic_picture graphicRef64556 \" href=\"UTD.htm?11/12/11459\">",
"     picture 6",
"    </a>",
"    ). Infrequently, diaper dermatitis may spread beyond the diaper area and become disseminated, with a pattern resembling seborrheic dermatitis; both of these conditions can be treated with antifungal agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/33/37401?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of diaper dermatitis in infants and children\", section on 'Causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Psoriasis is uncommon in infants, but can mimic seborrheic dermatitis, especially when it involves the flexures or the diaper area. The psoriatic plaques are sharply defined, shiny and bright red in color, with the typical large silvery scales of psoriasis (",
"    <a class=\"graphic graphic_picture graphicRef74892 \" href=\"UTD.htm?14/6/14432\">",
"     picture 7",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link&amp;anchor=H9#H9\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In older children, pityriasis amiantacea (tinea amiantacea) may be an infrequent scalp reaction caused by psoriasis or seborrheic dermatitis. It presents with a thick accumulation of whitish hard scales on the scalp (",
"    <a class=\"graphic graphic_picture graphicRef58114 \" href=\"UTD.htm?0/13/214\">",
"     picture 8",
"    </a>",
"    ). The scales are adherent to the scalp and cement the proximal part of the hair. Forcefully removing the scales pulls the hair with it. Treatment of pityriasis amiantacea involves frequent shampooing, repeated overnight application of emollients, and combing to remove scales.",
"   </p>",
"   <p>",
"    Langerhans cell histiocytosis may present in infancy as a refractory seborrheic dermatitis, or a diaper dermatitis with ulceration and erosion. Sometimes, papules and brownish-red or purpuric nodules can be seen on the scalp, retroauricular areas, axillae, and inguinocrural folds (",
"    <a class=\"graphic graphic_picture graphicRef57722 graphicRef69504 \" href=\"UTD.htm?38/9/39064\">",
"     picture 9A-B",
"    </a>",
"    ). A skin biopsy will confirm the diagnosis.",
"   </p>",
"   <p>",
"    In older children, tinea capitis may present as a scaly scalp dermatitis with moderate or minimal inflammation. Hair loss generally is present but is not always easy to detect. KOH examination of the hair shaft and fungal cultures will confirm the diagnosis. Tinea is rare in infants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=see_link&amp;anchor=H3#H3\">",
"     \"Dermatophyte (tinea) infections\", section on 'Tinea capitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H608072935\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H710058552\">",
"    <span class=\"h2\">",
"     Cradle cap",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infants, seborrheic dermatitis has a self-limited course and resolves spontaneously in weeks to several months. Therefore, we suggest that initial treatment should be conservative, including education and reassurance of parents, and simple skin care measures.",
"   </p>",
"   <p>",
"    Conservative measures for scalp seborrheic dermatitis may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Application of an emollient (white petrolatum, vegetable oil,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/28/20931?source=see_link\">",
"       mineral oil",
"      </a>",
"      , baby oil) to the scalp (overnight, if necessary) to loosen the scales, followed by removal of scales with a soft brush (eg, a soft toothbrush) or fine-tooth comb",
"     </li>",
"     <li>",
"      Frequent shampooing with mild, non-medicated baby shampoo followed by removal of scales with a soft brush (eg, a soft toothbrush) or fine-tooth comb",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In more extensive or persistent cases, we suggest either a short course of low-potency topical corticosteroids (group seven (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    )) applied once per day for one week or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     ketoconazole",
"    </a>",
"    2% cream or shampoo twice per week for two weeks. Corticosteroids are preferred if there is a predominant inflammatory component; ketoconazole 2% cream or shampoo is an alternative in diffuse cases or if the use of topical corticosteroids is a concern for the parents.",
"   </p>",
"   <p>",
"    There are no randomized trials of antifungal agents or topical corticosteroids for the treatment of cradle cap in infants.",
"   </p>",
"   <p>",
"    A systematic review identified five randomized trials comparing topical antifungals with topical corticosteroids in adults with seborrheic dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/8\">",
"     8",
"    </a>",
"    ]. All the studies indicated that the two treatments were equally effective. In a nonrandomized study of 48 children aged two weeks to two years,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     ketoconazole",
"    </a>",
"    2% cream was equivalent to 1%",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/28/35264?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    cream in clearing the lesions in two weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of lower potency topical corticosteroids in children is generally safe when used for short durations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link&amp;anchor=H10#H10\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Topical corticosteroids'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     Ketoconazole",
"    </a>",
"    shampoo may cause eye irritation. Systemic absorption of topical ketoconazole in infants has been evaluated in two studies. In one, ketoconazole 2% shampoo used twice a week for four weeks in 13 infants (&lt;12 months) produced no detectable serum ketoconazole levels and no abnormalities of liver function tests [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/10\">",
"     10",
"    </a>",
"    ]. In the other, ketoconazole 2% cream was used once daily for 10 days to treat 19 children with seborrheic dermatitis of the scalp and diaper area. Peak plasma levels of ketoconazole detected one to three hours after topical treatment were 1 to 2 percent of those measured after systemic administration [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other antiseborrheic shampoos (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/7/6259?source=see_link\">",
"     selenium sulfide",
"    </a>",
"    2.5%, zinc pyrithione, salicylic acid) have been used in the treatment of infantile seborrheic dermatitis. However, there are not clinical trials evaluating their efficacy and safety in infants. Observational studies in adults suggest that shampoos and ointments containing salicylic acid may result in systemic toxicity because of transcutaneous absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2278/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H710058559\">",
"    <span class=\"h2\">",
"     Non-scalp seborrheic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that seborrheic dermatitis involving body areas other than the scalp in infants be treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     ketoconazole",
"    </a>",
"    2% cream (once a day for one to two weeks) or a low potency topical corticosteroid (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/28/35264?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    1% cream once a day). The use of topical corticosteroids should be limited to the time needed to achieve the clearing of the lesions, but no longer than one week (see",
"    <a class=\"local\" href=\"#H16968893\">",
"     'Response to therapy'",
"    </a>",
"    below). Emollients can be used liberally.",
"   </p>",
"   <p>",
"    There are no randomized trials evaluating the treatment of non-scalp seborrheic dermatitis in infants. A single randomized trial in adults suggested that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     ketoconazole",
"    </a>",
"    2% cream and mid-potency corticosteroids are equally effective. We generally use only low potency topical corticosteroids for seborrheic dermatitis in infants given the natural history of spontaneous resolution and the potential for systemic absorption of topical corticosteroids. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link&amp;anchor=H14#H14\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Use in children'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2573302\">",
"    <span class=\"h2\">",
"     Neck folds and other intertriginous areas",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that infants with seborrheic dermatitis of the intertriginous areas be treated with a topical azole (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"     ketoconazole",
"    </a>",
"    2% cream or other azole preparation, once a day for one to two weeks). In addition, topical creams or ointments containing",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/11/31922?source=see_link\">",
"     zinc oxide",
"    </a>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    petrolatum may be applied liberally. Although there are no randomized trials evaluating this therapy, seborrheic dermatitis involving the intertriginous areas is frequently superinfected with Candida albicans. The topical barrier helps to limit skin maceration. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16968893\">",
"    <span class=\"h2\">",
"     Response to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the rash does not resolve after one week of corticosteroid therapy or two weeks of antifungal therapy as described above, the diagnosis should be reconsidered. (See",
"    <a class=\"local\" href=\"#H608072842\">",
"     'Differential diagnosis'",
"    </a>",
"    above.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/5/22610?source=see_link\">",
"       \"Patient information: Seborrheic dermatitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?6/1/6164?source=see_link\">",
"       \"Patient information: Seborrheic dermatitis (including dandruff and cradle cap) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29306861\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seborrheic dermatitis in infants is a common and self-limited condition most frequently involving the scalp (cradle cap (",
"      <a class=\"graphic graphic_picture graphicRef55801 \" href=\"UTD.htm?21/12/21702\">",
"       picture 1",
"      </a>",
"      )). (See",
"      <a class=\"local\" href=\"#H608072814\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial treatment of scalp seborrheic dermatitis includes education, reassurance and conservative measures (emollients and frequent shampooing) to soften and remove the scales. If conservative measures fail, we suggest either topical low potency corticosteroids (group seven (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 1",
"      </a>",
"      )) or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"       ketoconazole",
"      </a>",
"      2% shampoo or cream (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Topical corticosteroid is applied once per day for one week. Ketoconazole 2% shampoo or cream is used twice per week for two weeks. (See",
"      <a class=\"local\" href=\"#H710058552\">",
"       'Cradle cap'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For seborrheic dermatitis of areas other than the scalp, we suggest",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"       ketoconazole",
"      </a>",
"      2% cream or a low-potency corticosteroid cream (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Ketoconazole 2% cream should be applied once a day for one to two weeks. Topical corticosteroid is applied once a day for up to one week. (See",
"      <a class=\"local\" href=\"#H710058559\">",
"       'Non-scalp seborrheic dermatitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For seborrheic dermatitis of the intertriginous areas, we suggest",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/10/34976?source=see_link\">",
"       ketoconazole",
"      </a>",
"      2% cream or other azole cream (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The azole cream is applied once a day for one to two weeks. In addition, topical creams or ointments containing",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/11/31922?source=see_link\">",
"       zinc oxide",
"      </a>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      petrolatum may be applied liberally. (See",
"      <a class=\"local\" href=\"#H2573302\">",
"       'Neck folds and other intertriginous areas'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the rash does not resolve after one week of corticosteroid therapy or two weeks of antifungal therapy as described above, the diagnosis should be reconsidered. (See",
"      <a class=\"local\" href=\"#H608072842\">",
"       'Differential diagnosis'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/1\">",
"      Sachdeva M, Kaur S, Nagpal M, Dewan SP. Cutaneous lesions in new born. Indian J Dermatol Venereol Leprol 2002; 68:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/2\">",
"      Foley P, Zuo Y, Plunkett A, et al. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol 2003; 139:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/3\">",
"      Ruiz-Maldonado R, L&oacute;pez-Mat&iacute;nez R, P&eacute;rez Chavarr&iacute;a EL, et al. Pityrosporum ovale in infantile seborrheic dermatitis. Pediatr Dermatol 1989; 6:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/4\">",
"      Broberg A, Faergemann J. Infantile seborrhoeic dermatitis and Pityrosporum ovale. Br J Dermatol 1989; 120:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/5\">",
"      Wananukul S, Chindamporn A, Yumyourn P, et al. Malassezia furfur in infantile seborrheic dermatitis. Asian Pac J Allergy Immunol 2005; 23:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/6\">",
"      Sarkar R, Garg VK. Erythroderma in children. Indian J Dermatol Venereol Leprol 2010; 76:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/7\">",
"      Al-Dhalimi MA. Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 2007; 34:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/8\">",
"      Cohen S. Should we treat infantile seborrhoeic dermatitis with topical antifungals or topical steroids? Arch Dis Child 2004; 89:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/9\">",
"      Wannanukul S, Chiabunkana J. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. J Med Assoc Thai 2004; 87 Suppl 2:S68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/10\">",
"      Brodell RT, Patel S, Venglarcik JS, et al. The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol 1998; 15:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/11\">",
"      Taieb A, Legrain V, Palmier C, et al. Topical ketoconazole for infantile seborrhoeic dermatitis. Dermatologica 1990; 181:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2278/abstract/12\">",
"      Morra P, Bartle WR, Walker SE, et al. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996; 30:935.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16261 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-183.1.191.153-6CC31590FA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2278=[""].join("\n");
var outline_f2_14_2278=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29306861\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H608072793\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H608072800\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H608072807\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H608072814\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H608072842\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H608072935\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H710058552\">",
"      Cradle cap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H710058559\">",
"      Non-scalp seborrheic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2573302\">",
"      Neck folds and other intertriginous areas",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16968893\">",
"      Response to therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29306861\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/16261\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16261|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/12/21702\" title=\"picture 1\">",
"      Seborrheic dermatitis peds",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/42/34466\" title=\"picture 2\">",
"      Seborrheic dermatitis diaper area",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/14/15585\" title=\"picture 3\">",
"      Infantile seborrheic dermatitis multiple sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/35/37428\" title=\"picture 4A\">",
"      Atopic dermatitis infant 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/55/23408\" title=\"picture 4B\">",
"      Atopic dermatitis infantile I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/50/28448\" title=\"picture 4C\">",
"      Atopic dermatitis infantile II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/41/9875\" title=\"picture 5\">",
"      Atopic dermatitis infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/12/11459\" title=\"picture 6\">",
"      Diaper dermatitis candidiasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/6/14432\" title=\"picture 7\">",
"      Infantile psoriasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/13/214\" title=\"picture 8\">",
"      Pityriasis tinea amiantacea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/62/34786\" title=\"picture 9A\">",
"      Langerhans histiocytosis skin 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/56/4997\" title=\"picture 9B\">",
"      Langerhans histiocytosis skin 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16261|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/33/37401?source=related_link\">",
"      Overview of diaper dermatitis in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/5/22610?source=related_link\">",
"      Patient information: Seborrheic dermatitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/1/6164?source=related_link\">",
"      Patient information: Seborrheic dermatitis (including dandruff and cradle cap) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/28/21961?source=related_link\">",
"      Seborrheic dermatitis in adolescents and adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_14_2279="Cutaneous larva migrans life cycle";
var content_f2_14_2279=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F73772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F73772&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Cutaneous larva migrans life cycle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 453px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cutaneous larval migrans (also known as creeping eruption) is a zoonotic infection with hookworm species that do not use humans as a definitive host, the most common being A. braziliense and A. caninum. The normal definitive hosts for these species are dogs and cats. The cycle in the definitive host is very similar to the cycle for the human species. Eggs are passed in the stool",
"    <strong>",
"     (1)",
"    </strong>",
"    , and under favorable conditions (moisture, warmth, shade), larvae hatch in 1 to 2 days. The released rhabditiform larvae grow in the feces and/or the soil",
"    <strong>",
"     (2)",
"    </strong>",
"    , and after 5 to 10 days (and two molts) they become filariform (third-stage) larvae that are infective",
"    <strong>",
"     (3)",
"    </strong>",
"    . These infective larvae can survive 3 to 4 weeks in favorable environmental conditions. On contact with the animal host",
"    <strong>",
"     (4)",
"    </strong>",
"    , the larvae penetrate the skin and are carried through the blood vessels to the heart and then to the lungs. They penetrate into the pulmonary alveoli, ascend the bronchial tree to the pharynx, and are swallowed. The larvae reach the small intestine, where they reside and mature into adults. Adult worms live in the lumen of the small intestine, where they attach to the intestinal wall. Some larvae become arrested in the tissues, and serve as source of infection for pups via transmammary (and possibly transplacental) routes",
"    <strong>",
"     (5)",
"    </strong>",
"    . Humans may also become infected when filariform larvae penetrate the skin",
"    <strong>",
"     (6)",
"    </strong>",
"    . With most species, the larvae cannot mature further in the human host, and migrate aimlessly within the epidermis, sometimes as much as several centimeters a day. Some larvae may persist in deeper tissue after finishing their skin migration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Hookworm. Available at:",
"     <a href=\"file://www.dpd.cdc.gov/dpdx/html/hookworm.htm\" target=\"_blank\">",
"      file://www.dpd.cdc.gov/dpdx/html/hookworm.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2279=[""].join("\n");
var outline_f2_14_2279=null;
var title_f2_14_2280="Epidermal inclusion cyst";
var content_f2_14_2280=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55769%7EDERM%2F50581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55769%7EDERM%2F50581&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Infected epidermal inclusion cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 268px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEMAXoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5hsQDPhl688+tdtoYSKdOVKkbV6A5z39fr71x2lBRdgvgAfkK7TT7VVeVnz5I4xnHBAyD3yMg+1ctcIvU73RICJWCttZRznnIPtWD8UbIxPpmpjJ2OYJNoAOGGVP510WhxtHFlgpCDGSSSP8APB496PHNi974L1BcKZo088YOeVIPH4V50Hapqdc17hwNlIMr8+R6/rWieZIySArk8ke9YWlXAkWFgeDyCa6GI8oVAzz7H3rokrMiDuilEgJJYH5W2lTxjPer+ngxyqCc7cqcjHGc4/z7VCir5rkbcqQCP71WYFImjyDnoffmolqWlZnR6floi+7G1wc+3b+Va1s5IdVBOe/XrXO2MwyIo+WO75gOOpxWzasFclSrfKpBz6j+dcs1qzoR0ts2/G3oBgAfqTWjATuYdT0UjgH6/nWLYsfmxnPy55/M1swP5bjA4I+YGkbQL8W7EacBmySuc5Ht+NSXlw0FuQAML1JzgnsKNPlR4SG+djkjd14J71leIpnQrEHEcjYdSAeO2D7cnmpk7RbOynbdnN65OZ0itwNgZj8uSCCCePfk49604oUtNPTC7mQqmB0JOOn86w7Iefrd3IDuggPlA/3mHJ/IkiuiiiEhRZMEA5C5xz2/Ks0tDOpUvIu2qMsRMgUJkkdQfetfToDLJ5hPyt0UnjHqfrVWJQYiMnnADA/5+n0rSQlYidwBxzzjNa2saU9S7EVDRNtCtIcEOeBxTpGBmRGUbFOfl4AP8P8AP86h83zht2mQNghducketPhQkOoO5OvPp7/jn8KGbpJDLty4iUNjLkEDsBjvUYEm7adoUfdVfTp19adFuMowAzAkHsBj/P41ArkRu+TtCnPPQdef5VLKJIHJkZcEdM7ugGcZzVyFeN2eFOdwB55z69OP5VBHLGB5rnJXqV9O2R/n1q1aSCZ5BCSTE4Rv9hgc4GevXOelBLJckwkSjhSdxBAAGAc4+nr9ajWOJQhyDuzjJ4yP5ZqWKTyiysA3Gcn5iQeSPeop+MhAdh5I6j/6/Pp60CS7j2aPDDcAGAyMY/Lr71ACAoEh+YAux5/X0z7elRzLKzxzZdVAwFTjp7/pTzbsmVBDKTjPrzxn06UBYYyeWeN2ZDjPpwOlTFQyADCkv8yjuMCnL80qeWQxU5BzzjHT8f6mp8qYtg3AOMAjqPQj/PagCERMDtk+VQQ2Bzggev8AhUqIVEiqx4BKtnG7jjIpzZ8sgKCAMj3weaSFMAtgsC2AScgH2/wpjEhi3p5cUYjVlBLyKck+mOOnv/8AXqwVWNG3AbuhwOD70xc9fMXGMk46H/CpCsmQAmVzyrHPXvQJ+YxN2wlMkLnAJ61EkEUFyZAdsjH5tvQ8fzqZEBOWxux+P/16SX/UYUgnGdvpk/ypiZWDkb1kA/eNkndxz0NTQsHYq5IKj5Tj731HY0kahhiTaRyuTkEA8H9arTITs2SEsuGIZQwA6H8Kohku0Rks2T/D93gg9j6UxmYXEp4GDtGRxzjn+nNSyEoVwWKjuOQT2/rUM2/y0IB8voMdhnn+dBDInYKwVgVyeO5P+f6VWJjneZApRkIA8xcZ91zUlyrqQBhlJzz1HcHP51FcMPKJJCqTjnk/X8KpEMoTKGTDuC4yV5ww9h61VZd0MeCckZ6VbkwpIIwM9Thj+BqEE7QQWCjr3H59uO1UZsqM5CqYzggZPf8AGqNzNJH8s6hWblSG4PHHX/PNaByhkyMZIx6Ef5NU7siRGR1A7En8+lMxkUJB56ttfZKq5yODn/JqA3NypKm2yRxlXGPwqS8gVE81RmRBliRnOOox/L/69VYykiLJGg2MAy4K4wfxq4mUu580WIH2lTux7n+VdzpUyzwxJulHysZFxjepHX3rg7PAl5Pf14PtXZ6K26NYUMhjmkI2hsccEkenXmu6utDzIfEeiaJMjnMaSurtjeDyecDBzn8frXSQ26zW0lo4UxPlXBPBz7eneue0DMCGGaPafukMNufQgdx09/XtXVW8e7gMSSMNzznjvXly+I71qj59tY3sdUnspcBreRo/ybj9MV1VvcgRlmzuwSuD7+lV/itpw03xbDqCDEN7H83H8agA/nxVfTXWSKIEnc2UJb1I6/0/Gu2dpJSOaF4to1o1yPmALHkEjGe2asQEeduzz054yADmqEU4J3xgnP3j0zz2q6mCRnqx4xxnrx9KxaNrmnpaiK6lwSFbDYPPbH+fWti0AeVjjG5vzFYdk215CCpbJAz6Ejj04rd0+LFwcN8+0KeOMA5/Osai1ZtHY6CxGYyDuyTkk9PoK37SAszNxkj1yB/kZrK06LJAQZ3MT/n9cV0thEixKcBiDjd/n+dRayOimrkE6qLdRHGpVQChIzuPb6k56Vzmvho9OurhZDmNljto8Y3zNkLn2GGP4V1NzcQx7nmkweSdvRVHU+x5x+NcLqd5/beqKLUMllagpCcjEkvRmUdwPuKfQE96h67nVOSgrEGgWotbaCGPnaxyT1ZsnP6109og3BVAyRgnpye/86zLBEUARoCFAC8dq2NOtgkSRAnav909s9efepRhFXZoxRtgMCueqq3Tk+g9s1bRgXMS7cI2Xz1Gf61XiBQMuwBAf4R1PfNT2kaqQ7bducck5zVHZBaE8K47L/vNxjvxVvDqpLYxt3ABd30JP8v/ANVV4cZl3oAMhunsccfh0p6xxuPvRAqd2zH8WD17c/59aZqrjI4TDKzAPuJ53dj14FMB8xsgM0mehHzZPOf1xVlYPMhDZ2gdVHGO4/P0qJolRNik7yMAHsQR0+lSx7hbbhIxAZmycL0HIxj+p9ausc258x1JTnPUZz/T0qKSJUQmRiFIxtHI79CMU4ojDczgc5XHvwefx/SgLdSdWjGE3Ergj5Rk4+tQGLfPGrfKD0VR9339yKcrYfeWyAoG5Bn/ACagnndwZWIjRiACxOOnB/lSE0S7i0eFwWQbiwyQCMjj15FMDgKWUAqOSOpH0qScEBRuPmbQMNjjHr/ntUAAVUIUnjPA5+uaGSPikYFWdcMy49c/T6ZB/GmmXzU2s2XU54Bz/wDrpmwBcxrkjAXn7xJI4/z0p8EDqNgZG/2OeSeST6nrQ2V1J9pQIRKHXjPT889SPapFdhO8QbaANxUryM9Mfj9aIlPlSjZnrjaQR7frV0IBHlhuPBYBs4x/k1a1E3YqRys8jogQKDgYHyn6HNMVvI4c7yMZOOef89KsG3G1WV8EDv8AxY+lKuUZEcttclvmODQO6FlUx7XwMgcnHNRPJ5iiQoSc42lsdf1/CpWcbF2kE5GGU5B+tVSySwhiskRGcK2N2M+2aEiHcbIyuu9mcFuNx6f/AFj7VA29JSYw7fMcoe568H1/nU8kjooY7Tnk5UHOfp+BqqJBAxwhdVwcYxtPpz+BqiGWGcACYKWLrncvGR1zg9+tMFwXYwAsuFAHSqkd4pkPlsQCcsjZB55yR29/XtVpRkeYFUgdxx3pifmROQQ6kqpBB5Pb1x9arSSMGdRkBs4yP6f561cV3kQnpHwChHJ+vpVK7USjDblZfugjpxmmjNlKZWDllYKhb5h3Ge9MIymQpPPBA4GKkKYEiOQWUdu+agYuEO4BOMEHt6H2qrGbIJy+0x5BIORkdfpVJ9skUYYDGMbh3zVydCVySWU/w7qyHEkTjO8j+8RnjuD/AJ/xqjCQ92MYGGYHOeRkED0HasE2UROY4mCfwgMRxWndyxjHz4UjgEke/FZIkKDb5uccfdc09DJnztpxxcKOldZokcpaSaMgMysGX++AcdOvX+QFchaZE4wSPTHFdt4caRGkA2xMSc98jtj8ya76zsebHc9F8OyxhCwRY487V5zu75JrpbeRlcgAKx+ZcDtXFaWkjzJhmCIcjcOC2eOB0ODnNdTE7rEqMxEpyAu3PGfmOe3BxXmTep3xWhzvxSsH1DQJZERnaLM0ZH8O0c8e4JFea6NdlrdSh4Uc+pr3XUD9pWOHaDmIoMnAwxCE/rXz/e2z6Hrt5YSYKRS4X0Kk8c100nzRcTCorO50dpLtcDqBzV+KQG5QAKCM1gWMytLwVPpxxWnaSguzH5huHXv/AJ/pSkrAnc20wRGsZbO8Zz1yCOPxrqtHy7DfhWOWOORjOfyrkrIyPMFiAY7wucfdOQP8TXY6PHskkY5XnaF6txk44rCq+h0Q11Ov0uMLjOMZ7cfhW20ix27lzlAMdMACsXTASqkDA3DnNUfFGpvFIun2RWSWUDeuB8q85JPbgfjkDvWUnod1JWV2Z+sag15crZW24RbfMlK9s/cHt3P1p1laqkQRQqgLgY649veoYo2gARVZpGyzOBjOe5/D+ValrGyOMBWIXJAXJ4P+eTWdrmcpuTuWYVxtGQxHfpxWlaB8lMYU5AHTI/xrOjiIAdxgkZCk88dAOwq9E58qPPG4Bhg5xTbNaa0LLHPCthl4OTnFSWsL7380hkYYUZ9qqSLIQApG7O4Z9en8q0LWTfhFzuXgH/PsDRc64baF9HVGjzy5GMdgP89qlXCsixKCWw4yp57AcdP51ViKtIiKoL4+U5wF9/8ACpYwqDLZKYz75z2yfoM0XNEWzkKQChPQttzz/jz9arBAzFTwR/EcfXH1+lTiOMSOY2JOBlck4z3/ABpfLHJWQkegGMUmPbYgMuTsJ3DAxxgg9hk/h61OLfZGVhbc5GAOoIwf0/WobRgs8hKxgsSyuwLHr/nFTR7QJFjGGOQy45U9yCOo/wAKLgx8RAty77cqpbaOBwc8/wCe9Kdm1o8KSOvGQOc/rxx7VHCMSnlccAjnHB/nUZcF2UhlAxkE57YAx2pXBoRvkhCkFQp+9jP/AOuoPNVguG9QOOT7fz/OnTO4ZPLjLo4LO5fGCAOMd+9VXDwsnlLukbHyk9D6n0/+tSuKxatWJjzkjLcHH16VcPmZcKx2kAA56VBbowV2l5GSAQeBV5Xbk+XlhxtY/wCfamPqPiIBKZOVwuBjFSg7YldmGOBk8EmmQrxnJYE4+7374qXaOqZKsOCMc1a2M5DF++CTjPB7Aj1p5VpV+RckDIz2oRU8ogbsgZHq34U1z8jAuVJO3K44wPQjpTE2QQRJGSFyqEbgF4APoaS7SMA7kXbgMSM/nTv3qACTbjqW24DY74+lKy+g5Iydp/zxSG3fUzLtTs2MAhPIPQAjOMjtWVfiRgsjkBoxtLHlWHrx0rauI2WIoHV+MgEYx+PNYWorNDuJtiCwzjcASPT2P/16ogpLehpvLkAG3plu3txz/wDWrSs5HGGk/wBSfmLZ4x2z7ZrGliZmVljDsQW2n+H6Hrnr+tMS4+wvE0jG4ikwvAwEOOmOlUJ9mdMZn84tE4CMdpIYZ9cUjK+7nO3BDAnoe36VTtpBECVb5Dg8AdaurcF0wccjHt+VO5ElbYhkjILq3JOACeOvr7fyrPkjYkszAvnoAMfQjvWl5hkXa4GQM4xjOeePWqMjEoMrwAQeO54z/OmYsp3DjZvGAy847e9Z0rKoJjbkHI+pq7dFREBsK44x9ccVmXmVfBI3AH8eapMxkU2By6nLKQCD7+34VCHwMFVz+H+FTSMUjXC5GcjBHSs5zCXbckmc84IpxZjPU+brdtsuSce+cYrtNBfGWYgMOo7L7H6iuJjJ3j0zXS6BPsZ/Mbkvxu6emf0r0qy0PNitT0jSb93uIIlR1DbmaQjK4H8Xqe+K6iPfKBhQhPBYHkD0/GuT00eYrEuVKrncR1x0H06V1NjJ5iMFXaEPzJ/dOO3qP/r15dRanfBaXNV083CKEXbjHtx0/IZryz4taGzRwa5EAWACzY43DPBr1SBtySjB3BsMf9rAFUvENkuoaVNE4DK6kHI/XHrVU5uEuYJw5lY+fLS7wJCCN+PlYHv9P89K3dIY7FbfuDdNw6muWu7WTTdVltmLKYnxz9a19MkGzHC+Wd2NvXnp9f8AGu2pFbo4720O+0lwEDDg8sF9/wD63eutsmk8lWdUABBJ34z0JJ446friuM0PbKdhwSSFGa7O0JiDbyAqgE+m7qFHqehrz6x30FfY6BtVNtb7YYwG25becAZ6Z9OOfpWRaIbmaWeRAolOd5J3OoPH0yefpR5264uLd0DbnUyNjO5io+Uev+elaCvk/OG3k7nzz36cd/pWF76s6ZOy5USW3Mzq4GwYbOe3+BOa1LUHK5QfOxyOnHoapQoBM0owCTtJxz06fTjNW0YrtkY7cHaoJ5J6n/PsadyYokndUYvKTgYHt7cfpVlmxy3XOCB0HFZoDiQebKW5JIVRgn+f+FXEZTF86kyDqBnnt+NTc6Yos7wd7ZJBGA/t/nNS20+wKAw3Sc5HUL39/as6Rn3Z3lUBGfXNSxTbX2fLuHJH61LkbxSsbEVwqMGBbfjDMB941MrrkYUPGwy24fN7fTms23bPIPKjAY87fYVet+oc5Iznk8fn2/CmzVGjZszIZDEYxz2x04+Y/r+VSBhh44wg4JO7+Eev+eOKhG44jjLEBsbdxAB/LNXI0SJWThZCMlkIy3r/AD460DuQw7yrZUiMEZbGNxx05/wpI0eS4dlUoFXYc9DycfSpIFd1O5st2JPGOwJNNVHw0jujEqAgA4A9xTYxZfkXMbJuJADMMAEdwO46/wA6hEO5GAzIqgMdoA5P45zj+dPug5JVGPmZBAyDs9TQo2lmIJkbGAcjnoTmkFupAxRUQIFAXIwoyB2z+hFJAu6Mhl4Zucf55JzUjIJERcqxdSOB046Y9cHHWnqzq7D5sqc5C4wO/wDKpEPjV5GVTjj9P88VI4w64yxByQh/nSQK0Y35xvwCAf0/U1IvzO6Ahsc5J6n2/lVATlhKhiLEZ4BX+E+lTLjy2UnOMDnqM1GAUUiP5W2/41Io3IV3kHPoPTn9KsxkVpSAjOXKp3HfGf8AP0qV1AVhIoIwSD7VFcv5eSwyCMAbSxPvj06fSmBiMJtDLx8wOeQKTLSvqPDuQBuLJtweOWPqf896aYwAoUApzkHj8QRTt6kIMYz39eajtZ2wxVmZQMYOTn6U0DTtoQ4UK6FZEPI5yc/SqNyhmTDFQwyQo4Y4HNarqvzNjIJHUdf85qnMUSAMJCMNjHHrxVIzaZhSl4VlRlO3G5WAzgev41g3kEylmY4TuIzjbnrkV109uzRHaFXBALbupznIHrWfPDIPMBJ2g/McA4J/z1phuULNkdY0tikIxwrdGPue/wDnntV+Ik2xJzkLnd0PuKdHbzR4dtrfNlQEK7jjHegKC0hJMfXgjB9cj+tVchpIsNGhjPmDaQMKev41QuY2Kh1Y/KOBjHHf/wDVVp/n2jof4sev4VHLxgnaenfrTMJ6GbcnMecb13DHNY92ZFdj5J4B53AZrTmjCyF1YYHAHrzzz/npWdduG3srBC3Ud8imc0mZ1wxMYGG7c9CMen/1uKoKWZQyFdhGR34q7eTDYBzuHQDpXNs8asV8o8HHGcfzq46mT1PBf4/XFbei7mugVLs+3HOTx/j9KxMfMQOlaejS+VcxsWbhuAOK9SorxPOTses+Gpy/3gCOufc8/liups2ZVCqwAHAGOB7EV5z4duVJSNZCCTkL65P/ANb8K73T3DkPuDYUAkjr7V5FWNmejTd0blnvjVg+CCSwyMdTUd5cpGhxgOcHaxxu9/8A6/tUcTn7wbPzYA2kn6VI4Ezgrlicrz3Hf6VF+ho7Hi/xWsfI1wXkYbEh+ZtuM9P65rmtMlzhN3TOfp6frXrnxE0r+0NILjhogQB14J//AFV4xYt5UzhsgrkEZ969CjLnp27HBWXLK56L4WlMs65+71Jzkn3/AArpXvmZ0RT9122YPG4eo79evpXG6PdC10iSTzMNkhc9weP8/StbQyJEkkZyCAyZJzk46/iTmuWrFNtnZRnZW7nbaSxBB+ZmbLZYcgE8Z9z1x6CtW03SNI5BIDnoOmK53S8hyEZsJ97nILevP862lZUURbm81sH1wO9cktGzo6muhAO8EYAOST8q+3vmntcqhSMr+95MaE5LY4z9OetVFcv5W3LeqgAAHn079atW22OYyFOqhcnrnuR7cipvc0iizFHtiYjnnA9c9yKDIAwXcUKgA+p9s/rSqwnZJG+qgcdO9QT3BjLM+GAznaeelJ2sbRJZZETLNktwAD7/AORSWm95CXB2nk8cg49azoWeUrn7oPQ8/jWvZISw242AEnnlqnc0T6It2pLTbQNwUE5AJFa9s6hQYWAI6gjr7AfyFZ9vAF++GWM5yQcZJGamgiK7WQ5Q8BepJ9QfwqzZGrHGRksvK5IGMAc/z7Vetiz5Jxjdg89PbFVYtsrAcgA5K4yeBjt71dggImBI+X7y7e/1x0qkim9NRRsJZFcbuM5GO/B/GnsoQlgpDDgEnNKxj2fu2O4sMYXr9fpQWRMkqHGMkk8rk96GiblNMCcOE6ckA5J9DT7kI0e52UBMg4PHoR7n/Cl+0xqUHId8pnPB+g/Gqtw6bZM7cEgbSck/WotY1s27ld5hGpmyxIb5gOuc/oOv/wCqrBR3yu0kKMgt3/8Ar8fqarx5VnicqDH+6z1GOev55zn2q0wKoU2hgSFO/j/PqaGhMnidNzKw3KvONuQfw/KlKLgbQwYY5A5x14Hf/wCtUO4lAzjGBy6cEjjBq3ADhX52k4CMefp/OjcT0JGdjn5gCw4YjGf8+lMklKlVOSMkkEfd9s04OFHzOAo68YH1J7Uxowdx+cOODnHH09OmatEK19RroZGBeRlI6EtkA+x680jKwDM+fvcAcdfbpU6quzb91scf/XzTSAqsGO3Az1/lQFyAErDlwUYdQV4Pr06UirHtJRiQBkANkfhT2C+Xu5RcZOOo/wDr0xAX2yNjDr0xn86BkjKzpkAjcAeent+NU5U8mRth3KxyoxkDp19alZhlvKbYB3UDmond9xU4Mh7qeCKpECxEh9rO+9VOwnnIPb34xVZAMtuUFR97PrnocfhSxzi3laPzAdw3KSoGz1APpTn2NAGhLFzktu43f/X96rYhqw1wDncevTFV3IznO4kYzT96qhDtgbuMcAZ4qvMXGQCFLE8+g9aZEkQo/wAriIkhSV+bjnpjp9aqTD5SCTgZGMd6nuAojZovmwONpzn/ABqtNMxPUqeuD3qkYzM+VlbKSqGU54xjJ55/L+VZd+hGUWV1TGcjkjn3rVkbKAshOOTjqee+ayJnf5jnHByADjOfzp3OaSZj3QVQS7OTgqWY9sj0rKCKRkKMHp8orU1NVkjIbIbGCcfj9KxNvqFJ9fmrSmYydjwvuenSprRiso2nBHp1qHLE9T7UsZO5sDcOp57V6z2PNPQdLZDKjISckqQBk9O1drok5iVvMlMihs7iMYPQD/Irzbw9MYpGSRzt+6M98/5FdnYXDTOVR8OmCeehwf8AD+VebWXQ7aB20M3zoW3ZkcjGe3+eKspKNpVdobB4Hsf/AK9YdlMW3bF3lRlmf+EHrz7HNasMiRxKXVUZj97GBzx1rkd0zq5Rt5AlxE8UgwHjK4POf8mvC/GOkSaTqbMQPLlXII6f5/8Ar17jcysLiEYXbgKp6kZ64+nH51l+LNAj1qwaPaN4B2n1zzj25FbUKvs5eRjXp80dDxuG9MkscT4CBxk++On+fSuv0qbaHO4EDK56ZH+fSuCurWXTdQMUwYEE4yK39IvgEGWG/wC8Tn8+PXrXXVgrXRyQk09T0nTZgu9lbdjAB28tz6d63LWTezRll3Jgvj1POK4nR7wtMNoOzOcnoMc5/HFdTpI/fJ5a7UdQSD7D07HNedVielTfMjorOIImN3Xlh3z3q+shkkVSo25z0rNtLkBsArsI65x+tMu7/YfKjIZlGSuenua5+h0R0Lr3Swt5eTI4AGSepFVTK1xIzAjk/wCcVQild1b5su7AZPv125rRsYcruJBJHDY7e3vUtvqO99EWLSMrIGDDdnByOB7VuQGQMq7fl9cD/PWqcO2ODkEj1PJ64qxFIzSBUQhTxuJ5+tNOx0U49WX4QS+HyTzyR1x/hV/zSAp2q3qcfM2P51VgX5o9rEryWYdfwq7bRrwcgttyWIqrnQti1pr+VhXZgyjgMMZ/zxWjNkSglR5RTLyMeSR2FVLSAFQwG0f3wQCD2wfXpV6KIgFvNMrqoADfN+lUhS0ZVgkk8149paIgfe/iJPHHT3pkcEt5aZnJQMASCcbjnA6/StNUlk3jghAOVXb05zk9eKSZJJQ7ll2qAw2nBAz35qw9or6FCDTlkusNjy1dyoPJ5A/w/Wsu6WOKaVJipuBk+xBGAD+vNbU1v+6kkJbcz53Kcce341mLatGZBMI5JnO75F659fTjgiolLSxpCTetykJXe4jW1+ZGCqwIxz1OPX61pAsWYsflK54x64x/P8aWODY4lt4wJFzyT2xwBj6dafGMEssbHIAHOBwcE5/CswkwyFkP3XJ7dcjoRz9KmhAUx4XKk9R0IHHP+e9Nt9pzvKsMfwnn86UM2QArbW+YN0IIPr/T29KoT10LZEXzQthkOeDzgZ7+tOHDFdy5IwMHg+/9KbDtaP5n68gjpj096jkLEAAEN0K4wRn3/rVGVruwkrPu2rtJ5Aycn1A/Gm5UsEfdkAsCy9vrTuSuTISoHLHOfzqFzm1k+Zo29SMkN/L+dItIXKRuPMYZU565x9adOf3eUICsdzEdT7EVWtWCBo0K7wo3qCe/cHuPU1IM5ycspGcHGQT6DvzTTBruV5Yw6HMSsmQMFsdsetV44iGYRPhiOQxOPzq3Mq+UzBVUY5APb/PaqsmwKMsfmO4jJ2mqJaEnTOEmB7bXHX/PvUJfYpVAqux3Ej+L0xThI3mN8zPGOMMMH/GotodQyqAp5yCPmHpg9O/5U7mbXceFEjfMRgnHqPxpJI4woUoDH69ef6UxVdj82GC4yF4/IflTGuXjXGAVJJHGPw96aIlqRTskUezadoxyo6/lWbLksGwvJzjv06mrzTmSIlQGHXHT/wDXWfPGuRsfDAZytUYyIJ5sA+Xnr1HI/wA+9ZVwwG7gNnIyeO9WVR4owMnPGABgj6e1UZ2LKwJOfTHOPWi5zTRn6gAU4bBz6Vzjrl2+71rY1MExbfm9c5x+FYslvmRiTjJPp/jW9LY5aiaPEMYY8e/SkH3jwaX+I7RkUnOSOOK9Y4TZ0icLvBAzjPJ7d/8APtXb6BIzhsHDrkEk5DDrn3Fec2Mmy4QsOhwa7TwvdmK6khfMink9xjHX9f0rjrwNqMkmegWSsXYGQk5AVh2OOQR3HT8quXKyvwCI4iMYzkE/3e2P/wBdZWmuAG8rKMCCWxjg4z19sYrURC3mRPsVDIXcOSccAj6Z/wAa86WjPRWpafJEUuANjIGx/CM8/lVl5NkOQflXD8HAOemfaq43qyybkG4coRkYJA/lUMIAguLVDtjj3hXxztxkfUio6jtocH490hJZXlixsUc8dWJ6/hXntlK0U7K/UEqa9o1e3L2UqzKqkpu7ZLe/4V4vexGHU5Y8BcnOPxr0cNLmi4s4cVBRd0d34dmJIwC52n8fxrudKbagJ+Zl9+/Nee+FTsJYuxQDj8s5rpI9RkjCxxtgkYbHdfX+XNctaN7pG9CaUTqdQ1NEjxFt83px0X61UhDEupB5O+QkcsSegrEtm86Tc4AQEfia29PiErLt647HAHPf/GuecVFM64S5kbFvGGG7ZgKpCr1z71pacRJHGCh2bchWYcZHHHQVnWWZQQAVQHaueC3v9DXQWUGxB8oyMbRj/PFYPU1gi3ArvtduCOAoOfpVy2jVRvZM46gj7tQwLKFbfsGSSp6nb6H361oxEFCxUkhccDNXY6oIkgjfGc5YkkEDr9T6VoafGQz4OQD3Pt6/WoY9qDDMFj5LMf5fhnmiG7ES+WmCpHLk9f8Aa9h70amqTeiNK3VIpCUJ3r/EMNj35q4t5FhQpJO/PU4B6Z965w3RPm87lXBYq3GP61as5FbqQSF4JOCPwqoot0Lq7Oi3K8btgMeBhs8Yz2zzUUQP3zjc/JPUgdsfyqrBOhh4LBtvGCe3fGMn8PxqOW5kZykZ3KFxkcnP175rZowVJ3aL7upIDKScjI6NwO/pVWU4QOgTZg9s88c4Heq63ZSIBmzgYyT949gfeoROhVvKZpFYZAAzlsHK59Ae9YyRpGk4lzbuVmGS275fUHOR29cdfWqOqIziVUbEbJtXaeQccYz/APqPSrykbT5hyCRuOOB19OnPXNRKBKuzJyCRkDPHT9eRWbY07O7I4IcwIwyzhclcbcHkA5+n+FSxfu5AoG0Ng/Qj09uPegPbpOU53bCdmMD65Ptz3p0MjSO0qxhoRwMZBx3PX1x+VUJt9R0g2RlAB1457565HtSLvd3LNzzgHkD8RUhy0b4XcCOWA/n+mKbIDETkJnOPung/570xJ9ARsgkjdt4LYySKCiHIK7cnORxn6+tMwyykrsOec5/TrSxkx5J+UkZAJ4H1NA2uw0wq5XbhE6DA6f1quyyb2ydyk4JHQj/69SJI7OwkXOBk/LwM84z9R/nNBQuXyDnaRgfLx68UD23I5HAA3LGC395uv4euKriYM5fDYJ4Xp+WKLhUj3AqSFXrjofX1/HpVSWUkKVcsOhzwT7VVyGhrSRsd+cMc53H9abNLuy2T5S4ZSpyD/n8ajEkbP5a/LtHIIxjJ7Z/HpUbRhJMwspyvz5Hyn6Y5zTJZJO4dNyZOcZK9veoJVYM33Rg7e+CKR90Uhb5WH93HU46/59KjlnBVQWAJ9eoqkZSXYjmIUlyCBjGFz61UkGVPlkH5sp8vI471ZLNIq+WcKpOT+veql3KkZKEkFV3fKPvD0HrVbGEihNMWjDAZ2DBXJzVCbKQhpXEjdc7dp/AevtVq6VsCSJCpY5ABxkdcEf41nXEoCqpBO77oK9MD6cUI557GXdkmHDuzbjgYXg59PesZw+9sBcZq/qSpCmY/lYNn5flJyfyrFaQhiME89a6aS0OStJHjmMtxSEDJ5/GlPXpTTnJNeojiJIyVkGOPpzXTaE26cFTgsCSSep/oRXLKTu471p6VNtdvlJ64IPOewrKtG8S4NpnpWkzPPlDK6EAjAxgg9zkdeeldBb5kBM2eNpKdyMj9e1cTok++aBclhggO3GVIHfv/AJ9K6zTptsT7imHzCMduf17/AJV5dRWZ6VKV0bRUXDFmLbY3I+XkHA4x6gnnn0pcEMzbQSo3feyuT0/liqgvPLeNvJ2oVChVGAGwRj8P8ahhumjlECRO8rJvD4ABDHufbmsbM1Ev5Vn+07ucRHaM55J45/L/ADzXjeukf2uzLjDDOa9fu7ZYS2c7RGWKn0JHpx+FePeITjWJSVCjqPpXdhfi0OTF7I1NKufLtyEI4521u6eTLudz8pPr1+v6VyWkZeUlscdsdPWur0tFuJlTkJwW4z74/wATRWXLcxpXZu6dulkAjUbR3bpjvk+uOgrrdNhEUe05wTnnqTWRp0QK7QmNucEKOPcenpXR2qhUGR2znHQV51V7npR0VjUsVw2ensOTWwpUqqj0/P6+1ZNj8zd8YrUiB8r5c+/HJNZrY6IWRct9xjCnkhgSc4GKtNN5aEqQQwGQOQfw61SyFTcwycZx1qHzmKNgksBg4GM8daqx2U482ppm7ZzgkDqB7io5JtrZ3ADGcY4rO80xovygkjG09/eoJpgULSuRg4UFuv1pnbCFi/8Aa921S3JAOW6n2q3BeqZGCS4Jwc46fmeT14rkbq6GCI1bJAU/N78EZqtbX7rKoZFLjq7HkAdsY5z1zTUtTo5FY9MeVFTdCwbaAMgZOR+PI/yaa94FVkLBy6bj82OCfYcfSsG2u4WizE7iNSUO5Rkrg4LHpu4Gcf8A1qZFfPvWB2UEADbyTn1HByeeK2Zjyrqaszkq0jYMajL7j90E9yPqOnHH1qaOQ7ohI27YMsxHyjrycdM8n6Cs2xYiXA2uWLKnO5VAB5Hbjn6E9qliYOu1XwEPUuCQdv3h2BGeSeBkVkwa6G8HleE5HmkN8207SeoJyPxP41MwbYhwgRxu5Ofxz1z0OfYdKzrWVyGKBYl6nOeBzx7jkknvV2KNcTEJ+8kYSHLcE4HAOTgcdu9ZNanJLRkqRtIJGblieEf+H8Pwz9eR6U+1O2IIzHzAMYbGR+PTtTAfLdg7DMgHLJkA9Afx/nSttAdsEjGRt54x19gfqRTsZ3voTRqIwzjIdcnduHXt35qLzdj8lgnXJOOff9KaYgjMWcYJHPY/5HfGOlMb7+5XHzHG7aVx7e3b170FKxK7qr8qrOT13cAfh3xQ53IpjUnIGQehHb61E6IVBjYo2c8ADIz0PtTxF+6VlG0qDlM/5xTSuPQit5xOJFVCpDFSduCx/wAKdO5CDCuznIBXt6GjI+d2VSoGeR+HU8VDIHj+Sb7rdsZz9cUAyvNKZM7lIIHPGR9c1WlxvZ/L2q38JOMn+hqad8syBQOeOCTn1GagmdxneW35wec1REitNLuO5VVWx0PXgdzUIT5WdWGQuQoPSnyyg7mJTOQG7kDp/k1WkQBSSRnqQPr3FBk3YWeSVLdzGkby5HyM2PyPNNfLQ4wmAMDHJHrULh9rZAdc8D19MVCZmjjCEbjg8g9arYyciR3OR5WGjYDI6HGffvUU0ySNy65xn3pGuMcKqEqBu459qgyQPvbieu/+VVfUxk9CtdNt3fOR2PNZF7lgSzlsc57itGd/kYYDD0x0rKm+XdhQuPQD8aaMJmHqU67CRw3Oec45/lWI0jbj82efU/4VpamzBgOOMY56fX9KyuBwYzn6V2UlocNfVnk/fr0pvO44pc8nFIfvHqQK9E5QGN3GT6Vb0x1WT5lyMHvgiqY61LbY85enOeW6ClJXQ0ddoUrLvkYBc4C49R3rqtPuvMn2rzsbLleQrZyc/T+tcbpdwUkzg+WeGPbk/wBM/lXU6NLEk7+afnzukzx3xt/rXmVVqzvpPWx1DhHCyySA/MAVHYHgn2GMjPWnRKitO4wFjwMMBgrzznj8PXFUtMkjJI3IFX5GkB6Ac/4VLYos1ukbRLHISOCv5HP5muZqx2LUvXh3wGSQIJHBKKR0C84/lXi3icbdSU8g7enoMnFewzEm3cjmQIQdycdy3H5c1434iK/2kcYK4GADXVhF7xyYxWiTabEzIScBSpymOTz39jz/AJNddoEziMeZxJwrYGOfSuU0l8sqjf8Al9P1xXW6bIkY3HOem0fWnWvdnPSZ11hgBmB5YdSOlbdiXCR7uMcY61haLIHjBLKc9hwCc+ldHp7bkJYDB6Hrk159RHpxuatupdeS3Pt/Ota2yFA5DH8azbTczkNnGMlc1dVgM4x0A5PH50rWOinG5JJJ8zRjAB49Kg3AMSu5U7oT3pGTeUD7WVv4gc9fSpFRCpIzgEjHYmk+p6dNcqGSSqXYKoxgn1OKo3iMwABbgc84H5VfnA2gZTbjnJ75qJ1KooLBQejN3NOSvc2i2jmiHywDuHJG0ElhjrjHarFlYo6/vU3FgN5xnd9RUl4EB3RbXBPChsY57D86bb6iqJtXJYHcec/gCKn1NlzPY6G3tSYUSKL5Bzwxyec854qEO0DMF8wk87hJj68A9xxknp2qpBqrSDyhvHGWB7Z75/z9atTOjZ3kMQMH5s4zx1/ma1ctDKzvZk8THzwCPMGCFYZdeOw/vH0+ta1skhQ7hMqr1QL05zgDGPQcnr+lGxQrgko3IBPcjPY4wB71r2sYkYKyhAw42r8oxxjjk9x/LHNImciW3jlim4zkjAAB7HnGTyev4VpW582JV8tdzdAR+ox296qJGiyZUCPcBnZhMH02k8dfr1zVsEeSUC7i3yhiBzx2Pr09BzUSOabuCzMVySS45bHU+mQfzx3weeKmCKk27Bz5RUHeDuPH/fWeP0ppd1UDccoTuCndyff/ADzUAkkjZ9sLeVymXIAGf5/THWkZlt3C5Eg2EDAwM8+vXrTWTG5eEOcfKuQPpjoKjLMFGJVVXB5AIJHXr0/H3qN5m+zxkqVwM7AxIHPrTKSLToCoO0kg4xyRx7GoSpEgG9s5JIx1/wAKE8sEM4JXpxjj0NTqhHzbS2T+JH9BQPYq3MWUIQlSejAYz/j/AFpPM81hGvXblkLEEH/Crqoyq4DYOThtvTnj8KhmDkHEY3MMnce//wBb6VQXuZE0UvkMXIEY5AxyR061EVm2qCo3g9Dz2960pFcMqBcrj7o4LY/yaidfLAClQM53En6j69aBMyrlCJGaYbhgE4Xp/wDWqooARhk4PTuQf6Vs3KyjceN2ecjqP8ayr5PIj3MpPGB5fXj+lBhJFCRsRn5TjOB2qs86iTDZGOgxwfrV6WPdnPzcc9sH2rKuLWSMHy1YKDkof50anPJDmLSBmOwsPmAWq7lgAyN0GMMM4PaoZ42eLOd2R1B6j1NUGaRFHlvJEB03NRfUxlcnuneNirRhgf4ge2e1Y11cL5agsVPIyxx19e3Sp5ryaNQwUZ7jr79azri+gmjIaMxseOTla2gmYydtyjeEtHx+XrzWUXTJy3Pfmrt2yMgaEgcDOOaoea553oM+o5rsp3scVV3Z5UPvZHWm0/8Ai4/SmZ5NegjmE60+L7xAP5U0Glj++KGM6PRJw6rAy8HJzwc8jj8s1vafhrgxPIoVhjBOSOf5YOPyrk9KkWKWOQ8KOD/SunsmVkdfusckH0A56/WvPrKzO2k7nUWfl7nleMiMgOxbA4zk/wA/0rWtVxBHk7WJKE5xgnoR7fdrEtrhktUUJ8xUKSwxg/061as5tygAFR82S3p169j2rjkrnfE0J5EmtwYNuCdzDB5P3cnNeReKxjUiQACSc46HHGa9R3+XasNoZEVmB9AecfnXk/iGUS6kxUgnuR/n611YRe+cuN0iLpDOZQBwMc812mkwNsXccjqSTya5vw9bggufujvXc6dCvynPIGWG3PHrRiJamFCJtabDtVQoGzOemQMGupsVVWTdkqV4OOMVj6eiDHyBVzndnqP61t2zqxGABXnTlqemjShIjlyAuMeuM/WrEjtGudpKk5XJ/Kq9uyy7QABuPTH61pJho/mVCxGRznFK99jpp6FRGLL1G32HNWF4U53M45I6fhUTxzDIAVO4BHHFSxxuGZnfafx5445ppnoQGBeRgZPOMDvUDK21lY4HGMHp7dauonygAnaaUFYw56H6en69KbNkzBvYWLowKglgCSRwPUetUVstzs2xSCecqp59eOa6KSEMGwMZxyVxn0oFnggqA3rg8g1LRrz2MawsLiZyOQAflAXbz+JGfqa6C1slXZkJHk9VTJHtjJx9afZwZd0dF2qepXp7j/IrQQEYEZPPDDfj26j19apKxjOpdjrSA9Ew8YOA0YbAHdT7n17e1W4oht34jKLgYIVTzwADz26YyaW2hIJlkUyBR0JDcdsEcDmrECSyH7pRidokkPUkdyMcepH0ps55yHQxbw6MWT5cKCBt+hGM5OOvfvVmLMccittICjG5cDGPmAP5frTFje3yzMplBO4IecfQd+3PapXkjDEIB5ikZG7PHf2x+XtWbZk9SGdJWClCCWIPzgttBBxwPUY/+vUsUjyKEZlCknKk9CR04zxx26YpGG4gFSsmM5HOe4P8xSMmW/dMwZv9nIwe+f50XE9iJkZtwwGIPXkH8T0NSShtuRtyp5+Xr+NNaPru2gL82Qdp68+361XnLR7eHZA2flJ/I470DLEO0kFVdG75Ug9f881KkimULyM8/KMfhz/WqgczLLtTKHhmKggg8dD1yP8A69SIYUCrGwABz8xPB+v+etML3L8cmRygC5xlm+9RhPOOCCQOgOSeev14qupAX5TkE8YY9P8A9dAZA2044J42kfmTTuKxZkEaLiWMFGPQcYqKVUZSc4XnOVx7UoR1bJZmBG3awLfj7UrblOdhfHQjkD8KYkVWj3dhnpkjgY781nTxBZ2YHAKgDPIHJzn9K1yNyMEDYBAPOc1XmRiq52kA9AOaAdjCu4kDcDcSMDBHQ1Tu4B5m3J/P2/WtqZFwpMaYPBZVwQevXsaqzhixOBkj1BFNGU4o5i5so1YsMqQOcEjI/wAazrmJAwPOG4HGMmulnWQMwyqnHClf61nzqqqwfBzyAfWho5pRsche2xROVQq2TwuCB6+9YF7A3ltjdggkhh29cV2l6gZPkO09Qx6A1j3cG2Nt2GX72cZP+NXTnYwnG6szh7sNGpDJk8dM+ves7DfwvLjt8xrptStY+SAqoeMHsT7/AIVkm2XJzu/75H+NehSmmjzqtNp2PMBwT/Wjgk0pxu4/+vSHqa7jnE4z3oQ4PfPtSd+TQOtMC9ZSAOADjnk9a6LS7hopH+ZtgOAvpnqa5OI7ZMnpnpW/ZzIkfybi/crwNufw57ZrlrxOmjI7PSLj5FeckrGNu3Hc98etWLYMCzoxMcrkPGzde2f61zVjcJC6qjDaGBIznp7Vs2l6hBzw+TgMevt781wSjqd8Zq2pZ1xxFZyBhjzPlO456Ecj2rzOZvtGouTnqR06V1viicLlN5eONNvXNchp6b5ucZINddBWi2cWKnzSsdToSAEKiZA6A9+cEiuy01SxKg7dx5OByPauZ0WL5UztUcE9hzXS6UQqkt90EKN/GecZrlqvc3w8TpbIoylSxwACTgAVr2aiUHuDzjHWsy12IAEB+YYBz6ZFbNtlQCV2kcn29ga4JanoRRqWqbEH3Qq8k+o/xrQiRnVQC244IwMEenNVYgHVWXawB6VpWkYyNqrwP4h2qkbRQjx/3m3Anbx0J9anVQqqBgjoT7VOrI7Ej7vIPsemPrVhIUZMhDleQSAKo6IysZqJwCFwMnknqfUVLPBGy4kwD32qPmFXzajOGfof4QOPxomslwDEwVyeDnggUzT2qMvy48AcAemAB/8ArpDCduAV5/iYHAB6jNajWixITKOVG7A6UCOPILquAeuOp9BSbE6y6GcIQpYFWZOAOOBj0q9FA6/u9u2NmwQ4GR3OPT69asebHHE2wlc5+U4AFRIxIPlsB2yR/P0pNkubZfgtwh3bsscYMh5HPXnOfoPzqz828MiqyRZHm7ep9ARz16nA9Khs5WKJg/eHzAZGR/8AqqwpyrMoIBXjAwcdR3zSuZt9yJsshjKgoB5jEYHJ9R07frTlicqoJyGH8K4yfXcfz9amQABuQMDJ5/X/AOvQxCyBc4Xbs/vEj1H+NLcLleKJ9/mcEjgbm4z3wffg9Ke0ShVLLtYrnZjk++OMn8qmcuJHDAoSo/ecgEflUcm1kXeGxt+b07c+h/8A10WC9yMhhuDZDADO5sbfpmo3AO8shGcnJGBj0/8ArVdHy/ddFBGBg4AGM/j9cVCWIhkWPciJjJ+9nA6e/wCtFguUZItwIeMOScjI5x3XHXipoocuyxsox1QNgAehAqRj5sZcKW5HzDnnPXjp9KicMrPtaMMOjnv9BTGOYLGwMSbRgkgAZPHYcVJBF+8XGVXHJJ6/4d6jYsAFSRt5OQRnP/6uaRXk3GOX5eOhx27CmhXLwRg7lWPyjghj/k0+NgD5ZdQ3QHGKrrk7cby3fnP8+tSSSAFgU+/yQcZ//VTRIh8uNZJXHQ/M57e9VN7fcZSMqSCq/KB2rQKqxIRDn1xgA/0qKRPk+Ytjvzn8KBXMe5ZWhbew3Km7AGSDVNzmMFiOACdh68dqv38f7pw6Ru2MDDYOT9R196zXi3RKz5YkDoD8vFUJ6mXeTHcq70CHJLHJ/DI+tZkz7mC8qRn5eR9OnWtG4tDCrDc2SeWOPzqhKSIyCcp6bckf59anUymihPlo+NoYDgEdeP1rKvYmbO35MDn3rQljkJQw+XIvViWO4c1UuWYbxIVXC5OGzkf57UK9zGSOeu4ywJyM9AVxgA//AKqyTbnJ+cf5/Ct6+R1UMzHG1RwAAPYYrH37ud6c88rXXSehzVafNqeK8bj6Uh6nNLn5qQ8E4r1zyg5zQOuKQ8E0Uxju/tVzT7ny5QGbA9fSqkb7WBIBPvUqmAj51ZSe/brUTV1ZjWmpt2ju0wZCvzcD1wPfvWvYyPAczMrEckgg89Olc/pEgRshvmGMc/yrXbUEWCVRlZejAHBzmuCrF81rHbBpq5j63dNIeQQTnO7qef8ACmaKv74N6cGqN3J5tweTgetbWjIeeT1wR0xXRNclOxzt88zpdLYMBtZmJHAzW/aK29TJjYBjHp/hWNpZJ8x8AYODgc10dooEaxtI4DHnA+b8B39PxrzajPSoR0ubulKwZcsWX73XoM8dvrW3bGSUOAyo2/GUYZI7E1mWSsoDn/Vt/wACIHocV0FlGrRDbjB4GRg49RmuSWrZ1RaLNr80rxylNpx94jDHuK1bWNlbBLnBAGcD/P4VSsvLKFUxlCRnHIIPWtBNjxgkHPt1Apo2WhehgGMMQik9M9f8+tTxwIhGdi/L971qKKImRfkBUdSTz7DA61IqFSrd+2f6e3aqNLlpdy7C+G5wCOT+VM42fMF3bsnIxjHSo4MyHKKwGduepqRrcmTnGOv3smmybla5cf8ATTr+XHP41RkeWRCsXQ4UZyAMdP8APFagtlfsxbs3Tj0x/hTJo1GCn3M7jk7RnnPHWpbHexShUso81ldjj7oGB9MdPpWnaZUlicgnOAOmOlVsIFLIm1WJCnHOMdT+JzUsRAIxv6YJA7/4UmHNcvRYD4VnO0/3cH8fpU7zgPwOPXINVo5R8mNvHBUdaHfzFVdw24zg/wBQKQX7k5uOd20kkfMm7jH+fSmSagjACTPIPAyW/lwfSqUu4RssZPmYyAO/OcVEZUeF3uiWLrkn+ecfy68UXFuaS3URQ7Spjzjoc59ff8afJNyzAKcckEcKAcZx0I7VTtoElj+UESleHGRkY6f/AK6maKCBZQ/mROcDjO7njIFO4XLwUFi4G1pF5boP55qu2H3RqMkjkj5uO/I7e1Ll1fAG0nqzyKvH+f0quJY7lPmBRWwPLUAF29Svb6Uw5h8yK5EsfDcbjlQrf1/GmLKQirCwVsnnH3fXnv3qOV9zKN6xZyoaMZJPXBJHX6U9owsbkyFiO5YAgevA7UguTxKVZGyZSBuB6fl2/wD1055Y127njwwyVwOfw7/Ws8SHy5GkZWTPGV5bHpz/AJ9qnhVhAT96R/mwrZ2gdh+FMLl5T9/GVQYIG4AHPehQPMZtrsflA49ewplpEkuGKKxHQE8n3PoauRx5ZiCXBOck98dKaE2JhASVCjnk5xUMqySY8xFGCeS3/wCqrRQkKEIAx0I4qGYgHB6Y4wP1NUJalC5RScys3XcDjBB9qoSSbV3fNIW7Agbfr+VXJ2PzKBvYkZOOn1rMvVYsoYBpM5YAYH05/rQirJFWQmZz8hB7gDgVlXcJjHOB1yBgHNacm5Bja5BPA6D6VnXUhkB8xCpAJxgYpmckY1xAFBYdxz659K56a3mjLbTKx3ht5IyR6dP89K6mZ43jBUfNjaDng+/NZsjZDZcYyedvSlszFuxhzh2jVWRlIOck8Hmsx4X3tgMBngbj/hWzdOWhCyKMNggqeo9T/hWa7rvblevcmuindIwkeB87iO9NyMn0pxPz5IFNHXgV7J4od+KbTu5z1pOM0xiU5Tg02lPWgC3YyBZhkZ7dM4q7fyoygADcAc59f/1VjjqKe0hbqT6VnKneVy1OysLAN8vIzntXUaNvUsPlUjkd8VzdgP8ASFPvj+ldRpsJYrt9M4rHEPoVS3N/SgVckYHcD3/rXUWCgHDAtuGPpz2/xrndMjGAYxgkAg9PxrptPLtLtP3mGdueT715tQ9ai9DobOTy4fviQp34Gc1rWU2QNowGGRu61h28Zcl+CxPO7njnjH5GtTTtzqrH5s9CemBXI7mysbNhCu4Fc5PcnOf8/wBa1LaEb1YcMOxJ4NZlvLGHGdyhehPQ57+9aNlLC6MfvgfxEdfemjaOurNK3EjSA5AVRnnt+XWrqtukXDElhjBUf59KowuWQK6beMhT2q9CZN26RctjGW6Ae2KZZMVW2QP5RclgMRLu5Pp7dSTUjjYGyE2g7Tz0H+TUYx5gdVJBONy4x/8AqqzBtYjPzE5K7up5x+FDAoz5XJWMZZgCQvQdPp9KY8Y8shyGAOdpBGeO2OMVcjhEYl2wKFHI74456nio3jkJZWA2quCUHIo1EymU+UAP0+bLD/63SokDbSy4yTzgA/jTbiOeOJ3dYhE/zeWys2R6Ht/SmRIJQpEgODwFXaNvqeOn1/nRYm46Fi8p+/nBUufu59qnkmWILy2ec4HHvTJFVSfnRQflXsf/ANVV5AIFyRwRk5P+NTYdxtzPJlV2hEQdAeT+v51Bp0ss85MY5L/dQAkj29vekkmWOLZFsl+XJ2Lux+JGKybPUJEutoWLGSQydcEenY/jSkrBznb6dDIkzs8sm7dluVJA/L69ulW5EeOSGMy5R2HzYAcNgnHoePXnjvWLpmpbgIxhXB6kEF/c55Jq0dQNxC1tLjBb5nRsFADxhuoPp/OtEiJPqWjA3lnCQCMOcjYWx2H58dKqNItvK8fzrtKlk43FcdTzk+w9quQu6b2lVwQwTO5djYHr071Xv1it4ZGO3eoYCRCFdSePlPfjqKYr9jE1TUJJbCFh9oVZZVEOzByQcjvwcA1Nb3E7ndcW2woMrl9qZDZIB7kcfWs1o55wdsiLHFhBKRyWI9B3PrnOTxWxIkgFu8sueTkEgKCABgdsc5pWBNtj2cTXwjdGbeOHU7kJPUkn2A+v41cjJXzGjc7V4XJPXH6AVQ2kXsVwG3x4+dmBwCM4I/M/lVmBpRHujfbG+SNpHOTjA68UGq8y5ZuoUPGzBsZbaB1/rVtZS7YLAke3y5qlbK4J/eKWGMDb07/nViynDAIzKsi8FMDn6fzz71SGXX+8Q27JxjA6+3pUUjOEIKDIIGT396ZJcorRpIVTccAngf4VWlfyvNEskmXfc3zlwDgD5c/dHHKjvk9+aEtBs86qirCc87Wzx+Pp/wDrrMuJAF3bgQTn5ug/D1pmo38kMKARFFwdpOCM+3HFUItU+0jyjGRKq8kjgH3Przmgqw0sFAQgAsSflyAee9U53JDAghRjPPSp51dwTgYHXI7VSuB0UHhudgP6+1MymZ1zPu3MisuT0OKzLpzswfmznkDp71Y1W5W32rDaT3LNkMIRwnqSTgD88+1UJyZo2YbQqkgAHr9M/lStqc8noUr1l8oBmcRngt7euPSq/m+gcj1BODSSS7I2zlcEg59M9qzvtjDjzG4/2jXRCN1qZTaR4hjn8abzk8U7HzkYNN/iOP0r1zxQ6H0x6UlGDR3pjEopTSUAFFKKSgC1YZM64POeK63SRtmkVucHqO+eetcjYuUlGD146V1elsHcnIOOmTwRmuWuaU3qdHZk7l3qcDjOcf5/+tXTWDOI0EjJtON23gA/0rl9Lb5nIyWHA9vSul00nn5t2BhQepB6/lXn1EepSeh0VmqlQApXacY9Me9X4Bucsg5Y5xgjNY1rKu5t6lQx5J4yO1aduxeQnPzDHy9MY7+1cclY6Is2LZzlhIMY5ye9alrIvqA2cEHvx+tZFnKC4Kj8+pxVyGZXw6KcNg8dx70WNYs2odxdTjAHO49zV+FS5BUDqe+QP8Kybef5VBGGznrn8q1IG3nJGOOD3qrG19DQhXeFDCNlP8W45BHerUcbGUbjuT3OB1/+tVS2LBUO8DPHK9DV/G/ttI/iwO/pQ0Kw/Cp/CdvXZnkHuRUL/NGEXBXBJVsjHce9EZVdqyNI4JwpHVm9Pr3/AAoVGD+ZuCIPk27SSy5zn0HSixL0KskQt5BtJK5yfmzjgY4NVUtmMBkl2Bh85XklSegrS3FiTHHvO8457fTuP8iqF3NsVjOzBc9doH/1h+NOxN+pUntyv/LUK27kqMnA9z2pI40k3IhWbHoOR9acm1gP3yMTyEBx15/z+dS2ymLmEEluQDyaFEGysbZ40dvLSLA/1p7D0OeMHiuJ1i58nVlMd5Ftlj3BHTA3DqAx6gDmu5v4XcOpLOjcgcld2eue/wClcf4hhiurEWNxGGgIDtx8ww3Dg+uf0omtNSHqaGn3DCYWzqmflDBW42YOCBzWoryQyOIUZvOdMqpGdoA6c9RzxXn2naXLp00U9vcSyQlSquyk/KOuCOeMdOfy4rq7aeRyhmkk8wAAMTjH17fSmkZ81nY62zm3JIA5+RmVUPykknr147/nUNtBCLq4k2It0jEOSTuyPQ59MdKpQzxxOrvjcVC5DcMM+3Q9T6Uk94jebIlvhC+7co79B/IfSqauWpFrUhIUSCNkVi2WXPr1OOoNQoZvtCxtEDFD9wYIbAHr260yC7WNxHDCVJXOVAAU856fhzUYu3eR3hCs+dv3cgKOw9eamxa1NB7gCKTbHN5gGAp+Xk8AU+2khktCuUAwM4+96Z9un4YrNh8+8uI45f8AR12lso4HPoR278frVkWluiBNkcgOEUDntycDrTSKT7mnGXc74gjqwG4I2M+n0+v1qWaENGhkVgDz8oPHbnj6Utn94GP92R8oG3qv/wCuleQszEbwzAksnfHGBVKI1IkWNEXYGdgRjkcZzyKo30amQgs7oGyU3HGB3z1qa7nMYLEMpQBlXGNwPH51VnuwVUqiuAO3enYOYiu4o/MXKKCwPO3OB2P+fSqE0aRIyksznkngFu/IxUz34ClowqkkE+3HSsjUb1DH5bSBSOdwPOarlZm6i6i3qhsEKcKOQDjJ96x727cEqUycdyMn6+lNvNRATCvsUdcnn6nNcrqPiPTbMM01zEHDYyW6/nTUW9jCVZdTauTGVJcgg84zxxWJPKQjozpKp5XA75rKl8QNcxlrO2vbgHJDwwsVHuTjH5muZvvEcm+XL2toI/8AntMCfwRNxzWsKEmcdTGU49bm9e3KoNuNrg/n/jVL+017u/6f41xF/rMbFkFzNKABgwxbFPtljnH4Cs06gCSfLuf+/wCf/ia64YeyOKeLlN6IyDwT9aQ9TjpTsYY4GfrTcfN9K6jITvSUvU0o5JxTGNooooAKKKUUAPhba4PH410Oj3K+YOcE8c8EVzVWra5MTg9Bn8vpWVSHMhp2dz0LTbkKCxZSTznsa3bWaQvlRuKsByeevauA0nU03Yk4z3H+elbtreo8nzMc/wB4N0/H1rhqQezO6lVR3NvOdwdpB8wBAJz+fpWpp1wxwC4DZ5LDr2x7HvXKWc6sPk2mPuD6nPH6Zra0+eL5QpIfJw55x6cVxzhod0Zp7HUQr86srZB6gnjNalngxBdwbYM5Ix0rnLS8wSp2nPUdq1dPlV1BA2rjoO9ZWNFOx0luSCChU+mOv41oadMs75UnGSBgAD9awrZ0aTD4Ixx6/T2rYs5RHtKs2ByMHOD+daWNI1FY3lEbOQGxwRxn8P61PGZFG0KzIfmBQ5yfUfT6Vlx3IIDA5Yg5XGCau2dwwIQZLDqR0waVinOyL7rmICQSlSvDDAx/Uc96pyfKSJZ32rwFz2IznjqfwNMkuGjQlgyYONxHJ56ZA59fpTmYeZjehJU5DKy4OB09uvIp2JukTwfJmSMHLZK4IwB+P0FQXQjEBeVeM43EAlB6/Sn2zs8LBAny/MDuHJz0B9P5d8VDIH81MSYLqcKOjdO340WsJyuUo4I/MLl40D/w9QOnzAep6f8A6qdPI+VICbCN4YcZB9M9OvQ1bhtoH3tKpIABIIOD3z+H4VA0sDBd0S7nH7vksRz6f59800QytL5Zg+YljkfKynBx2HrXJ63ZbbRbzezXIkKMyH+Flxt9OwI57GusuLq2j/eXBjSUcMqkAjvjb1x6Y7VTvbL+0bBktra+bdKpLw2UkgIOeenOMD8zScHJaA5xirSZi6Rve2AIABA3bPX+h4/yK0La1dr+VUjDDGQD8uR0wB3PP5GrXh/wrr/lpKdGuUd1+bzZI0/MFs4+gyPzFdbb+D9WdMSrZwfxKVmYujYxn7uOlaxw9R/ZOZ4il/McRHDIt4UZCBtLEKTlD6e3erTB5rhEXLKoLMWUgk8Y/mfy9q7EeA7+ZUN1q8HmAYbbak7hxxkuOmODirUXgIBNsmqTDHQxR7efU5JzV/VKr6C+uUu55+YHlcecCpBJXkEFfcev1/nU8ipEi4uo1yd3AIx+Fdq3w409o2F5qd6YtwbCFEGPQnBPX3FSf8Id4UhLEQzTOfvETyOSfcg4q1gp9bIzlmEFsmcLFNHtG2UkdANpx9Se9QxSIkrmPOf4sdQfQD/P61295oXhO3tjNe2BQjCGSe8Me4+7b+frXC6/rvwu04sLjVtNhf8AiFvfyXLA8g8KW9PTtT+qvuvx/wAhPMdNIstjVTApKO2SMBjjBHce3FZ9/wCI7WJWJmt1BHOXA46dARXIzfEj4e27BNF0DV9euM53tE7x4z6SMP8A0Gq8PxM8RSxPJ4b+GtnZwY3edcJwMHOSVVMYHv6H63HCyZjPM1Ht950Ta40yYs4L+4LHGIoJHX0HODn0605LbxPcwPLb6FdeWg6ySxxL9fvZ/T6153rfjP4nzW286hZWitlo4baBSzjZuYqWDHgHOc9+MnIHnPiO61a8sBLquv6jfrKSVSaZyn+1xnAxx0z29q1WDfU5XmnM7J7n0AtlrVzGDbRwOXOFMRZ0PvuOAw46iuZ8bTReE1tj4t1LV4/taM1vHp0EZ34OGyz9McfgRXVfsva3DqPgHUdNlkJfTLzCRk5KQSjco9xvD/pVj9pjSItS+FstzbQgy6ZeRXRIHIRgY2H05Qn6DpQqME7Ml4ipJXbPDtV8e+HGX/QPDmoXjAf6zUtTcg89THHgfrXPzfEDWAuNOg0vS1xjFnZIGC9Mb2DN+tcn0BOD600cJwOvvXQoRWyM99y7farqOoL/AMTC/urok5/fTM/6E1UBwuMcevTvSYG0k/8A1qXsQfTpVDHfw+o6df8APtSjdj7h/KkONvT8qcHAA+Uf98UJEkH8TYPT9aTvgdPQGl3ZNNJ5pmgd+RQDyaOh560nHemAY9aKSigYUUUUAFLSUUASROEbJXcPTJFaFlc2mALjzlbqGEpAB/X+VZdFJxuJxuekeE9DvdeEknh5ry5SHakql1+TOcZLBcnAJwPStq50S+0q6itdR1NLG6lAdYrsJv8ALI4fCydDx2HtnFaPwEmNv4b1F1IBN6oPI6bB6+ma4b44CQfFbxEJSSfPXb7JsXaB7BcAewrndJSk0TGc1KyZ2enW+qctbXmk3ADYKNcmJj17EEDj371sWT+IIZDF/Y0kwDEn7PNHJ0HPRs46c4FfPVFJ4SD3OhYisvtXPp+K61xQHl8Paska+lu7c9M5UHucVoW+t3QYibTdUTBwQ9nKNvt936V8rxXdzEQYriZCBgFXIwKv23iTXLZNltrOpQp1xHdSKP0NQ8FHoy1iqnW39fM+pm8QlVBkt72NM4HmWsqc+n3anh8Ro1wgjW7aVhwvkSEgDJz93/OK+YF8deLlUKvinXgoBAA1CbAB/wCBVYT4jeNEK7fFeugrwD9uk45z60vqXmX9cmfUlvql1dSFkh1FlA+XNrKOvuVxWzaQ6ndIyi1eOLggXEyxKPcZbI49BXyanxX8eooX/hLNXYD+9cFv1P1qyvxj+IKrtHim/wAf8Bz+eKawa6sl4uq9rH2Lp/h4MAJtX02EAYCxSeYP1x/+utWDRrDzFe41+3kYd41RT+GS2K+Jv+FyfEDqfE10cYxmOM9P+A1PD8aPiCrYTxNMBnGTbwn/ANlqlhorovxM5Ymq/tH24dL8PEFJ7qWfPBIcjP4oB7VPDa+F7S2X9xC0OcbpkeTknHJbPt+lfDv/AAuj4geWAfEW9cZw1pbn27pX1Po/h8Xmj6VPfX93PLNZ28sribALMgJYDPAyc1TjybRRk6sn8TbPQ4NW0q3B+y2bIxJ+VIAh9ienX/8AXip115JULW9pO49SVA/PJr5G+N/jXxP4P+IVxo2h69d2lhHBBIoADMWdFZjlgT19+1ea/ETxYNbltYLHUdcurdIV+0yahetIJ5urMsYwqKDwBjPqa0SqNbpEJq9kfd2peOdO02JX1G80mwBzzdagibeSOhwa59/jF4TgL/a/FegAKpP7l2l/9BJz+FfD/iq20yC004abbTwy+SGuPOPJc4PB7jB9B179a56GRopFkjOGU5BqnCSerFCaqR5kfeU3xZiuvLOgWHiXWlk+62n6K4Q55HzS7RjHOc1AfFnxD1K1Y6Z8Or5I2YbW1HV0t2Iz3QDP618i6L8SPFumxJBZa9qECIojQJMR8ucgHvjPpjrVybx/4k1K2RNT1e8ugjlv9JkLY4AyT+HXGfyFNQj1ZlOc46NH0+0HxNnkd77WvBugIDwqxtPL/tY3MckEkdskdMYrFv8ARUvblB4i+L+ty+YNwj02L7MjnGflKcMNpzwOQCfSvnnStTnnkk8wTSwysEdlIboDjaBjceV7Z7DBOa19KvY4LiG2mjxEu4Pc+Ssi7jxnruCghs9DwPmx0tU4LZHNKvO9r/1+B6pJoHwkhuY5L5NY16aQb0l1C7YGVTkgkja3p1APQYxurbsNV8A6U1wuieCtOi+zh5Wa4JkCqByzAg4zwAc9+ehrzRZrk+YI1e1QBp5fNYxcgkk7wArE9sDp2GebtvfSWkjMLlXjQpJDFMih125Ado8cNkgjONrEAHHTRQSMJVpPc72T4gXyzo2n6Xp1rZyM7JJbWSbSA+08HO4/xA5XvkAYJ4/Vtd1G+gJv55kg/wCPcyK6/vCysEXOR5hwHJ+bHzZySxWobbdJePJ5M8srf63a5kc8H5QxABBJ37AFxyecEVW1JZBGICrhY4ykvzFchmGQdqA85XBAGBtz2rSxjKTZympXTz6RNBDKm+HE3nGM5fLfOTyWQA7RuPJIGMda4nVG+0oHztkBO4ySAs+STu568emOg78Dtr+NZo7g2Ra5gt+HcRLGpL5B2IMjkgZIOcJwRkGuHv45JIvNulkCABVY87yVzxgY5xn3zms53sbULcx6j+ytqgtvGmp6UxXbqVi2wD+KSJg44/3d9fRutWS6zoOq6ZJuZb6ylgJ65LIQO/UHFfGnw51X/hGfiNoOqF9qQ3cYlLDZiOT5ZOB0+V2/+tX2vKzW0xjDEmOQjH0ORx7VxzVnc9K90fn2ylOHVlcdQQcgj19KYMBDXX/FnSjo3xG8R2W3bF9seeIYwPLkO9Mfg1cgSSuATn3rQqLurig/Jg8Ae/SnKdynA6D1qMD5eBjn9acPuYAORTGxxPyAEfkc09WIAwJMf71MxuUcACnKH2j5W6dlP+NBLsQAfMcD9ab1zjil68/WkXk4pmog60DrQeCaSmMKKKKACiiigAooooAKKKKAPcPgVGsnhLVc8FbxTnj/AJ58friuP+PAP/C0tWZgAzR2rHHqbaLNdn8Af+Ra1c+l0n/oBrj/AI+f8lN1D/rhbD/yAlZR+NmUfjZ55RRRWpqFFFFABRRRQAUUUUAFFFFAC9q+8/BF/wDafAfhSVvmkfSLXJwDyIgpPr1Br4Lr7L+ClxJd/CPw08zZKxTQj2VbhwP0rGtsSzxv9q6LZ8TrebnM+l28hz7bl/8AZa8n0W1N5fxxAMSSMbV3HOePl/iPsOTXt/7WdtENW8M3QXE0llLGx9QsvH/oRrwi1nkgcmI7WIxuHX8PSrg7xTJd3F2Ou8U2hkwiTfanAULhG9OMMfvHJYYHfOOuK44oysVKHd0x3BrorC4kmlCuVysWNwQAkHg54x079eh6jNSS2Mdy8byvIWcTZOf7jED8+/rzWk+5y0ZuC5WcwoOKu2gAxuEZZWz8x6/qM9evbFR20KvcJGxbawHOeR06VLHApWZSThQMe/8AnNSdE3fQ6OySS0EQvLZoJIQCA8TszAnnowHIbPrgHBFXra2W4JhZmLKoQEKzRkKATk55PA45wc8Z4qjYgJpzzqqj5zGYyMofmUZ2njPJrqtNtgLGSRXI+zzxpGu1SBtYqCcg5ON3XI+Y8YwBaXQ86T6jbS02ypNHLfRx+cr+cqN5nCFgTIMEYHsOVJPQY6/QrPbAipJ5zBjmJjuBGThmwRuAJLY46Z7gNS0jTbcxTXKB454wvzxnbkMwBBHTB3noB/PO/ca7JbWyziztJJGjaSTeHw7Kd6kgMAMbcYAAweQTzWiRjuan9k3Elti0tWEJdh+7VVCc4KHaDkbssc+4yDmugfwVd5llufMBnJcRFT5Q8wDPQAs3BAT7xzjpxXh1x8bvF9rbk6c2nWMhUqHt7RVI+Y84OQeGI5BGO2ea5S8+J/jW8B8/xNqh4YDE7DaCAMDHTj/HrzQ5cu5tTw3Oj3jxz4YsrSSeSfUFWTcEjimdVKbMq6kDKpgnOTxhl6Hg+M+IbnSLGaeOzvop1hyB5MeFdGTleRyfm27uuBxiuDMklzkzyySHrlmJ7e9CxqYycYwCev0/xrOVQ2jg1F6sW5ljKhYFIj2jIJ6t3OPyH4V9y+HtTGt+G9E1XK/6bYwzODyAxTD/AJMD+Ir5f+F3gTTPFcpTUZ7yNev7h0X+amvpHwzplvoXhuz0ywD/AGaznlhi8xizbS+cE9+WNc1SSaOi6WiPD/2ndP8A+Kp0jVIuHvbPyXRVzh4j7f7LLx7V5pp/grxNqCgWmgam4P8AE1uyj82wK+vbt2E9pKDh181B9Bg/0FNlU7ZMuzYYJyeufWo9rbQqN7aHzbpnwc8STZOoG0sFAz88glb6bVz/ADrq9L+C+mRr/wATTVbqdiPu26LHg/jnP+FevSIqK+3PA9evIH9apX07QQK8YXcM9vQkf0pe0bE79Wcha+AfDVhHGLXSVlkiYEPcHzCzfjwc+mMdK2QLdRtWO22jgYjWsK61G8vZI2Nw8G8AkQ4Xn2zkis7bL/FdTse5JGT+lON5dTnqSSP/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A discrete nodule is present with surrounding erythema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Epidermoid cyst",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 375px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A skin-colored nodule is present on the chest. This particular lesion does not have a visible punctum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2280=[""].join("\n");
var outline_f2_14_2280=null;
var title_f2_14_2281="Ependymoma";
var content_f2_14_2281=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F78765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F78765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Ependymoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 376px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A true ependymal rosette is present in the upper left portion of the photomicrograph and a perivascular pseudorosette in the lower right-- both cardinal histological features of ependymoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. David Louis.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2281=[""].join("\n");
var outline_f2_14_2281=null;
var title_f2_14_2282="Treatment of systemic and extraglandular manifestations of Sjögren’s syndrome";
var content_f2_14_2282=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of systemic and extraglandular manifestations of Sj&ouml;gren&rsquo;s syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Robert Fox, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Paul Creamer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?2/14/2282/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?2/14/2282/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H6865243\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sj&ouml;gren&rsquo;s syndrome (SS) is a chronic multisystem inflammatory disorder characterized by diminished lacrimal and salivary gland function. This results in the &ldquo;sicca complex,&rdquo; a combination of dry eyes (xerophthalmia) and dry mouth (xerostomia). A variety of other disease manifestations may also be present, including systemic signs and extraglandular features.",
"   </p>",
"   <p>",
"    SS occurs in a primary form not associated with other diseases and in a secondary form associated with other autoimmune rheumatic conditions, including rheumatoid arthritis and systemic lupus erythematosus.",
"   </p>",
"   <p>",
"    The treatment of systemic and extraglandular manifestations of SS will be reviewed here. Other issues in SS are discussed separately, including the clinical manifestations, prognosis, and diagnosis; the treatment of dry eyes, dry mouth (including the use of muscarinic agonists such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/36/33344?source=see_link\">",
"     pilocarpine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/40/12932?source=see_link\">",
"     cevimeline",
"    </a>",
"    ), and other nonocular sicca symptoms are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=see_link\">",
"     \"Classification and diagnosis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=see_link\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=see_link\">",
"     \"Treatment of dry eyes in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6865250\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both local and systemic medical therapies are used in the treatment of SS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/1\">",
"     1",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preventive therapies and attention to other conditions, medications, and environments that may exacerbate dryness complaints",
"     </li>",
"     <li>",
"      Topical therapy of dry eyes, dry mouth, other dry mucosal surfaces, and dry skin, as well as the use of systemic cholinergic agents to stimulate secretions",
"     </li>",
"     <li>",
"      Systemic antiinflammatory and immunosuppressive therapies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach to management of patients with sicca symptoms is generally the same for primary or secondary SS and depends upon the severity of symptoms and upon the responsiveness to therapy. Patients with mild SS may only require local treatment for ocular, oral, and other symptoms of dryness, in addition to monitoring of their condition and usual medical and dental preventive care. Patients with moderate to severe SS, including extraglandular involvement, may also benefit from systemic therapies, including the use of immunosuppressive and biologic agents.",
"   </p>",
"   <p>",
"    Most patients will benefit from multidisciplinary care. Treatment should be coordinated by a single clinician, usually a rheumatologist, in collaboration with the primary care physician and other clinicians. It is important that patients also be seen by both an ophthalmologist and a dentist, with an interest in keratoconjunctivitis sicca and dry mouth, respectively.",
"   </p>",
"   <p>",
"    Comprehensive patient education should be provided regarding SS and its management, including use of available materials from patient support groups. This is especially important because of the multisystem nature of the illness and because of the degree of self-care that is required. There should be particular attention to self-management strategies for tear conservation and for effective use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24211?source=see_link\">",
"     artificial tears",
"    </a>",
"    , to treatment of dry mouth symptoms and oral hygiene, and yo recognition of symptoms requiring medical attention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=see_link\">",
"     \"Treatment of dry eyes in Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=see_link\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic and extraglandular features of SS include cutaneous, respiratory, renal, hepatic, neurologic, and vascular involvement. There is also increased risk of non-Hodgkin&rsquo;s B-cell lymphoma. The treatment of systemic manifestations in SS generally parallels the treatments used in SLE; immunosuppression is also a logical approach to treatment, given the immunologically mediated lacrimal gland destruction that occurs in SS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=see_link\">",
"     \"Pathogenesis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015873\">",
"    <span class=\"h1\">",
"     IMMUNOSUPPRESSIVE THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is insufficient evidence to recommend use of systemic immunosuppression to treat sicca symptoms alone, although such therapy may be necessary for severe extraglandular manifestations, particularly for arthritis, myalgia, cutaneous or neurologic disease, and vasculitis. (See",
"    <a class=\"local\" href=\"#H26015950\">",
"     'Treatment of extraglandular manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015880\">",
"    <span class=\"h2\">",
"     Initial treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial treatment for arthralgias, myalgias, lymphadenopathy, and skin manifestations includes antimalarials (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    up to 8",
"    <span class=\"nowrap\">",
"     mg/kg/day).",
"    </span>",
"    The next step is usually the use of oral or self-injected",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    at weekly intervals.",
"   </p>",
"   <p>",
"    Evidence that supports use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    does not include large randomized trials. Instead, therapy with hydroxychloroquine is largely empiric in SS, and its use is based upon its efficacy in systemic lupus erythematosus (SLE) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Small, open-label studies have demonstrated improvement in arthralgias, myalgias, acute phase reactants, and hyperglobulinemia in SS patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. One SS patient was noted to have a flare of vasculitis shortly after being tapered off hydroxychloroquine [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/7\">",
"     7",
"    </a>",
"    ]. Several reviews have suggested that hydroxychloroquine is beneficial in arthritis, myalgia, and cutaneous manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. However, significant clinical improvement was not seen during a two-year crossover study [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/10\">",
"     10",
"    </a>",
"    ]. The effects of HCQ on sicca symptoms are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=see_link&amp;anchor=H93302381#H93302381\">",
"     \"Treatment of dry eyes in Sj&ouml;gren's syndrome\", section on 'Systemic antiinflammatory and immunosuppressive therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=see_link&amp;anchor=H316655#H316655\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\", section on 'Systemic antiinflammatory and immunosuppressive therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients who have not had an adequate response to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    , oral weekly",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (generally 7.5 to 15 mg weekly) is used. Again, treatment is empiric and is not supported by large randomized trials. Reduced symptoms of arthritis have been reported with use of methotrexate in SS patients not responsive to hydroxychloroquine [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/1,11\">",
"     1,11",
"    </a>",
"    ]. Review articles on the treatment of extraglandular manifestations have suggested low-dose methotrexate can be of benefit in SS patients (either alone or in combination with hydroxychloroquine) for arthralgia, myalgia, and cutaneous manifestations, particularly as a glucocorticoid-sparing drug [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/8,9,12\">",
"     8,9,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our clinical experience has been that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and a combination of both drugs have shown benefit in symptoms and signs of arthritis and cutaneous manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/13\">",
"     13",
"    </a>",
"    ] in SS patients. We use these agents particularly in patients with an elevated erythrocyte sedimentation rate (ESR) or with a positive rheumatoid factor. Other agents such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    , mycophenolic acid, and biologic agents are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015887\">",
"    <span class=\"h2\">",
"     Refractory keratoconjunctivitis sicca",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic immunosuppression has been employed for patients with refractory sicca symptoms but with little substantial benefit. The available evidence is described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=see_link&amp;anchor=H93302381#H93302381\">",
"     \"Treatment of dry eyes in Sj&ouml;gren's syndrome\", section on 'Systemic antiinflammatory and immunosuppressive therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=see_link&amp;anchor=H316655#H316655\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\", section on 'Systemic antiinflammatory and immunosuppressive therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7728805\">",
"    <span class=\"h2\">",
"     Treatment with biologic agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with severe systemic manifestations of SS, particularly if refractory to conventional therapy, are candidates for biologic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/14\">",
"     14",
"    </a>",
"    ]. These would include patients with severe vasculitis, cryoglobulinemia, neurologic manifestations (of both central and peripheral nervous system), cytopenias, and active interstitial lung or renal disease. Patients with severe parotid enlargement and intractable ophthalmologic problems related to SS have been considered candidates in some trials. The use of biologic agents in patients with disabling fatigue is uncertain, although the symptoms have been reported to be improved in some trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015908\">",
"    <span class=\"h3\">",
"     TNF inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several small studies and randomized trials of both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    have failed to demonstrate benefit in patients with SS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. In one randomized trial involving 103 patients with SS who received infliximab or placebo, there were no significant differences in the change from baseline in pain, fatigue, or sicca symptoms or in objective measures of salivary flow, swollen joints, tender joints, ESR, or C-reactive protein (CRP) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/15\">",
"     15",
"    </a>",
"    ]. Similarly, no benefit was seen in a trial involving 28 patients who were randomly assigned to receive either etanercept or placebo, despite a 19 percent decrease in the ESR over the 12-week study in the etanercept group [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/17\">",
"     17",
"    </a>",
"    ]. A previous study, which had reported benefit from treatment with infliximab, was subsequently retracted [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015915\">",
"    <span class=\"h2\">",
"     Life-threatening disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;For life-threatening extraglandular manifestations,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (oral or intravenous),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    are often used. Specific uses of these agents are discussed below. (See",
"    <a class=\"local\" href=\"#H26015950\">",
"     'Treatment of extraglandular manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015922\">",
"    <span class=\"h2\">",
"     Emerging therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatments directed against B cells are an active area of study. Preliminary results are available for studies of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    (anti-CD20 antibody) and epratuzumab (anti-CD22 antibody). In the future, inhibitors of B cell activating factor (BAFF), such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/31/37365?source=see_link\">",
"     belimumab",
"    </a>",
"    , an anti-BAFF antibody, and interference with T-cell adhesion or costimulation with alefacept or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"     abatacept",
"    </a>",
"    may be applied to SS. Potential targets include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      T cells. Inhibitors of T-cell costimulation are also in early phases of clinical trials in SS. The agents under investigation include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"       abatacept",
"      </a>",
"      and alefacept. Efalizumab has also been studied but has since been voluntarily withdrawn from the United States market because of a potential risk to patients of developing progressive multifocal leukoencephalopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/21\">",
"       21",
"      </a>",
"      ]. Its use has also been suspended in other countries. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26681?source=see_link\">",
"       \"Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lymphocyte homing receptors, including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/11/26806?source=see_link\">",
"       fingolimod",
"      </a>",
"      , which have been tried in multiple sclerosis patients [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/22\">",
"       22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Chemokines, including CXCL13 and CCL1, which are important in T-cell trafficking to exocrine glands",
"     </li>",
"     <li>",
"      Lymphocyte costimulatory molecules, including CD40-CD40L",
"     </li>",
"     <li>",
"      Cytokines and related molecules, including IL-1, type 1 interferon, BAFF, and Taci, which either are under study or are available for clinical use patients with SLE",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015929\">",
"    <span class=\"h3\">",
"     Rituximab",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     Rituximab",
"    </a>",
"    , a chimeric monoclonal antibody directed against CD20, which is expressed on B-cell precursors, appears to be a potential treatment option in patients with extraglandular manifestations of SS [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/23\">",
"     23",
"    </a>",
"    ]. Rituximab leads to the depletion of peripheral blood B cells for a period of 6 to 12 months or longer in some patients.",
"   </p>",
"   <p>",
"    Several case series and a small randomized trial have illustrated the potential of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    as a therapeutic agent in SS. However, larger randomized trials with anti-CD20 therapies, such as rituximab, are needed to assess long-term effects of such treatment, to determine which SS patients will benefit most from anti-CD20 treatment, and to assess which retreatment schedule should be followed [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The range of findings is illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Improvement in extraglandular manifestations with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      treatment was reported in a trial involving 30 patients with SS, all of whom had evidence of functional stimulated salivary flow rates, who were randomly assigned to receive rituximab (20 patients) or placebo (10 patients) [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/25\">",
"       25",
"      </a>",
"      ]. All patients received IV",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      before infusion and a tapering course of oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"       prednisolone",
"      </a>",
"      afterward. There were significant improvement in salivary secretion in patients in the rituximab treatment group and significant improvement in the visual analog scale for oral dryness.",
"      <br/>",
"      <br/>",
"      The frequency of extraglandular manifestations was approximately equal in the rituximab and control groups (2.9 and 2.3 per patient), but the specific manifestations differed in their distribution. These included (from most to least frequent) &ldquo;tendomyalgia,&rdquo; arthralgia, Raynaud phenomenon, vasculitis, arthritis, renal involvement, esophageal involvement, and peripheral polyneuropathy. The greatest difference between groups in the number of these manifestations present per patient was at week 24, when there was a decrease of about 1.5 manifestations per patient in those treated with rituximab, in contrast with an increase of about 0.5 manifestations per patient in those who received placebo.",
"     </li>",
"     <li>",
"      In a retrospective study of six patients treated with four infusions of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      (375",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      weekly, five of six patients had regression of parotid gland swelling and improvement of arthralgias [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/26\">",
"       26",
"      </a>",
"      ]. Two of the six had major improvement in cryoglobulinemia-related vasculitis. Another study of rituximab noted a sustained response at six months in 45 percent of a group of patients with immune-related thrombocytopenia [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Open label studies of small numbers of patients have reported that extraglandular manifestations of SS have improved with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      but that a serum sickness-like syndrome may occur [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/28-37\">",
"       28-37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      An analysis of the French (AIR) registry group indicated improvement in 17 patients with peripheral neuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/38\">",
"       38",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       Rituximab",
"      </a>",
"      was effective for treatment of neurological involvement in 9 of 10 patients with vasculitis or cryoglobulinemia at three months but only in two of seven patients without vasculitis or cryoglobulinemia. A separate analysis of rituximab safety in a French registry concluded that the risks of therapy were justified by the therapeutic response [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Extraglandular manifestations of SS, particularly cryoglobulinemia, that were refractory to at least two immunosuppressive drugs responded favorably to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      , with an acceptable level of toxicity, in patients with SS in a Spanish registry [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an open label study of 28 patients, there was significant improvement in extraglandular manifestations, as measured by the ESDAI (disease activity index), at 60 weeks after treatment with two 1 gram doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/41\">",
"       41",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Noninfectious interstitial pneumonitis (ILD) has been reported as a rare complication of treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/42\">",
"       42",
"      </a>",
"      ]. These reports include two patients treated for extraglandular manifestations of SS [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015936\">",
"    <span class=\"h3\">",
"     Epratuzumab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epratuzumab, an anti-CD22 monoclonal antibody, may be of benefit in patients with SS. CD22 is a transmembrane sialoglycoprotein of the immunoglobulin superfamily. CD22 appears during the late pro-B stage of ontogeny, shifting to the high levels on follicular, mantle, and marginal zone B cells. The CD22 molecule may act as a homing receptor for recirculating B cells through its affinity for sialic acid-bearing glycans on high endothelial venules [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/43\">",
"     43",
"    </a>",
"    ]. This type of adhesive molecule may play a role in the entry of B cells into lacrimal or salivary gland of SS patients.",
"   </p>",
"   <p>",
"    Antibodies to CD22 were initially used in non-Hodgkin lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. Epratuzumab appears to function by modulation of B cells rather than by depletion of these cells in the circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Given the differing mechanisms of action, combined therapeutic approaches using both anti-CD20 and anti-CD22 antibodies may be feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In an open label study of 16 patients with SS, four intravenous infusions of epratuzumab (360",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    were administered (one infusion every two weeks). The follow-up period was six months. The following results were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fourteen patients received all infusions without significant reactions. One patient received three infusions, and one patient discontinued all infusions following a mild infusion reaction with the first.",
"     </li>",
"     <li>",
"      B-cell levels had mean reductions of 54 percent and 39 percent at 6 and 18 weeks, respectively, but T-cell levels, immunoglobulins, and routine safety laboratory tests did not change significantly.",
"     </li>",
"     <li>",
"      CD22 overexpression on peripheral B cells was down-regulated by epratuzumab for at least 12 weeks after therapy.",
"     </li>",
"     <li>",
"      A composite endpoint involving the Schirmer-I test, unstimulated whole salivary flow, fatigue, erythrocyte sedimentation rate, and IgG level was used. At least 20 percent improvement in at least two of the parameters constituted a clinical response. Fifty-three percent of the patients achieved a clinical response at six weeks, with 53 percent, 47 percent, and 67 percent responding at 10, 18, and 32 weeks, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional investigations of epratuzumab in SS are ongoing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015950\">",
"    <span class=\"h1\">",
"     TREATMENT OF EXTRAGLANDULAR MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the sicca symptoms, therapy in SS may also require attention to extraglandular symptoms such as arthralgias, fatigue, and systemic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015957\">",
"    <span class=\"h2\">",
"     Cutaneous",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of cutaneous manifestations have been reported in SS patients. The lesions can be divided into macular, papular, or vesicular. Further, purpura may be palpable or nonpalpable. The finding of palpable purpura may indicate leukocytoclastic vasculitis and may require therapy similar to that for SLE patients with cutaneous vasculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=see_link&amp;anchor=H12#H12\">",
"     \"Hypersensitivity vasculitis in adults\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nonpalpable purpura, especially of the lower extremities, is common in patients with hyperglobulinemia. The finding of localized vesicular lesions should raise the possibility of herpes zoster. General approaches to macular papular rashes include the use of moisturizers as well as antimalarial agents. Topical corticosteroids are useful in areas other than the face, for which topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    is preferred to prevent thinning of the skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015964\">",
"    <span class=\"h2\">",
"     Arthralgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arthralgias and myalgias are common in SS even when it is not associated with another connective tissue disease. Simple analgesics are tried first, followed by nonsteroidal antiinflammatory drugs (NSAIDs).",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     Hydroxychloroquine",
"    </a>",
"    is generally well-tolerated, and mild improvement of arthralgias and myalgias was noted in some uncontrolled studies [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/4,10\">",
"     4,10",
"    </a>",
"    ]. However, one small double-blind, placebo-controlled trial using a crossover design in 19 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/49\">",
"     49",
"    </a>",
"    ] found no clinical benefit of hydroxychloroquine (400 mg daily for one year) in terms of symptoms, tear gland function, or salivary scintigraphy.",
"   </p>",
"   <p>",
"    Although there has been controversy about the risk of ocular (retinal) complications, the previous problems were largely reported when doses as high as 15",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    were used [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/50\">",
"     50",
"    </a>",
"    ]. A series of large studies using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    (up to 8",
"    <span class=\"nowrap\">",
"     mg/kg/day)",
"    </span>",
"    indicates that the risk is extremely low (probably less than",
"    <span class=\"nowrap\">",
"     1/10,000)",
"    </span>",
"    if the dose is maintained in the suggested range (preferably at less than 6.5",
"    <span class=\"nowrap\">",
"     mg/kg/day).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/9/43161?source=see_link&amp;anchor=H12#H12\">",
"     \"Antimalarial drugs in the treatment of rheumatic disease\", section on 'Ocular effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients should notify their ophthalmologists that they are taking an antimalarial drug so that eye examinations can be supplemented with visual field examinations, if indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015971\">",
"    <span class=\"h2\">",
"     Cardiopulmonary manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac manifestations include a spectrum of disorders such as pericarditis and pulmonary hypertension. The finding of interstitial changes on chest radiography raises the entire spectrum of infiltrative processes ranging from lymphocytic interstitial pneumonitis to usual interstitial pneumonitis (UIP). Further, the sudden development or rapid worsening of dyspnea requires evaluation for pulmonary emboli as SS patients may have circulating anticoagulants [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with SS and potentially life-threatening cardiopulmonary manifestations are treated with glucocorticoids with or without other immunosuppressive drugs, including oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (up to 2.5",
"    <span class=\"nowrap\">",
"     mg/kg/day),",
"    </span>",
"    oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"     chlorambucil",
"    </a>",
"    (4 to 8",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    or monthly intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (500 to 1000 mg) adjusted to achieve a white blood cell count nadir at 7 to 10 days of about 3000",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of cycles of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is generally limited to six in an attempt to limit toxicity related to the use of alkylating agents (including sterility in younger patients); this has led to the development of treatment protocols using alternative immunosuppressive agents.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015978\">",
"    <span class=\"h2\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Renal involvement in SS may take several forms. The most frequent is an interstitial nephritis that produces renal tubular acidosis. Renal disease in SS is often asymptomatic, but subclinical renal disease may be exacerbated by the use of certain medications (including NSAIDs). Renal involvement may present with life-threatening hyperkalemia but usually is reflected by low bicarbonate levels on screening electrolytes. The renal tubular acidosis can be corrected with oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/46/5860?source=see_link\">",
"     \"Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with primary SS may also develop glomerulonephritis (GN). However, in SS patients suspected of having GN, amyloidosis and mixed cryoglobulinemia must be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/54\">",
"     54",
"    </a>",
"    ]. Therapeutic interventions generally include the use of glucocorticoids,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, or other immunosuppressives and depend upon the results of the renal biopsy. Treatment of GN in SS is the same as that of lupus nephritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37466?source=see_link\">",
"     \"Therapy of diffuse or focal proliferative lupus nephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other renal problems include thrombotic glomerulopathy as in the antiphospholipid syndrome (APS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35287?source=see_link\">",
"     \"Antiphospholipid syndrome and the kidney\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=see_link\">",
"     \"Treatment of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015985\">",
"    <span class=\"h2\">",
"     Gastrointestinal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high frequency of SS patients exhibit symptoms of gastroesophageal reflux disease (GERD), due to the decreased flow of saliva which would naturally buffer the reflux of acidic gastric contents [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/55\">",
"     55",
"    </a>",
"    ]. Further, the use of NSAIDs and glucocorticoids predispose patients to gastritis and peptic ulcer. Some patients with GERD will present with symptoms of laryngotracheal irritation.",
"   </p>",
"   <p>",
"    Treatment of these problems with proton pump inhibitors, promotility agents, and dietary modification is similar to therapy for patients with GERD without SS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=see_link\">",
"     \"Medical management of gastroesophageal reflux disease in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The finding of an elevated serum alkaline phosphatase level should suggest co-existent biliary cirrhosis, in which case use of agents that chelate bile salts (eg, Actigall) may prove helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/19/34105?source=see_link\">",
"     \"Overview of the treatment of primary biliary cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Elevation of serum aminotransferase enzyme levels usually suggests the presence of hepatitis C viral infection (that can mimic SS and that may have positive ANA, positive RF, and mixed cryoglobulinemia) [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Patients with hepatitis C infection who have positive ANAs and SS-like symptoms with interferon alpha have a higher likelihood of complications including arthralgias and thrombocytopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=see_link\">",
"     \"Overview of the management of chronic hepatitis C virus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/52/36682?source=see_link\">",
"     \"Treatment of the mixed cryoglobulinemia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015992\">",
"    <span class=\"h2\">",
"     Endocrine disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;SS patients have a higher frequency of hypothyroidism than the general population, perhaps because both conditions appear linked to HLA-DR 3 in Caucasians [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. Periodic questioning about symptoms of hypothyroidism and annual monitoring of thyroid function with a serum thyroid stimulating hormone (TSH) level are prudent. Hypothyroidism in SS responds to thyroid replacement and is treated in the same manner as idiopathic hypothyroidism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=see_link\">",
"     \"Treatment of hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Use of mineralocorticoid analogues may be needed to treat autonomic neuropathy presenting with orthostatic hypotension. (See",
"    <a class=\"local\" href=\"#H26015999\">",
"     'Neurologic manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26015999\">",
"    <span class=\"h2\">",
"     Neurologic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic manifestations may be separated into peripheral neuropathies, autonomic neuropathy, and central nervous system manifestations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26016006\">",
"    <span class=\"h3\">",
"     Peripheral neuropathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a peripheral neuropathy is asymmetric, then consideration of mononeuritis multiplex is warranted. If mononeuritis multiplex is present and is a manifestation of systemic vasculitis, then aggressive therapy with glucocorticoids and immunosuppressive agents may be required [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16215?source=see_link\">",
"     \"Diagnosis and treatment of vasculitic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Peripheral neuropathies may be sensory or motor. Symmetric peripheral neuropathies are usually predominantly sensory and frequently occur in the setting of hyperglobulinemic purpura. Treatment is aimed at the underlying condition (including immune and non-immune factors such as elevated lipids, endocrine abnormalities, or hypertension).",
"   </p>",
"   <p>",
"    The use of tricyclic antidepressant agents (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/30/27112?source=see_link\">",
"     amitriptyline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/21/30040?source=see_link\">",
"     nortriptyline",
"    </a>",
"    ) is generally avoided as their anticholinergic side effects may preclude achievement of a therapeutic effect. Thus, symptomatic therapy often begins with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7369?source=see_link\">",
"     \"Overview of polyneuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Peripheral motor neuropathies are more difficult to manage, and attention to peripheral demyelinating disorders (such as chronic inflammatory demyelinating polyneuropathy [CIDP]) may lead to therapies including intravenous immunoglobulin (IVIG)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    immunosuppressive agents.",
"   </p>",
"   <p>",
"    Use of intravenous gammaglobulin (IVIG) may be beneficial for patients with motor or sensory neuropathy that does not respond to glucocorticoids or to other immunosuppressive therapy. The possible value of IVIG has been suggested in several small uncontrolled series. The following are illustrative:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Five patients with SS and ataxic sensory neuropathy were treated with IVIG; four improved, two of whom did so following the first infusion [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Among a group of four patients with vasculitic neuropathy who improved following IVIG treatment, one had SS [",
"      <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The optimal dosage of IVIG is uncertain. Randomized trials are not available. Doses that have been reported anecdotally to be beneficial range from 1 to 2",
"    <span class=\"nowrap\">",
"     gram/kg",
"    </span>",
"    given at biweekly to monthly intervals. A typical course of treatment is 400",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day for five days. Each of the five doses is administered by slow intravenous infusion over two to four hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=see_link\">",
"     \"General principles in the use of immune globulin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26016013\">",
"    <span class=\"h3\">",
"     Autonomic neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autonomic neuropathy develops in a subset of SS patients and can be documented by tilt table test [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/66\">",
"     66",
"    </a>",
"    ]. The treatment options include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    acetate or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"     \"Treatment of orthostatic and postprandial hypotension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26016020\">",
"    <span class=\"h3\">",
"     Central nervous system manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central nervous manifestations may occur in SS, but there is controversy about their prevalence. They may mimic multiple sclerosis, including transverse myelitis and optic neuritis. The underlying pathology may be vasculitis, thrombosis, or demyelination.",
"   </p>",
"   <p>",
"    Treatment for these life-threatening disease manifestations has not been examined in controlled trials. One observational study of 14 patients with myelopathy suggested that intravenous glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    may be of benefit in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/67\">",
"     67",
"    </a>",
"    ]. Other immunosuppressive agents may be valuable for maintenance.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vasculitis &mdash; Central nervous system involvement due to vasculitis that is confirmed by biopsy or angiography is treated with glucocorticoids and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      in a similar manner as isolated central nervous system vasculitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/50/25386?source=see_link&amp;anchor=H30#H30\">",
"       \"Primary angiitis of the central nervous system\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Ischemic stroke &mdash; As discussed earlier, thromboembolic events may be more frequent in patients with SS and may be associated with the presence of antiphospholipid antibodies. The evaluation and treatment of stroke and the antiphospholipid antibody syndrome are presented separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=see_link\">",
"       \"Overview of the evaluation of stroke\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=see_link\">",
"       \"Clinical manifestations of the antiphospholipid syndrome\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=see_link\">",
"       \"Treatment of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Since patients with either Alzheimer disease or multiple sclerosis frequently exhibit dryness signs and symptoms (as part of their autonomic neuropathy and demyelinating process), it is important to make sure that important underlying conditions are not mislabeled as SS, which may result in a delay in initiating therapy for the non-SS CNS disorder.",
"   </p>",
"   <p>",
"    In addition to the central vascular thrombotic complications associated with anti-cardiolipin antibodies, it is likely that SS patients share the risk of accelerated atherosclerosis seen in patients with SLE and RA [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26016027\">",
"    <span class=\"h2\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue is common in SS. It may be multifactorial. The fatigue associated with active autoimmune process is usually reflected by elevation of acute phase reactants such as erythrocyte sedimentation rate (ESR) and C-reactive protein. Also, patients with inflammatory arthralgias and myalgias may have disrupted sleep. In these patients, treatment with antiinflammatory drugs and antimalarial drugs may prove helpful.",
"   </p>",
"   <p>",
"    In other patients, a disrupted sleep pattern due to dryness or polyuria (as a result of fluid consumption during the day) may play a role. Treatment of these individuals emphasizes the use of oral lubricants and artificial salivas, and minimizing fluids after dinner (to decrease resulting nocturia) may prove helpful.",
"   </p>",
"   <p>",
"    Endocrine factors such as hypothyroidism or autonomic neuropathy (in which orthostatic drop in blood pressure may mimic fatigue) should be considered and treated.",
"   </p>",
"   <p>",
"    However, fatigue in SS is rarely associated with elevations in acute phase reactants, and the fatigue does not correlate well with either glandular or extraglandular manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/69\">",
"     69",
"    </a>",
"    ]. Fatigue is often attributed to fibromyalgia [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/70\">",
"     70",
"    </a>",
"    ] or to nonrestorative sleep [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/70,71\">",
"     70,71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Components of fibromyalgia resemble agitated depression and may respond to agents such as selective serotonin reuptake inhibitors (SSRIs) or other antidepressants that have few or no anticholinergic side effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link&amp;anchor=H2#H2\">",
"     \"Initial treatment of depression in adults\", section on 'Initial evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Progressive physical therapy for the associated muscle deconditioning and vitamin supplementation may be helpful, as diets in SS patients (who often have difficulty chewing certain foods) may be relatively deficient.",
"   </p>",
"   <p>",
"    Inflammatory myopathy (myositis) may require immunosuppressive therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?2/14/2282/abstract/72\">",
"     72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/22/11626?source=see_link\">",
"     \"Initial treatment of dermatomyositis and polymyositis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26016034\">",
"    <span class=\"h2\">",
"     General anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with SS are at increased risk from any surgery requiring general anesthesia. Factors responsible include the use of anticholinergic drugs, which further reduce tear production, and the low humidity environment of the operating theater. The reduction in airway secretions in SS increases the risk of inspissated mucus and postoperative atelectasis, while oral dryness may increase difficulty of taking oral medications. Management may include prophylactic use of ocular lubricants, with humidified oxygen and chest physiotherapy to mobilize secretions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3652901\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of SS is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link&amp;anchor=H34#H34\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44212?source=see_link\">",
"       \"Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26016048\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment of SS is generally symptomatic, with most patients requiring treatment only for dryness. Patients with moderate to severe involvement may require systemic medical therapy, including the use of immunosuppressives and biologic agents. (See",
"      <a class=\"local\" href=\"#H6865250\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of other manifestations of SS has been influenced by our treatment of other connective tissue diseases. The most serious (and fortunately rare) complications such as vasculitis and neurologic disease probably require immunosuppression with drugs such as glucocorticoids and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      , as in systemic lupus erythematosus. Therapies directed against B cells are under active investigation. (See",
"      <a class=\"local\" href=\"#H26015873\">",
"       'Immunosuppressive therapies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26015950\">",
"       'Treatment of extraglandular manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/1\">",
"      Thanou-Stavraki A, James JA. Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum 2008; 37:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/2\">",
"      Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/3\">",
"      A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. N Engl J Med 1991; 324:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/4\">",
"      Fox RI, Dixon R, Guarrasi V, Krubel S. Treatment of primary Sj&ouml;gren's syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 1996; 5 Suppl 1:S31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/5\">",
"      Fox RI, Chan E, Benton L, et al. Treatment of primary Sj&ouml;gren's syndrome with hydroxychloroquine. Am J Med 1988; 85:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/6\">",
"      Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sj&ouml;gren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis 1999; 58:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/7\">",
"      Okan G, Karaaslan M, B&uuml;y&uuml;kbabani N. Systemic vasculitis developing after hydroxychloroquine interruption in a patient with Sj&ouml;gren's syndrome. Clin Exp Dermatol 2010; 35:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/8\">",
"      Mavragani CP, Moutsopoulos HM. Conventional therapy of Sjogren's syndrome. Clin Rev Allergy Immunol 2007; 32:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/9\">",
"      Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sj&ouml;gren's syndrome. Nat Clin Pract Rheumatol 2006; 2:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/10\">",
"      Kruize AA, Hen&eacute; RJ, Kallenberg CG, et al. Hydroxychloroquine treatment for primary Sj&ouml;gren's syndrome: a two year double blind crossover trial. Ann Rheum Dis 1993; 52:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/11\">",
"      Skopouli FN, Jagiello P, Tsifetaki N, Moutsopoulos HM. Methotrexate in primary Sj&ouml;gren's syndrome. Clin Exp Rheumatol 1996; 14:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/12\">",
"      Vitali C, Palombi G, Cataleta P. Treating Sj&ouml;gren's Syndrome: Insights for the Clinician. Ther Adv Musculoskelet Dis 2010; 2:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/13\">",
"      Fox RI, Liu AY. Sj&ouml;gren's syndrome in dermatology. Clin Dermatol 2006; 24:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/14\">",
"      Ng WF, Bowman SJ. Biological therapies in primary Sj&ouml;gren's syndrome. Expert Opin Biol Ther 2011; 11:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/15\">",
"      Mariette X, Ravaud P, Steinfeld S, et al. Inefficacy of infliximab in primary Sj&ouml;gren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj&ouml;gren's Syndrome (TRIPSS). Arthritis Rheum 2004; 50:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/16\">",
"      Zandbelt MM, de Wilde P, van Damme P, et al. Etanercept in the treatment of patients with primary Sj&ouml;gren's syndrome: a pilot study. J Rheumatol 2004; 31:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/17\">",
"      Sankar V, Brennan MT, Kok MR, et al. Etanercept in Sj&ouml;gren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 2004; 50:2240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/18\">",
"      Steinfeld SD, Demols P, Salmon I, et al. Infliximab in patients with primary Sj&ouml;gren's syndrome: a pilot study. Arthritis Rheum 2001; 44:2371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/19\">",
"      Steinfeld SD, Demols P, Appelboom T. Infliximab in primary Sj&ouml;gren's syndrome: one-year followup. Arthritis Rheum 2002; 46:3301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/20\">",
"      Steinfeld SD, Demols P, Salmon I, et al. Notice of retraction of two articles (&ldquo;Infliximab in patients with primary Sjo&uml; gren&rsquo;s syndrome: a pilot study&rdquo; and &ldquo;Infliximab in patients with primary Sjo&uml; gren&rsquo;s syndrome: one-year followup&rdquo;). Arthritis Rheum 2013; 65:814.",
"     </a>",
"    </li>",
"    <li>",
"     FDA statement on the voluntary withdrawal of raptiva from the U.S. market file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149561.htm (Accessed on April 09, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/22\">",
"      Pelletier D, Hafler DA. Fingolimod for multiple sclerosis. N Engl J Med 2012; 366:339.",
"     </a>",
"    </li>",
"    <li>",
"     Cohen PL, Traisak P. Biological treatment for Sjogren's syndrome. In: Sjogren's Syndrome: Practical Guidelines to Diagnosis and Therapy, Fox RI, Fox CM.  (Eds), Springer, New York 2012. p.459.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/24\">",
"      Meiners PM, Vissink A, Kallenberg CG, et al. Treatment of primary Sj&ouml;gren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point? Expert Opin Biol Ther 2011; 11:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/25\">",
"      Meijer JM, Meiners PM, Vissink A, et al. Effectiveness of rituximab treatment in primary Sj&ouml;gren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010; 62:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/26\">",
"      Gottenberg JE, Guillevin L, Lambotte O, et al. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 2005; 64:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/27\">",
"      Brah S, Chiche L, Fanciullino R, et al. Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey. Ann Hematol 2012; 91:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/28\">",
"      Pijpe J, van Imhoff GW, Spijkervet FK, et al. Rituximab treatment in patients with primary Sj&ouml;gren's syndrome: an open-label phase II study. Arthritis Rheum 2005; 52:2740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/29\">",
"      Seror R, Sordet C, Guillevin L, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj&ouml;gren's syndrome. Ann Rheum Dis 2007; 66:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/30\">",
"      Gorson KC, Natarajan N, Ropper AH, Weinstein R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 2007; 35:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/31\">",
"      Bryce AH, Dispenzieri A, Kyle RA, et al. Response to rituximab in patients with type II cryoglobulinemia. Clin Lymphoma Myeloma 2006; 7:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/32\">",
"      Ring T, Kallenbach M, Praetorius J, et al. Successful treatment of a patient with primary Sj&ouml;gren's syndrome with Rituximab. Clin Rheumatol 2006; 25:891.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/33\">",
"      Devauchelle-Pensec V, Morvan J, Pennec Y, et al. Rituximab (anti-CD20) in the treatment of primary Sj&ouml;gren's syndrome: Results of an open label study. Ann Rheum Dis 2005; 64:S309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/34\">",
"      Ahmadi-Simab K, Lamprecht P, N&ouml;lle B, et al. Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab. Ann Rheum Dis 2005; 64:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/35\">",
"      Ramos-Casals M, L&oacute;pez-Guillermo A, Brito-Zer&oacute;n P, et al. Treatment of B-cell lymphoma with rituximab in two patients with Sj&ouml;gren's syndrome associated with hepatitis C virus infection. Lupus 2004; 13:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/36\">",
"      Harner KC, Jackson LW, Drabick JJ. Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren's syndrome. Rheumatology (Oxford) 2004; 43:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/37\">",
"      Botez SA, Herrmann DN. Prolonged remission of a demyelinating neuropathy in a patient with lymphoma and Sj&ouml;gren's syndrome after Rituximab therapy. J Clin Neuromuscul Dis 2010; 11:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/38\">",
"      Mekinian A, Ravaud P, Hatron PY, et al. Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis 2012; 71:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/39\">",
"      Terrier B, Launay D, Kaplanski G, et al. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) 2010; 62:1787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/40\">",
"      Ramos-Casals M, Garc&iacute;a-Hern&aacute;ndez FJ, de Ram&oacute;n E, et al. Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases. Clin Exp Rheumatol 2010; 28:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/41\">",
"      Meiners PM, Arends S, Brouwer E, et al. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sj&ouml;gren's syndrome treated with rituximab. Ann Rheum Dis 2012; 71:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/42\">",
"      Hadjinicolaou AV, Nisar MK, Parfrey H, et al. Non-infectious pulmonary toxicity of rituximab: a systematic review. Rheumatology (Oxford) 2012; 51:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/43\">",
"      Leonard JP, Coleman M, Ketas JC, et al. Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: phase I/II clinical trial results. Clin Cancer Res 2004; 10:5327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/44\">",
"      Furman RR, Coleman M, Leonard JP. Epratuzumab in non-Hodgkin's lymphomas. Curr Treat Options Oncol 2004; 5:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/45\">",
"      Goldenberg DM. Epratuzumab in the therapy of oncological and immunological diseases. Expert Rev Anticancer Ther 2006; 6:1341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/46\">",
"      Haas KM, Sen S, Sanford IG, et al. CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J Immunol 2006; 177:3063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/47\">",
"      Leonard JP, Coleman M, Ketas J, et al. Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 2005; 23:5044.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/48\">",
"      Manoussakis MN, Moutsopoulos HM. Antimalarials in Sj&ouml;gren's syndrome--the Greek experience. Lupus 1996; 5 Suppl 1:S28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/49\">",
"      Easterbrook M. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine. J Rheumatol 1999; 26:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/50\">",
"      Biyajima S, Osada T, Daidoji H, et al. Pulmonary hypertension and antiphospholipid antibody in a patient with Sj&ouml;gren's syndrome. Intern Med 1994; 33:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/51\">",
"      Bridges AJ, Burns RP. Acute iritis associated with primary Sj&ouml;gren's syndrome and high-titer anti-SS-A/Ro and anti-SS-B/La antibodies. Treatment with combination immunosuppressive therapy. Arthritis Rheum 1992; 35:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/52\">",
"      Friedman J, Larson W, Sorenson E, Ike R. How should peripheral neuropathy associated with primary Sj&ouml;gren's syndrome be treated? (abstract). Arthritis Rheum 1996; 39:S63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/53\">",
"      Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sj&ouml;gren syndrome: a randomized trial. Arch Intern Med 2002; 162:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/54\">",
"      Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sj&ouml;gren's syndrome. Am J Gastroenterol 1995; 90:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/55\">",
"      Tishler M, Alosachie I, Barka N, et al. Primary Sj&ouml;gren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol 1995; 13:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/56\">",
"      Jorgensen C, Legouffe MC, Perney P, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996; 39:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/57\">",
"      Garc&iacute;a-Carrasco M, Ramos M, Cervera R, et al. Hepatitis C virus infection in 'primary' Sj&ouml;gren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/58\">",
"      Verbaan H, Carlson J, Eriksson S, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sj&ouml;gren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/59\">",
"      Caron P, Lassoued S, Dromer C, et al. Prevalence of thyroid abnormalities in patients with rheumatoid arthritis. Thyroidology 1992; 4:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/60\">",
"      P&eacute;rez B, Kraus A, L&oacute;pez G, et al. Autoimmune thyroid disease in primary Sj&ouml;gren's syndrome. Am J Med 1995; 99:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/61\">",
"      Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sj&ouml;gren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/62\">",
"      Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sj&ouml;gren's syndrome-associated neuropathy. Brain 2005; 128:2518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/63\">",
"      Takahashi Y, Takata T, Hoshino M, et al. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sj&ouml;gren's syndrome. IV immunoglobulin. Neurology 2003; 60:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/64\">",
"      Levy Y, Uziel Y, Zandman GG, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 2003; 62:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/65\">",
"      Andonopoulos AP, Ballas C. Autonomic cardiovascular neuropathy in primary Sj&ouml;gren's syndrome. Rheumatol Int 1995; 15:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/66\">",
"      de Seze J, Delalande S, Fauchais AL, et al. Myelopathies secondary to Sj&ouml;gren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids. J Rheumatol 2006; 33:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/67\">",
"      Vaudo G, Bocci EB, Shoenfeld Y, et al. Precocious intima-media thickening in patients with primary Sj&ouml;gren's syndrome. Arthritis Rheum 2005; 52:3890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/68\">",
"      Tensing EK, Solovieva SA, Tervahartiala T, et al. Fatigue and health profile in sicca syndrome of Sj&ouml;gren's and non-Sj&ouml;gren's syndrome origin. Clin Exp Rheumatol 2001; 19:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/69\">",
"      Bonafede RP, Downey DC, Bennett RM. An association of fibromyalgia with primary Sj&ouml;gren's syndrome: a prospective study of 72 patients. J Rheumatol 1995; 22:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/70\">",
"      Tishler M, Barak Y, Paran D, Yaron M. Sleep disturbances, fibromyalgia and primary Sj&ouml;gren's syndrome. Clin Exp Rheumatol 1997; 15:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/71\">",
"      Kraus A, Cifuentes M, Villa AR, et al. Myositis in primary Sj&ouml;gren's syndrome. Report of 3 cases. J Rheumatol 1994; 21:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?2/14/2282/abstract/72\">",
"      Pijpe J, Meijer JM, Bootsma H, et al. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sj&ouml;gren's syndrome. Arthritis Rheum 2009; 60:3251.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14921 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-ADE86C94E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2282=[""].join("\n");
var outline_f2_14_2282=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26016048\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6865243\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6865250\">",
"      GENERAL PRINCIPLES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26015873\">",
"      IMMUNOSUPPRESSIVE THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015880\">",
"      Initial treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015887\">",
"      Refractory keratoconjunctivitis sicca",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7728805\">",
"      Treatment with biologic agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26015908\">",
"      - TNF inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015915\">",
"      Life-threatening disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015922\">",
"      Emerging therapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26015929\">",
"      - Rituximab",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26015936\">",
"      - Epratuzumab",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26015950\">",
"      TREATMENT OF EXTRAGLANDULAR MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015957\">",
"      Cutaneous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015964\">",
"      Arthralgia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015971\">",
"      Cardiopulmonary manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015978\">",
"      Renal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015985\">",
"      Gastrointestinal disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015992\">",
"      Endocrine disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26015999\">",
"      Neurologic manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26016006\">",
"      - Peripheral neuropathies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26016013\">",
"      - Autonomic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26016020\">",
"      - Central nervous system manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26016027\">",
"      Fatigue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26016034\">",
"      General anesthesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3652901\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26016048\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/9/43161?source=related_link\">",
"      Antimalarial drugs in the treatment of rheumatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35287?source=related_link\">",
"      Antiphospholipid syndrome and the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/22/18794?source=related_link\">",
"      Classification and diagnosis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16215?source=related_link\">",
"      Diagnosis and treatment of vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/57/30614?source=related_link\">",
"      Hypersensitivity vasculitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/22/11626?source=related_link\">",
"      Initial treatment of dermatomyositis and polymyositis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/53/42840?source=related_link\">",
"      Medical management of gastroesophageal reflux disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7369?source=related_link\">",
"      Overview of polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/45/43735?source=related_link\">",
"      Overview of the management of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/19/34105?source=related_link\">",
"      Overview of the treatment of primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=related_link\">",
"      Pathogenesis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44212?source=related_link\">",
"      Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/50/25386?source=related_link\">",
"      Primary angiitis of the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26681?source=related_link\">",
"      Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37466?source=related_link\">",
"      Therapy of diffuse or focal proliferative lupus nephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/46/5860?source=related_link\">",
"      Treatment of distal (type 1) and proximal (type 2) renal tubular acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=related_link\">",
"      Treatment of dry eyes in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=related_link\">",
"      Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/12/23754?source=related_link\">",
"      Treatment of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/52/36682?source=related_link\">",
"      Treatment of the mixed cryoglobulinemia syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f2_14_2283="Risk factors for DVT";
var content_f2_14_2283=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78473&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78473&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk factors for deep venous thrombosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        History of immobilization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Previous history of venous thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lower extremity trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malignancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Estrogen therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postpartum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stroke",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2283=[""].join("\n");
var outline_f2_14_2283=null;
var title_f2_14_2284="Risk acalculous cholecystitis";
var content_f2_14_2284=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F82539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F82539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk factors for acute acalculous cholecystitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Acute myelogenous leukemia&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acquired immune deficiency syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ampullary stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Burns",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiopulmonary resuscitation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Childbirth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Choledochal cyst",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cholesterol emboli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coronary heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cystic duct obstruction by a&nbsp;percutaneous transhepatic catheter in the bile duct",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        End-stage renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heart failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemobilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunosuppression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infections",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Major trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mechanical ventilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medications (eg, opiates, sunitinib)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metastases to porta hepatis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple transfusions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonbiliary surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sepsis/hypotension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Total parenteral nutrition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vasculitis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2284=[""].join("\n");
var outline_f2_14_2284=null;
var title_f2_14_2285="Risk factors for heat illness in children";
var content_f2_14_2285=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F73292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F73292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medical risk factors for heat illness in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Increased fluid losses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        GI or renal losses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Gastrointestinal illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Diabetes mellitus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Diabetes insipidus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Dehydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Insensible losses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Burns",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Febrile illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Increased sweating",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Cystic fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Congenital heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Impaired heat dissipation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ectodermal dysplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spinal cord lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Impaired thirst mechanism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Young children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Children with developmental delay",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Impaired temperature regulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anorexia nervosa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital or acquired brain injury with impaired hypothalamic function",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Environmental risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High heat index",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Poor preparation (lack of heat acclimitization, inadequate prehydration, lack of sleep or rest, or poor fitness)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excessive physical exertion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insufficient rehydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clothing or equipment that causes excessive heat retention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other or multiple mechanisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prescribed medications*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug abuse",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Juvenile hyperthyroidism (Grave disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prepubescent age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sickle cell disease and&nbsp;sickle cell trait&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GI: gastrointestinal.",
"     <br/>",
"     * Eg, dextroamphetamine for attention deficit disorder with hyperactivity, anticholinergic agents.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Eg, metamphetamine, cocaine.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Ishimine P. Hyperthermia. In: Pediatric Emergency Medicine, Baren JM, Rothrock SG, Brennan JA, Brown L (Eds), Saunders Elsevier, Philadelphia, PA 2008. p.992.",
"       </li>",
"       <li>",
"        Policy Statement - Climatic heat stress and exercising children and adolescents. American Academy of Pediatrics. Committee on Sports Medicine and Fitness and Council on School Health. Pediatrics 2011; 128: e741.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2285=[""].join("\n");
var outline_f2_14_2285=null;
var title_f2_14_2286="Prevalence of atrial fibrillation with age";
var content_f2_14_2286=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77268&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Prevalence of atrial fibrillation with age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 260px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a cross-sectional study of almost 1.9 million men and women, the prevalence of atrial fibrillation increases with age, ranging from 0.1 for those less than 55 years of age to over 9 percent in those &ge;85 years of age. At all ages, the prevalence is higher in men than women.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Go AS, Hylek EM, Phillips K, et al. JAMA 2001; 285:2370.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2286=[""].join("\n");
var outline_f2_14_2286=null;
var title_f2_14_2287="Gallstones OCG";
var content_f2_14_2287=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral cholecystogram showing gallstones",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 390px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An oral cholecystogram showing floating cholesterol gallstones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of of Salam F Zakko, MD, FACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f2_14_2287=[""].join("\n");
var outline_f2_14_2287=null;
